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INTRODUCTION 
Siddha medicine is of (some)2500 years ago, siddha means siddhi, 
which means achievement in life arts such as philosophy , 
yoga,wisdom,alchemy, medicine and above all the art of longevity. The  
concept of siddha based on 96 principles which is the base of human life. 
The persons who attained this siddhi are respectively called as 
siddhars who are also can be called as spiritual scientists. 
In old days siddha system received patronage of Tamil kings and 
general public all through. Yes it’s true it’s our medicine that is suitable for 
our climate, culture and so on. 
‘kWg;gJ cly;Neha; kUe;njd yhFk; 
kWg;gJ csNeha; kUe;njdr;rhYk;  
kWg;gJ ,dpNeha; thuhjpUf;f 
kWg;gJ rhit kUe; njdyhNk” 
- jpU%yh;;;; 
According to the above lines by thirumolar he states that medicine is, 
 That which cures the health problems 
 That which cures the psychic problems 
 Not only enriching physical and mental health and prevention of 
diseases.  
 Medicine is that mankind from death. Paving way to holistic health. 
The statement of Thirumolar gives a clear and brief knowledge about 
what is siddha system. 
The ancient Dravidian’s science is applicable to the Modern world 
also. This is evidence from WHO’s aims about holistic health. 
It is defined as sum of total knowledge,skills.and practices based on 
the theories, benefits and experiences indigenous to different culture. 
Whether explain or not, used in the maintains of health as well as in the 
prevention,diagnosis, improvement or treatment of physical and mental 
illness. 
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AIM & OBJECTIVE 
Now a days people are more attracted towards the herbal remedies due 
to the minimal unwanted side effects of the drugs.Herbal drug formulations 
are easily manufactured by simple pharmaceutical process in the form of 
powders ,decotions, syrups & ointments .  
The main aim and objective of the dissertation is to do a scientific 
review on the haemostatic activity of madulaipoochooranam (Flower of 
Punica granatum) based on its indication for kuruthimoolam in 
GunapadamMooligaivaguppu page no.749. 
The symptoms of Kuruthimoolam are, 
- njhg;Gspy; typj;J ntspf;F Nghk; Nghnjy;yhk; FUjp 
gPr;Rf;FoypypUe;J gPr;RtJ Nghyg; gPwpl;Lg; ghAk;. 
- Clypd; FUjp Fiwjy;> cly; ntSj;J td;ik 
,oe;J> if fhy; Xa;r;ry;> kaf;fk;> jiy Neha; fhZk;. 
The symptoms of Bleeding Piles (Haemorrhoids) are, 
 Bleeding Per Rectum (splash in the pan) 
 Anaemia 
 Tiredness 
These symptoms resemble with the symptoms of Kuruthimoolam.so 
the Kuruthimoolam can be correlated with Bleeding Piles (Haemorrhoids). 
Prevalence of hemorrhoids  
Although hemorrhoids occur in everyone.  They become large and 
cause problems in only 4% of the general population.  Hemorrhoids that 
cause problems are found equally in men and women, and their prevalence 
peaks between 45 and 65 years of age.  
This study is aimed at exposing the exemplary medicinal values of this 
drug. So far no scientific study has been done to prove the haemostatic 
activity of this drug. 
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In this dissertation work, Madulai poo chooranam is done with view to 
acsess. 
 Botanical aspect 
 Chemical aspect 
 Siddha aspect of the disease 
 Modern aspect of the disease 
 Gunapadam aspect  
 Bio chemical analysis 
 Pharmacological analysis 
 Microbiological analysis 
 Geo Chemical  analysis 
 Acute toxicity study 
 Clinical assessment 
 Bio statistical analysis 
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REVIEW OF LITERATURE 
1Botanical name : Punica granatum Linn 
  According to Bentham & Hooker’s classification punica granatum is 
classified as follows 
Kingdom  - Plant kingdom 
Division - Angiosperms  
Class  - Dicotyledons 
Sub-class - Polypeptalae 
Series  - Calyciflorae 
Order  -  Mystales 
Family - Lythraceae 
Genus - Punica 
Species - granatum 
Vernacular Names : 
Hindi  - Anar 
Beng  - Palim 
Mar  - Palimba 
Guj  - Dadam 
Tel  - Danimma 
Tam  - Madhulai 
Kan  - Dalimba 
Mal  - Matalam. 
Habitat : 
 In moral trypt China, Afghanistan, Pakistan, Bangladesh, Iran Iraq,  
India, Burma, Spain, Moroko, Baluchistan, Arabia and California. 
 In India, Maharashtra, Gujrat, Rajasthan, Karnataka, Punjab, Haryana, 
Tamilnadu, Andra  pradesh and Uttar pradesh. 
                                                           
1Hand book of Edible FruitsPage – 402-404 
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 It is an attractive chrunb or small tree, 6 to 10m tall, much branched, 
spiny and long lived. It has strong tendency to sucker from the base. 
Leaves: 
 Leaves are evergreen or deciduous, opposite or in words of 5-6 short 
stremmed, oblong  - lanceolate and leathery..  
Flowers 
Flowers are showy and characterized by the thick, tubular red calyx 
with pointed lepals. The flowers are bright red, 3 cm in diameter, with four 
to five petals (often more on cultivated plants). Some fruitless varieties are 
grown for the flowers alone. The edible fruit is a berry and is between a 
lemon and a grapefruit in size, 5–12 cm in diameter with a rounded 
hexagonal shape, and has thick reddish skin. The exact number of seeds in a 
pomegranate can vary from 200 to about 1400 seeds, contrary to some 
beliefs that all pomegranates have exactly the same number of seeds. Each 
seed has a surrounding water-laden pulp-the edible aril-ranging in color from 
white to deep red or purple. The seeds are embedded in a white, spongy, 
astringent pulp. 
Fruits 
Fruits are round with a longly leathery skin, yellow, light or deep pink 
or dark red in colour. The inner portion is separated by membranous walls 
and white spongy tissue into compartments packed with transparent sacs 
filled with flavourful, fleshy, juicy, red, pink or whitish pulp. In each sac, 
there is one white or red , angular, soft or hard seed. The  aril around the 
seeds from the ediple parts consist of delicious juice. 
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2Actions : 
Flower and Rind : 
 Astringent 
 Stomachic 
Stem Bark and Root Bark 
 Athelmintic 
Fruit 
 Refrigerant  
USES: 
 All parts of the tree can be utilized as source of tannin for curing 
leather. 
  Both the wind and the flowers yield dyes for textile. The juice is rich 
in citric acid and sodium citrate and used in the treatment of dyspepsia 
and leprosy. 
  The bark of the stem and root contains alkaloids like iso-pelletierine 
used against tape warms extracts of bark, leaves, imature fruits and 
fruit pind have been prescribed as astringent to half diarrhoea, 
dysentery & Haemorrhages.  
 Dried pulverized flower buds are administered against bronchitis. 
Detection of flowers is gargled to relieve oral and throat inflammation.  
 Tracks of different parts of the tree exhibited antibiotic activity. 
Extracts of whole fruit highly active against micrococus pyogenesvar 
aureus, E. Coli and Pseudomonas aeruginosa. 
 Fresh pomegranate juice is used as an ingredient of cooling and 
refrigerant mixtures and of some medicines for dyspepsia. 
 The rind is valued as an astringent in cases of diarrhoea & dysentery. 
                                                           
2Fzghlk; %ypif tFg;G gf;f vz; .750 
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 The expressed juice of the leaves and the young fruit and the 
decoction of the bark are seed in dysentry. 
 In java, an ink is sometimes arade from infusion of the leaves in native 
in egar. 
 The sweet types of pomegranate said to be acidly laxative, while the 
less sweet types are believed to be good in inflammation of stomach 
and in head pain. 
 The powered flower buds are used in bronchitis. The seeds are 
considered to be stomachic and the pulp cardiac and stomachic. 
3In Ayurvedic medicine  
 The rind of the fruit and the bark of the pomegranate tree is used as a 
traditional remedy against diarrhoea, dysentery and intestinal 
parasites. 
 The seeds and juice are considered a tonic for the heart and throat, and 
classified as a bitter-astringent (pitta or fire) component under the 
Ayurvedic system, and considered a healthful counterbalance to a diet 
high in sweet-fatty (kapha or earth) components. 
 The astringent qualities of the flower juice, rind and tree bark are 
considered valuable for a variety of purposes, such as stopping nose 
bleeds and gum bleeds, toning skin, (after blending with mustard oil) 
firming-up sagging breasts and treating hemorrhoids. Pomegranate 
juice (of specific fruit strains) is also used as eyedrops as it is believed 
to slow the development of cataracts. 
 Pomegranate has been used as a contraceptive and abortifacient by 
means of consuming the seeds, or rind, as well as by using the rind as a 
vaginal suppository. This practice is recorded in ancient Indian literature, in 
Medieval sources, and in modern folk medicine. 
 
                                                           
3
 www.wikipedia.com 
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4Potential health benefits 
In preliminary laboratory research and clinical trials, juice of the 
pomegranate may be effective in reducing heart disease risk factors, 
including LDL oxidation, macrophage oxidative status, and foam 
cellformation. In mice, "oxidation of LDL by peritoneal macrophages was 
reduced by up to 90% after pomegranate juice consumption...". 
In a limited study of hypertensive patients, consumption of 
pomegranate juice for two weeks was shown to reduce systolic blood 
pressure by inhibiting serum angiotensin-converting enzyme. Juice 
consumption may also inhibit viral infections while pomegranate extracts 
have antibacterial effects against dental plaque.  
Despite limited research data, manufacturers and marketers of 
pomegranate juice have liberally used evolving research results for product 
promotion, especially for putative antioxidant health benefits. In February 
2010, the FDA issued a Warning Letter to one such manufacturer, POM 
Wonderful, for using published literature to make illegal claims of unproven 
antioxidant and anti-disease benefits. 
Nutrients 
That fiber, however, is entirely contained in the edible seeds which 
also supply unsaturated oils. People who choose to discard the seeds forfeit 
nutritional benefits conveyed by the seed fiber, oils and micronutrients. 
5Nutritive Value (per 100gm of edible portion)  
Moisture  - 78gm 
Protein  - 1.6gm 
Fat   - 0.10gm 
Minerals   - 5.10gm 
Phosphorus  - 0.07gm 
                                                           
4
www.google.com 
5The pomegranate pg – 1Author –  M.K.Sheikh 
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Iron   - 0.30gm 
Riboflavin  -  100mg 
Vitamin C  -  16mg 
Seeds 
 Astringent 
 Athelmintic 
 Toenifuge 
 Aphoridisiac 
6Climate & soil  
Pomegranate is basically a crop of acid and semiarid region and it 
requires hot dry summer and cold winter for production of quality fruits. A 
temperature of 35 to 380 is ideal for quality fruit production. Cool winter and 
hot summer is favourable for this crop. It can be grown in tropical & sub 
tropical parts of  North eastern hill Region upto an attitude of 1000m from 
sea level. In a sub – tropical climate, it flowers in the spring but in tropical 
climate it flowers through out the year. However flowers of early rainy 
season give a quality in November – December. 
Propagation : 
 Basal step Cuttings with a diameter of 1.0 to 1.25 taken during rainy 
season and maximum success is achieved with the treatment of IBA at 
5000ppm. It is also propagated by air layering. Air layering during Rainy 
season and November & December gives profuse Rooting.  
 
 
 
 
 
                                                           
6.Wealth of India Page. 317. 
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PHYTOCHEMICAL STUDY 
 Pomegranate aril juice provides about 16% of an adult's daily vitamin 
C requirement per 100 ml serving, and is a good source of vitamin B5 
(pantothenic acid), potassium and natural phenols, such as 
ellagitannins and flavonoids.  
 Analysis edible portion of pomegranates from coonoor give moisture -
78.8, protein – 1.6, fat – 0.4, fibre – 5.1, other carbohydrates 14.5 & 
Mineral matter 0.7%, calcilum 18, Magnesium 12, oxalic acid 14, 
phosphorus 78.6, Iron – 0.3, sodium – 0.9, potassium – 33.6, copper – 
0.2, sulphur – 12, chlorine – 2.8, carotene – 8, thiamine – 0.06, 
Ribothamine – 0.10, xlicotinic acid – 0.30, & vit C – 14mg/100mg.  
 The fresh rind of the fruit contains wax 0.8, Resins – 4.5, mannitol – 
1.8, non – crystallized sugars – 2.7, gums – 3.2, insulin – 1.8, 
mucilage – 0.6, mannin – 16.4, gallic acid – 4, calcium oxylate 4.8%. 
 The following alkaloids have been Reported as occuring in the bark. 
Pelletierine (C8H15ON) – isopelletierin (C8H15ON) Pseudopelletierine 
(C9H15ON) Methyl pelletreuine (C9H17ON) & Methyl isopelletierine 
(C9H17ON). 
 D – mannitol occurs abundantly in the stem bark and in lesser 
amounts in Root bark, seeds & leaves. 
 Biological tests indicate that mannitol possess mild anti spasmodic & 
anthelminetic properties. 
 Frieldelin & betulic acid are reported in the bark, betulic and ursolic 
acid in the leaves and ursolic acid in the fruit kind 
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GUNAPADAM ASPECT 
7khjis 
Tamil name  :  khjis 
 Botanical name     :         Punica granatum. Linn 
 
NtW ngah;  : jhbkk;> gPrGuk;> khJsq;fk;> khJsk;> 
khJSq;fk;. fOKs; 
Eng   :  Pomegranate,  
Tel   : Danimna, 
Arab   : Rumaman 
Mal   : Mathlam 
Pers   : Gulmarn  
Kan   : Dalimba 
Hid   : Anar 
Sans   : Shukhdana 
Duk   : Darim 
khJis : 
 ,J> rpW kutFg;igr; Nrh;e;jJ. Kf;fpakha; Mg;fhdp];jhdk;> 
ngYrp];jhdk;> ghurPfk; Kjypa ,lq;fspy; msT fle;J 
tsUfpd;wJ. ,e;jpahtpy; vy;yhtplq;fspYk; gaphplg;gl;L tUfpwJ. 
(,jpy; ,dpg;G khjis> Gspg;G khjis> G+ khjis vd;W 3 
tFg;GfSz;L). 
g.c :- G+> gpQ;R> gok;> tpij> gl;il> goj;Njhy; 
ORGANOLEPTIC CHARACTERS :- 
gl;il;;;     
(TASTE)Rit    -     Jth;g;G  (ASTRINGENT) 
(POTENCY)jd;ik    -  jl;gk; (COOLENT) 
                                                           
7Gunapadam Mooligai VaguppuPage 749,750,751,752,753 
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(BIO TRANSFORMATION)gphpT -  fhh;g;G (PUNGENT) 
gok;> tpij;;;  : 
(TASTE) Rit    -      ,dpg;G (SWEET) 
(POTENCY)jd;ik   - jl;gk; (COOLENT) 
(BIO TRANSFORMATION)gphpT -  ,dpg;G (SWEET) 
nra;if :;;;  
nghJ    
Astringent  - Jth;g;gp   -  ]q;Nfhrdfhhp  
Styptic  - FUjpg;ngUf;flf;fp  -  uj;j];jk;gdfhhp  
G+> goj;Njhy;; ;; ;; ;   
Astringent  - Jth;g;gp   -  ]q;Nfhrdfhhp 
Stomachic  - grpj;jPj;J}z;b  -  [luhf;dpth;j;jpdp 
kug;gl;il Nth;g;gl;il; ; ; ; ;; ; ; ; ;; ; ; ; ;  
Anthelminitic  - GOf; nfhy;yp  -  fpUkpehrpdp 
gok; ;;;  
Refrigerant  - Fsph;r;rpAz;lhf;fp  -  rPjsfhhp 
tpij 
Astringent   - Jth;g;gp   -  ]q;Nfhrdfhhp 
Anthelminitic  - GOf; nfhy;yp -  fpUkpehrpdp 
Toenifuge  - rhaNkw;wp   
Aphoridisiac  - Mz;ik ngUf;fp 
tPhpak; P ;P ;P ; - jz;ik (FspHr;rp); ;; ;; ;  
jz;ik tPhpaj;jpd; njhopy;:; P ; ; ;; P ; ; ;; P ; ; ;  
kdf;fspg;G> MAs;tpUj;jp> jk;gdk; Mfpa fhhpaq;fisr; 
nra;Ak;. ,uj;jk;> gpj;jk; Mfpatw;iwg; Nghf;Fk;.  
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8T.V.rhk;grptk; gps;is; ; ;; ; ;; ; ;  mth;fs; khJisapd; tiffisg; gw;wp ; ; ; ; ;; ; ; ; ;; ; ; ; ;
gpd;tUkhW $wpAs;shh; :; ; ;; ; ;; ; ; - 
1. G+ khjis>a male variety of pomegranate 
2. Gspg;G khjis>which bears only sour fruits; fruits useful in vomiting 
3. jpj;jpg;G khjis>which bears only sweet fruit, fruits are used as tonic 
4. nfhb khjis> rPjsq;fha;>a variety of citrus 
5. nfhk;kl;b khjis>a variety of citrus 
6. jhJ khjis>same as G+ khJis-Punica granatum 
7. tay; khjis 
8. nts;is khjis>one with white pulpy seeds. 
9. rPik khjis – cynodia vulagaris 
10. jhb khjis – Punica Granatum 
11. rpfg;G ,ul;il khjis - a male variety of Pomegranate. 
khJis G+ 
 Fzk; : ,jdhy;> FUjp the;jp. tapw;Wf; fLg;G> ntg;gk;> FUjp> 
%yk; ,it NghFk;. ,J FUjpia ngUf;Fk;. td;ikiaj; jUk;.  
‘ the;jpgpj;j NjhlnkhL khwhf; fLg;gdyQ; 
  Nrh;e;Jepd;w %yuj;je; jPh;f;Fq;fhz; - khe;jsph;f;if  
khNj! Apuj;jG~;b ty;ygyd; cz;lhFk; 
  G+jyj;Js; khJisapd;G+.” 
gpQ;R;;;  
,jdhy; fopr;ry; tiffs; ahTk; NghFk;. 
 ‘kyf;fopr;ry; rPjj;jhy; te;j fopr;ry; 
ryf;fopr;ry; Nrhhpahw; rhUk; - gyf;fopr;ry;  
khSk; Gspg;ghd khJsk; gpQ;irAz;z  
MSk;fz; khNj! Mwp.” 
gok;;;; 
“khJisf; fdpAz kjdfh NkRuj; 
#njd thAsh; nrhy;Yth; kpf;fNt” 
                                                           
8T.V.rhk;grptk; gps;is mfuhjp ghfk; - 5 gf;fk; vz;.906 
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(nghUs;) : khJsk; goj;ijj; jpdKk; Grpj;Jthpd;> Mz;ikg; 
ngUf;F Kjypad cz;lhFk;. 
 ,g;goj;jpdhy;> Kg;gpzp Ruj;jpy; fhz;fpd;w the;jp> ePh; Ntl;if 
,itfs; NghFk;. gps;is cz;lhfhkw;gb nra;fpd;w #yfNehiag; 
Nghf;Fk;. md;wpAk; tha; ePh; Cwy;> tpf;fy;> ke;jk;>  ntg;gj;jhy; 
cz;lhd fha;r;ry;> neQ;nrhpT> fhjilg;G> kaf;fk; ,it NghFk;. 
NkYk;> cly; Fsph;r;rpailAk;> Nkw;$hpa gz;Gfisg; ngwj jhdhfg; 
gOj;J ntbj;j khJisapd; Kj;Jfis vLj;Jj; Jzpapypl;L 
gpire;J rhNwLj;J Ntz;ba msT fw;fz;L $l;b clNd Fbj;jy; 
Ntz;Lk;. 
 “ rq;ifawr; nrhw;wtph;f;FQ; rd;dpah rQ;rh;j;jp 
  Aq;ifajp jhfkikr; rhUNkh – fq;if  
,Ue;jhb kf;fl; fpuj;jiyr;nra; Neha;Nghk; 
,Ue;jhb kf;fdpfl; nfz;” 
 
 “tha;ePU wy;frg;G the;jptpf;fy; ke;jkpf;f 
 fha;ntg;gk; neQ;nrhpT fhjilg;Gk; - Xah 
kaf;FKe; jPh;e;JtpLk; khJsk; goj;jhy; 
jaf;fkwj; NjnkhopNa! rhw;W. 
G+it cyh;j;jpr; #uzpj;J mjpy; 4 fp vLj;J Ntyk; gprpd; J}s; 
4fp> mgpd; 195kp.fp> Nrh;j;J> Ntisf;F 260-390 tPjk; nfhLj;J tu> 
rPjf;fopr;ry;> FUjpf;fopr;ry;> FUjp ePh;> ,uj;j %yk; ,it ePq;Fk;. 
gpQ;irf; FbePhpl;L rPjNgjp> mjprhuk; KjtpaitfSf;Fk; 
nfhLg;gJ ehl;L tof;fk;. 
(t-F):- ,jd; gor;rhw;wpy; fw;fz;L Nrh;j;J kzg;ghF nra;J 
mUe;j> moiyg; Nghf;Fk;> Fsph;r;rpia cz;Lgz;Zk;>Ruk;> moy;> 
jhfk; ,it ePq;Fk;. 
 gor;rhw;iw ,isg;G Nehapdh;f;Ff; nfhLf;f> kpFe;ej ed;ik 
jUk;. Fzj;jpd; fPo;f;fz;l Neha;fis tpyf;Fk;. 
 goj;NjhYld; rpwpJ ,ytq;fk;> ,ytq;fg;gl;il eRf;fpg; 
Nghl;L Kiwg;gb FbePhpl;L 15-30 kp;yp tPjk; jpdk; 3-4 Ntis 
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nfhLj;J tu> ehl;gl;l rPjf;fopr;ry; ePq;Fk;. goj;Njhy;> 
kq;F];jhd; goj;Njhy; ghiy kug;gl;il tiff;F 40fp vLj;J 
>1400kp.yp ePh; tpl;L Kiwg;gb FbePhpl;L mjpy; 15-30 kp.yp. 
nfhLf;fyhk;. 
 NkYk; gytpjf; fopr;ry;fSf;F Jth;g;G kUe;J 
Ntz;bajhapUf;Fk; NghJ ,ij nfhs;syhk;. 
 goj;Njhiy cyh;j;jpg; nghbahf;fp toq;fyhk;. 
 goj;Njhy; nghb 17fp> nts;isg; Nghsk; 17fp. rPikr; 
Rz;zhk;Gj;J}s; (prepared chalk) 34fp Nrh;j;J fye;J gy; 
Jyf;f> gy; typ NghFk;.  
 Nth;g;gl;il> xUgq;F> ePh; ,UgJ gq;F tpl;Lr; rpwpJ ,ytq;fk; 
Nrh;j;J> vl;by; xd;whf fha;f;fpf; nfhLf;f> jl;ilg;GO tpOk;. 
“ntbj;JtPo; goj;ij thq;fp nky;ypa rPiy fl;b 
fLf;nfdg; gpope;J nfhz;L fz;lrh;f; fiuAq; $l;bf;  
Fbj;jpl ntbg;G khWq; Fsph;e;jpLk; mq;f nky;yhk; 
tbj;jjed; nkhopap dhNs! khJsk; goj;jpd;rhNw. 
(Nj-F) 
(t-F) :- G+ nkhf;if cyh;j;jpg; nghbj;J – 130 kp;fp.nfhLf;f ,Uky; 
ePq;Fk;. 
khJsk; gpQ;Rf; FbePh;; ; ; P ;; ; ; P ;; ; ; P ; 
“Kfkh Jisg;gpQ; rjptplak; Kj;jf; fhR ngUkuj;Njhy; 
jifNrh; Rf;F tpsq;fhapd; rijNah nuhd;W foQ;rpuz;L 
tifaha;f; $l;b apUehop Aof;fha;f; fha;r;rpg; NghjUe;e  
gifaha; tUkjprhuRuk; NghFk; ghhpw; ghhPNu”. 
nghUs;:;;; - 
khJsk;gpQ;R> mjptplak;> Kj;jf;fhR> ngUkuj;Njhy;> Rf;F> 
tpshq;fha;j;jir ,it xt;nthd;wpYk; ,uz;buz;L 
foQ;RfnsLj;J xd;W Nrh;j;J> ,uz;L ehop ePh; tpl;L mij 
cof;fha;f; FWf;fpf; Fbf;f> fopr;ry; Ruk; gwe;J NghFk;. 
khJsk; gpQ;R :; ;; ;; ;  
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 Nkw;gb nghbAld;> Vyf;fha;j;J}s;> frfrhj;J}s;> 
Fq;fpypaj;J}s; xnuil Nrh;j;J> 65 kp.fp. msT jpdkpUNtis 
nfhLj;J tu ehl;gl;l ngUq;fopr;ry;> rPjf;fopr;ry; ,it 
ePq;Fk;.  
 G+tpd; rhWk; mWfk;Gy;ypd; rhWk; Xnuil Nrh;j;Jf; nfhLf;f 
%f;fpypUe;J FUjp tbtJ ePq;Fk;. 
 Nkw;$wpa G+itAk; Gy;iyAk; Fb ePhpl;L nghhpj;j ntq;fhuk; 
rpwpJ $l;b> tha; nfhg;Gspj;J tuj; njhz;il Neha; ePq;Fk;. 
,jid 15-30kp.yp tPjk; fhiyapy; ntWk; tapw;wpy; ,uz;L 
kzpf;nfhU jlitahf MWjlit Fbj;Jf; nfhz;Nl te;J> 
filrpj; jlitapy; fopr;riy cz;lhf;Fk; kUe;Jfisf; 
nfhLf;f GO ntspahFk;. 
 Nkw;gb FbePiuf; Foe;ijSf;Fz;lhFk; ,Uky; Neha;> fz; 
Neha;> nghpath;fSf;Fz;lhFk; ehl;gl;l Ruk;> Kiwr;Ruk;> 
kz;zPuy; jhgpjk; ,itfspdhYz;lhFk; FUjpaoy; Kjypa 
Neha;fSf;Fk; toq;fyhk;. 
khJsq; FbePh;; P ;; P ;; P ; 
“khJsq; flk;G Gd;fpd; tha;j;jNjth; jpg;gpyp aj;jpj; 
jPjWq; nfhOe;J Rf;Fjphpgiytp Fk;gpf; $l;b 
ePjpah apuz;L ehop ePUof; fhf;fpf; nfhz;lhy; 
#jpiz Kiyap dhNs Rukjp rhuk; NghNk” 
 nghUs; :;;;  khJsk;> flk;G> Gd;F> ,tw;wpd; Nth;fs;> jpg;gpyp> 
mj;jpf; nfhOe;J> Rf;F> jphpgiy Mfpa ,it xt;nthd;iwAk; xNu 
vilapy; Nrh;j;J 4 ypl;> ePh;tpl;L mij 1 ypl;luhfr; Rz;l itj;J 
mUe;jpy;> Ruf;fopr;ry; jPUk;. (Njud; - E}W) 
khJsk; g;;; l;il;;;  
 gl;ilr;rhW 17 fpuhk; nfhLf;f> mJ tapw;Wg; GOitf; 
nfhy;Yk; 
tpij 
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 tpijahdJ ePh;j;Jg;Nghd nte;ePiu ,Wf;Fk;. nts;isapy; 
fhZk; ePh; fLg;ig ePf;Fk;. ,t;tpij> clw;F Cl;lj;ijAk; 
Mz;ikiaAk; cz;lhf;Fk; gy tpj ,Nyfpaq;fspy; NrUk;.  
 “Rf;fpyj;ij fl;Lke;jr; Rf;fpyNjh lk;Nghf;Fk; 
 mf;fzNk ff;fLg;ig Mw;Wq;fhz; - vf;fhYq; 
 NfhJdj;njz; zhjkyh;f; nfhk;gisa khNj!nrk; 
 khJsj;jpd; gPr typ” 
khJis kuj;jpd; Nth; gpQ;R; ; ; ;; ; ; ;; ; ; ;  
 khJisNth;> gpQ;R ,itfspdhy; the;jp> mjprhuk;> ePq;Fk;. 
goj;jpdhy; jhJ> Mz;ik tpUj;jp cz;lhFk;. jhfk; NghFk;. ,iy> 
fha;> kyh; ,itfspdhy; Kw;$wpa Neha;fs; ahTk; tpyFk;. 
“khJisNth; gpQ;rpitf;F the;epajp rhuk;Nghk; 
jhJTkhk; mf;fdpf;Fj; jhfk;Nghk; - #ijepfh;  
td;dKiy aha;! ,iyfha; khkyh;f Sf;FKdQ: 
nrhd;dit nayhk; NghFQ; nrhy;” 
khJsk;goj;jpd; XL; ; ;; ; ;; ; ; (Punica Granatum – Dried rind) 
‘rPuhf;Fk; tha;g;Gz;izr; rPjKld; uj;jnkdg; 
Nguhf;Fk; Ngjpfisg; NgRq;fhy; - Neuhf;Fk; 
jhJNk Nyhq;Fk; jdpahj jhfkWk;  
khJsj;jpd; ew;fdpj;Njhy; khz;G” 
Fzk; ;;; :- khJsk;goj;jpd; Nkw;Nwhypdhy; tha;g;Gz;> rPjNgjp> 
uj;jNgjp>Kjypaitfs; Nghk;.jhJ gyg;gLk; vd;f. 
nra;if;;; : rq;Nfhrdfhhp> tpajhNgjfhhp 
cgNahfpf;Fk; Kiw:; ;; ;; ; -  
 cyh;e;j khJsk;goj;jpd; Njhiy ,bj;J> 2½&gha; vil 
#uzj;ij xU gofpd kl;Flitapy; Nghl;L ½ gb ryk; tpl;L> 15-20 
epkp~k; nfhjpf;f itj;J tbfl;b itj;Jf;nfhz;L Ntisf;F 1 - 
1½  mTd;]; tPjk; jpdk; 3 Ntis cs;Sf;Ff; nfhLj;J tur; 
rPjNgjp> uj;jNgjp Kjypaitfs; NghFk;. ,e;jf; fpahoj;ijf; 
nfhz;L tha; nfhg;Gspj;J tu tha;g;Gz;> kUe;Jfspd; 
tPwpdhYz;lhd tha; Ntf;fhL Kjypaitfs; FzkhFk;.  
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khJsk; gpQ;R ; ;; ;; ;  
“kyf;fopr;ry; rPjj;jhy; te;j fopr;ry;  
ryf;fopr;ry; Nrhhpahw; rhUk; - gyfopr;ry; 
khSk; Gspg;ghd khJsk;gpQ; rhyapiy 
ahSq;fz; khNj awp.” 
Fzk;:;;; - 
 GspkhJsk; gpQ;rhy; kyk;> rPjk;> ryk;> uj;jk;> ,itfspdpwkhf 
Mfpd;w gw;gy mjprhu Nuhfq;fs; jPUk;.  
nra;if:;;; - 
 rq;Nfhrdfhhp> tpajhNgjfhhp 
cgNahfpf;Fk; Kiw :; ;; ;; ; - 
Gspg;Gr; RitiaAila khJsk; gpQ;irAyh;j;jp mjd;Nky; 
Njhiy ,bj;Jr; #uzk; nra;J itj;Jf; nfhz;L> Ntisf;F 10-15 
Fd;wp vil japhpy; fyf;fpf; nfhLf;f rPjNgjp> uj;jNgjp> 
epth;j;jpahFk;. ,jd; gpQ;Rf;fhia miuj;J xU rpW vYkpr;rq;fha;g; 
gpukhzk; japhpy; fyf;fpf; nfhLf;fr; rPjNgjp> uj;jNgjp Kjypaitfs; 
FzkhFk;. Gspg;G khJsk; gpQ;R fpilf;fhj rkaj;jpy; rhjhuz 
khJsk; gpQ;irf;$lg; gpuNahfj;jpy; Nrh;j;Jf; nfhs;syhk;. 
khJsk; G+;;;  
“the;jpgpj;j NjhlnkhL khwhf; fLg;gdyQ; 
Nrh;e;Jepd;w %yuj;je; jPh;f;Fq;fhz; -khe;jsph;f;if 
khNj fiwg;G~;b ty;ygy Dz;lhf;Fk;  
g+jyj;Jd; khJisapd; G+” 
Fzk; :;;; - 
 khJsk; G+ gpj;jthe;jp> tapwisjy;> ntg;gk;> uj;j%yk; 
,itfisg; Nghf;Fk;. uj;jg; G~;biaAk;> gyj;ijAk; jUk;. 
nra;if:;;; - 
 rq;Nfhrdfhhp> tpajhNgjfhhp 
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cgNahfpf;Fk; Kiw:; ;; ;; ; - 
 khJsk; G+> khJsk; gpQ;R> khJsk; jsph; ,itfisj; 
jdpj;jdpahfthtJ (m) xU kpf;fr; Nrh;j;jhtJ miuj;Jj; japhpy; 
fyf;fpf; nfhLf;f uj;jNgjp> rPjNgjp Kjypaitfs; NghFk;.  
9khJis tpj;J;;;  
“Rf;fpuj;ijf; fl;Lke;jr; Rf;fpyNjh ~k;Nghf;F 
kf;fzNk ff;fLg;ig ahw;Wa;fh – nzf;fhYq; 
NfhJsj;njz; Zjkyh;f; nfhk;gidaha; jpj;jpf;F 
khJdj;jpd; gPr typ.” 
Fzk;:;;;  
 ,dpg;Gs;s khJsk; tpj;jhdJ Rf;fpyj;ij ,Wf;FtJe;jtpu> 
mjpYs;s Fw;wj;ijAk; gpuNkfr; RWf;ifAk; ePq;Fk;. 
nra;if:;;;  
rq;Nfhrdfhhp. 
cgNahfpf;Fk; Kiw:; ;; ;; ;  
 ,jidg; gRtpd; ghy;tpl;L miuj;Jg; ghypy; fyf;fpr; rhg;gpl 
Nkff;fLg;G> Rf;fpy e~;lk; Kjypatw;iwg; Nghf;FtJld; kyj;ijf; 
fl;Lk;. 
 
 
 
 
  
                                                           
9fz;Zrhkp gps;is. Rp gjhh;j;j Fz tpsf;fk; (%yth;f;fk;) Pg – 593,594 
 
20 
 
khjis NrUk; %yj;jpw;fhd kUe;Jfs;; ; ; ; ;; ; ; ; ;; ; ; ; ; 
1. 10Rz;iltw;wy; #uzk;; ; ; ;; ; ; ;; ; ; ; 
Rz;iltw;wy; 
fwpNtg;gpiy 
khk;gUg;G 
Xkk;     1 ghfk;  
ney;yp tw;wy; 
khJsk;goj; Njhy; 
nte;jak;  
nra;Kiw;;;  
Nkw;$wpa ruf;Ffisf; fhaitj;J> gpwF ,stWg;gha; tWj;J> 
ed;whf ,bj;Jg; nghbj;J rypj;J itf;fTk;. 
msT 
1-2 fpuhk; 
Jiz kUe;J;;;  
vUikj;japh; 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ;  
nghUky;> ke;jk;> ,iur;ry;> fopr;ry;> vUtha; %is Neha;> 
ngUq;fopr;ry;> epzf; fopr;ry;> 
2. 11%y epthuz Nyfpak;  
msT:  
 nfhl;il ghf;F msT> 2 Ntis 7 ehs; 
jPUk;Neha;:P ; ;P ; ;P ; ;  
,uj;j %yk;> rPo; %yk;> Mrir fLg;G> %yf;fpuhzp  
  
                                                           
10(Njiuah; fhpry; 300 gf;fk; 88) 
11itj;jpa rhu rq;fpufk; gf;fk; -261 
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3. 12K];jhhp~;gk;; ; ;; ; ;; ; ; 
msT: 
 ½ Kjy; ¾ gyk; 2Ntis 
jPUk;Neha;fs;:P ; ; ;P ; ; ;P ; ; ;  
mjprhuk;> ntsp%yk;> cs;%yk;> fpuhzp> Fd;kk; Kjypad 
jPUk;> grp cz;lhFk;.  
gj;jpak;:; ;; ;; ;  
 ,r;rhgj;jpak; 
4. 13 rfy fpuhzp> mjprhuk;> tapw;W ,iur;ry;> fopr;ry;>; ; ; ; ; ;; ; ; ; ; ;; ; ; ; ; ;  rPjk;> P ;P ;P ;
,uj;jk; tpOjy;> %yf;fLg;G> tapw;Wf; fLg;Gf;F; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; . 
 khJsk;gpQ;R> tpy;tg;gpQ;R> tpshk;gpQ;R> khk;gUg;G> 
,ytk;gprpd;> neUq;fpf;fha;> mj;jpgpQ;R> ngUkuj;Jg;gl;il> 
Gspatiuj;Njhy;> nghd;KRl;ilNth;> ehtw;gl;il> 
eha;f;fLF>rhjpf;fha;> rhjpgj;jphp> FNuhrhzp Xkk;> ngUq;fhak;> 
,itfs; nta;apy; cyh;j;jpf; J}s; nra;J nfhs;sTk;. 
msT: 
 jphpfb tPjk; 
mDghdk;:;;;  
 vUik Nkhhpy; cl;nfhz;L tuj; jPUk;.  
 5.14khJsk;goj;Njhy;> tpy;tg;gpQ;R> fhl;lhj;jpnkhf;F> fLF> 
nghd;KRl;il Nth;> Kj;jf;fhR> Gspatpiuj;Njhy;> ,ytq;fk;> 
,ytk;gprpd;> xkk;> FNuhrhzp> jphpfLF> ntl;ghiyahprp> 
Misj;jpg;gpyp> ntw;gl;il> ngUkuj;Jg;gl;il> khk;gUg;G> fow;gUg;G> 
fUq;fhyp tapuk;> nts;sp Nyhj;jpuk;> ePh;Ks;sp tpiu> mjptpilak;> 
fUQ;rPufk;> ew;rPufk;> fhRf;fl;b> ,itfis ePh; epiwaha;g; nghbj;J 
nfhs;sTk;. 
  
                                                           
12fz;Zrhkpg; guk;giu itj;jpak; gf;fk; 478 
13itj;jpa rhu rq;fpufk; gf;fk; 283 
14itj;jpa rhu rq;fpufk; gf;fk; 284 
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mDghdk;:;;;  
 ney;ypf;fha;r; rhW> japh;  
msT:  
 fow;rpf;fha; gpukhzk; cUz;il  
jPUk; Neha;:P ; ;P ; ;P ; ;  
 rfy fpuhzp> mjprhuk;> tapw;W ,iur;ry;> fopr;ry;> rPjk;> 
,uj;jk;> %yf;fLg;G tapw;W fLg;G. 
156. %yf;fLg;G tiuf;fLg;gpw;Fr; #uzk;:; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ;  
 ,ytk;gprpd; 
 khjsk; xL 
 rhjpf;fha; 
 rPufk; 
 tpshk;gprpd; 
 fpuhk;G 
 rhjpg;gj;jphp 
,itfisr; rhpnail vLj;Jg; nghb nra;J itj;Jf; 
nfhs;sTk;> nghd;KRl;il Nth;> eWf;fp 8 gq;F Rj;j [yk; tpl;L 
vl;nlhd;whfg; fha;r;rpa f~haj;Jld; Kd;nrhd;d J}is %tpuy; 
nfhs;SkhTg; Nghl;L fyf;fpf; fhiyapYk; khiyapYk; 4 my;yJ 5 
ehl;fs; gUfTk;. %yf;fLg;G> iffz;lJ> tapw;Wg; fLg;Gfs; jPUk;.  
khJis NrUk; gpw kUe;Jfs; ; ; ;; ; ;; ; ;  
1. 16kfh Vyhjp #uzk;:;;;  
msT: 
 jphpfbg; gpukhzk; 
mDghdk;: ;;;  
 me;jp re;jp Neha;fSf;F Vw;wthW 
 Kiyg;ghy;>Njd;> VYkpr;rk; gor;rhW> khJisg; gor;rhW. 
                                                           
15ruNge;jpu itj;jpa Kiwfs; gf;fk; 298 
 
16guk;giu itj;jpak; gf;fk; 104 
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jPUk;Neha;:P ; ;P ; ;P ; ;  
 Njf vhpT> jhfk;> kaf;fk;> gpj;jj; jiytyp> m];jpRuk;> thA> 
tp~fuk;><is> ,Uky; tapw;Wg;gprk;> neQ;nrhpT. 
2. 17rfy fpuhzpf;Fk rhjpypq;f khj;jpiu:; ; ;; ; ;; ; ; - 
msT:- ghrpg;gapW khj;jpiu msT ; 2 Ntis ; 10 ehl;fs; rhg;gplTk;.  
jPUk; NehaP ;P ;P ; ; :- fpuhzp 
3. 18rh;t fpuhzpf;Fk; cUz;il; ; ; ;; ; ; ;; ; ; ;  :- 
msT:- J}jtpsq;fha; gpukhzKs;s khj;jpiu cUz;il 3 Ntis. 
mDghdk;:;;; - 
 japh; ePh; jdpNth (m) mUs;thjpf; f~ahj;jpNyh 
jPUk; Neha;:P ; ;P ; ;P ; ; - 
 fpuhzp 
194. fzk; vdg;gl;ljpw;nfy;yhk; vz;nza; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; ; 
msT:- 
 fhrsT cs;Sf;Fk;> NkYf;F G+r  
jPUk; Neha;:P ; ;P ; ;P ; ; - 
 fz;#Lj; jPUk;  
205. th;khzpf; Fspif; ;; ;; ; :- 
msT:-  gawsT khj;jpiuahf cUl;b nfhs;sTk;.  
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 <is> ke;jhufhrk;> mj;jpRuk;>Rthrfhrk;> cs;th;kk;><L Kjypa 
Neha;fs; jPUk;.  
  
                                                           
17ruNge;jpu itj;jpa Kiwfs; - 76pg. 
18ruNge;jpu itj;jpa Kiwfs;  Pg – 137. 
19fh;g;gpzp ghyNuhf rpfpr;ir  pg. 199.  
20rpj;j kUj;Jtk; (rpwg;G) lhf;lh; M. jpahfuh[d;> vy;>I.vk; 
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216. ma nkOF:- 
msT:- 2 Kjy; 4 fpuhk;  
Jiz kUe;J:;;; - nea;>Njd;> Nrhk;Gf; FbePh;> Rf;Ff; FbePh;  
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 vz;tifg;ghz;L> gpj;jntl;il> Nrhig> fhkhiy 
gj;jpak;:; ;; ;; ; - 
 magw;gj;jpw;Ff; $wpathW nfhs;f.  
7. 22Foe;ijfspd; tapw;Wf; fopr;ry; epw;f kUe;njz;nza; ; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ;; ; ; ; ; ; ; ; ; ;  
jPUk; Neha;:P ; ;P ; ;P ; ; - 
 Xahg;Ngjp> ,iur;rYld; $ba Ngjp ,itfSf;F ,e;j 
vz;nziaf; nfhLf;f fopr;rYk;> ,iur;rYk; me;j ~zNk epw;Fk;.  
8. 23khTy`k;:;;;  
msT:- 1 Kjy; 2 mTd;]; tpfpjk; ; 2 Ntis ; 
  3 NeuKk; Mfhuj;jpw;FKd;  
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 %isf;Fk; ,jaj;jpw;Fk; gyKz;lhFk;> jhJ tpUj;jpiaAk;> 
cjpug; ngUf;fj;ijAk; cz;lhf;fp Njfk; nfhLik ngwr; nra;Ak;> 
~Nuhfj;jpy; ,isj;jhh;f;Fk;> ehl;Lg;gl;L tpahjpahy; 
nkype;jhh;f;Fk; ,J tpNr~khd czthFk;.  
9. 24gpj;jthA rpfpr;ir ; ;; ;; ;  
msT:- 
 ½ Kjy; 1 Njf;fuz;b tpfpjk; jpdk; 3 Ntis  
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 khnuhpr;ry;> Fkl;ly;> the;jp> m[Ph;zk;> tapw;W Neha; mNuhrpfk; 
Kjypad ePq;Fk;.  
                                                           
21Fzghlk; jhJ [Pt tFg;G lhf;lh; ,uh. Jpahfuh[d; LIM. 
22fh;g;gpzp ghyNuhf rpfpr;ir Pg. 273. 
23rpfpr;rhuj;j jPgk; gf;fk; 286 (fz;Zrhkp gps;is).  
 
24rpfpr;rhuj;j jPgk; gf;fk; - 297 (fz;Zrhkp gps;is) 
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10. 25khJis nea;:;;; - 
msT:-  xU fhR vil ; 2 Ntis 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 rtiyapdhNyDk;> fzr;#l;bdhNyDk;> NtW 
vf;fhuzj;jpdhNyDk; ehSf;F ehs; ,isj;J NjhYk; vYk;Gkhff; 
fhzg;gLk; kf;fspd; Njfk; nfhOikiae;J 3 khjj;jpw;Fs; 
vy;NyhiuAk; Mr;rhpag;gLk; gbr; nra;Ak;  
gj;jpak;:- ,r;rhgj;jpak; 
11. 26k`h tpy;thjp ,Ny;;; fpak; :;;;  
msT:- 
 Rz;lf;fha;g; gpukhzk; ; jpdk; fhiy> khiy cz;L tu 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 gpj;jtha;T> kaf;fk;> fpWfpWg;G> gpurtpj;j ]jphPfSf;Fs;s 
the;jp> tapw;Wg;Nghf;F Kjypad FzkhFk;.  
gj;jpak;;; ;:- ,r;rhgj;jpak; 
12. 27ntJg;Gf; fopr;rYf;F kUe;J:; ; ; ; ;; ; ; ; ;; ; ; ; ; -  
 mjpkJuk; 
 mjptplak; 
 rhjpf;fha;  1 foQ;R 
 khjsk; G+ 
 rPufk; 
 ,ij Gspahiur; rhw;wpyiuj;Jj; J}Jsq;fha;g; Nghy; cUz;il 
nra;J nfhs;sTk;.  
mDghdk; :;;; - 
 khJsk; gor; rhw;wpy; fiuj;J nfhLf;fTk; 
  
                                                           
25rpfpr;rhuj;j jPgk; (fz;Zrhkp gps;is) gf;fk; - 206 
26rpfpr;rhuj;j jPgk; (fz;Zrhkpg;gps;is) gf;fk; - 175. 
27caph;fhf;Fk; rpj;j kUj;Jtk;> gf;fk; - 139 v];.gp ,uhkr;re;jpud;. 
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jPUk; Neha;:P ; ;P ; ;P ; ; - 
 ntJg;Gf; fopr;ry; 
13. 28fopr;ry; Ruj;jpw;F kUe;J:; ; ; ; ;; ; ; ; ;; ; ; ; ; - 
msT:-  Fd;wp asT 
mDghdk;:;;; - vUikj; japh;> nte;ePh; 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - fopr;ry;> Ruk; Mfpad jPUk;. 
14. 29fw;G+u nkOF:;;; - 
msT:- 
 2-3 Fd;wp msT ; 2 Ntis 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 [yNjh~k;> rapj;jpak;> ePh;g;gPerk;> Jk;ky;> grpapd;ik> 
GspNag;gk;> jiytyp> KjypaitfSk; rPjd rk;ge;jkhd gy 
gpzpfSk; FzkhFk;.  
gj;jpak;:; ;; ;; ; - 
 ,r;rhgj;jpak; rPjd gz;lq;fis ePf;fp md;dq; nfhs;sTk;.  
15. 30cyh;e;JNghfpw gps;isfSf;F kUe;J:; ; ; ; ;; ; ; ; ;; ; ; ; ; - 
msT:-½ fhnril 
16. 31it#hpapdhy; te;j fLg;gpw;F kUe;J:; ; ; ; ;; ; ; ; ;; ; ; ; ; - 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 mk;ikf;Fg; gpd;Nkw;gl;l tapw;Wf; fLg;Gfs; jPUk;.  
17. 32it#hp Nky;te;j fLg;gpw;F kUe;J:; ; ; ; ;; ; ; ; ;; ; ; ; ; - 
mDghdk;:;;; - 
 vUik Nkhh; (m) tpy;jf; f~haj;jpNah fhiyapYk;> 
khiyapYk; miuj;J cl;nfhs;sTk;.  
  
                                                           
28caph; fhf;Fk; rpj;j kUj;Jtk;> gf;fk; - 157 (v];.gp. ,uhkr;re;jpud;). 
29guk;giu itj;jpak;> gf;fk; - 102. 
30fh;g;gpzp ghyNuhf rpfpr;ir gf;fk; - 298 
31ruNge;jpu itj;jpa Kiwfs; gf;fk;.  
32ruNge;jpu itj;jpa Kiwfs; gf;fk; - 314. 
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jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ; - 
 itRhpNky; te;j fLg;Gfs; jPUk;.  
18. 33khJis kzg;ghF:;;;  
“fw;fz;Lk; gd;dPh; fdpkh JisurKk; 
ew;NwDq; $l;bNa ehl;Ltha; - nrhw;gky;y 
ghz;L ntSj;jnyhL ghjq; funkhpjy; 
khz;LNgh nkd;whh; kfpo;” 
 fw;fz;L> gd;dPh;> khJis ,urk;> Njd; ,itfis xd;whff; 
$l;bf; fw;fz;L fiue;j gpd; tbfl;b mLg;gpypl;Lf; nfhjpf;f 
itj;Jg; ghFgjk; te;jTld; ,wf;fp Gl;bapy; milf;fTk;. msTg;gb 
nfhLf;f ghz;L> ntSf;Fk; Neha;> if fhy; vhpT> the;jp ,itfs; 
jPUk;.  
19. 34gh];fu ytzr; R+uzk;; ; ;; ; ;; ; ; 
msT: 
 Mfhuk; cl;nfhs;tjw;F ½ kzp Neuk; Kd;G 
 fhy; &gha; vil> 2 Ntis> 20 ehs; nfhs;s Ntz;Lk;.  
mDghdk;;;; 
 Gspj;j Nkhh; (m) nte;ePh; 
jPUk; Neha;fs;:P ; ; ;P ; ; ;P ; ; ;  
 grpapd;ik> gpj;j thA> m[Puzk;> Ngjp> ghpehk #iy> tapw;Wg; 
nghUky;> 
gj;jpak;: ; ;; ;; ;  
 ,r;rhgj;jpak;> thA gz;lq;fisf; js;sp Mfhuk; nra;jy; 
Ntz;Lk; 
  
                                                           
 
34guk;giu itj;jpak; gf;fk; 102.  
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35vUtha; Kis Neha;; ;; ;; ; 
NtW ngaHfs;:;;;  
 Kis Neha;> mupg;G Neha;> mbKis Neha;> %y Neha; vdyhk;. 
,ay;G:;;; - 
 fPo;f;FlypypUe;J vUtha; tiuapYs;s Flypd; fz;zike;j 
fhHf;FUjpf;fNsOs; VNjDnkhd;whfpYk;> gythfpYk; jhgpjg;gl;L> 
tPq;fp> vUthapNyhH tif vupr;ry;> eik> mhpg;G Mfpa 
Fwpfisf;fhl;b> ntspf;Fg; Nghifapy; vUitf; fl;b ntspf;Fg; 
NghfKbahJ.  jLj;jhYk;> mjid Kf;fp ntspahf;f Kaypd;> ePH 
twz;L jPa;j;J ,Wfpa FUjp ehsq;fisf; fPwp> mjdpd;W frpAk; 
FujpNahL fopjYk;> Kf;FjYf;Nfw;g Kis ntspahf;FjYkhd 
,ay;Gila Nehahk;. 
Neha; tUk; top:; ;; ;; ; - 
‘fe;jj;jpy; fUiz nahopa Ntnwhd;Wk; GrpNahk;” vd;wjhy;> 
fUizf;fpoq;F jtpu kw;w fpoq;F tiffisg; Grpf;fpd;> mit 
fPo;Nehf;Ff; fhiy nfLj;J ,e;Nehapid tUtpf;Fkhapd;> 
mf;fpoq;F tiffis kpFjpahf Grpj;jhYk;> kpFe;j fhu 
nghUl;fisf; nfhs;Sykhd tiffshYk;> fPo; thia cWj;Jk;gb 
nra;af;$bajhd vg;nghOJk; cl;fhHe;jpUj;jy;> Fjpiu> ahid> 
xl;il ,itfspd; kPnjwpr; nry;yy;> clw;wPiag; ngUf;f $bajhd 
czT tiffisf; nfhs;sy;> xf;fy; epiyajd; td;ikf;F 
kpFjpahf epiyj;jpUj;jy;> %r;rlf;fy; Mfpa ,tw;whYk; ,e;Neha; 
gpwf;Fk;. 
md;wpAk;> ngz;fs; fUj;jupj;Js;sNghJ #y; ngUfg; ngUf 
fPo;f;Fly; mOj;jg;gLk;NghJk;> ngU tapw;WNeha; KjpHe;J tapW 
kpfg;ngupajhFk;NghJk; ,e;Neha; njhlUtJz;L.  rpyNtis jha; 
je;ijapd; topNaAk; tUtJz;L. 
 
                                                           
35nghJ kUj;Jtk; Pg : 434 
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Kw;Fwp:;;; - 
tspf;Fw;wj;ijg; ngUf;ff;$ba czT> nray; Kjypatw;why; 
fPo;Nehf;Ff;fhy; nfl;L vUitf; fl;b> Gifiag; Nghy; fWf;fp 
ntspa nra;jy;> fhw;Wghpar; nra;a Kbahik> fPo;tha; 
fdy;Nghnyupjy;> jtsk; nfl;Lg;Nghjy;> tapW ,iujy;> mbf;fb 
rpWfr;rpWf tapW nehe;J fopjy; Mfpa Kw;Fwpfisf; fhl;Lk;. 
Neha; vz;:; ;; ;; ; -  21  
1. vUtha; ePHKis 
2. vUtha; nrz;L Kis 
3. vUtha;g; ngUKis 
4. vUtha;r; rpWKis 
5. vUtha; twy; Kis 
6. FUjp Kis (,uj;j %yk;) 
7. fPo; Kis 
8. Mop Kis 
9. Jkuf Kis 
10. tsp Kis 
11. moy; Kis 
12. Ia Kis 
13. Kf;Fw;w Kis 
14. tpid Kis 
15. Nkf Kis 
16. Fop Kis (gfe;jpu %yk;) 
17. foy; Kis 
18. mbj;js;sy; 
19. ntspKis 
20. RUf;F Kis 
21. rt;T Kis 
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FUjp Kis (,uj;j %yk;); ;; ;; ;  
,e;Nehapy;> njhg;Gspy; typj;J ntspf;Fg; Nghk; Nghnjy;yhk; 
FUjp gPr;Rf;FoypypUe;J gPr;RtJ Nghyg; gPwpl;Lg; ghAk;.  ,t;thW 
kpFjpAk; FUjp ntspahjyhy;> clypd; FUjp Fiwe;J> cly; 
ntWj;J> td;ik ,oe;J> iffhy; Xa;r;ry;> kaf;fk;> khHG Neha;> jiy 
Neha;> fz;kQ;rspj;jy; Kjypad cz;lhFk;. 
nghJf; FwpFzq;fs;:; ; ;; ; ;; ; ; - 
vUthdJ ,Wfp twz;L ntz;ikah ,opjYk;> jhkiug; 
G+g;Nghy; Kis vUthapyhjy;> rpyNtis gytifahd nfl;l 
fPo;Nehf;Ff;fhy; nfhLik gy nra;jYk;> mwpit kaf;fp 
epytukw;wplr; nra;Ak;.  ,J nfhba vUtha; Kisapd; jhgpjk; 
MFk;. 
Fw;w Kjypa NtWghLfs;:; ;; ;; ;  
czT> nray; Kjypatw;whnyOe;j fPo;tha;f;fdy; 
kpFe;njOe;J tspf;Fw;wj;ijj; J}z;b mjdsthff; fPo;Nehf;Ff; 
fhiyf; nfLf;Fk;.  ,itfspdsthf moy; Fw;wKk; J}z;lg;gLk;. 
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MODERN ASPECT 
36Haemorrhoids : 
Piles  
Greek, Haima – Blood  
Latin, Pila – A ball  
 Saccular dilatations of the rectal venous plexus or cushion is formed 
by the superior & inferior Rectal veins.  
Definition  
 External skin tags are Redundant fold of skin that arises from the anal 
verge.  
 Internal Haemorrhoids arise from the superior Rectal venous plexus 
above the Hilton’s line and are covered by columnar epithelium of the 
rectum 
 External haemorrhoids arise from the inferior Rectal venous plexus 
below the Hilton’s line and are covered by anal squamous epithelium  
Internal Haemorrhoids  
 Common 
 Dilation of the internal venous plexus with an enlarged displaced anal 
cushion.  
Internal Haemorrhoids 
1. Vascular Haemorrhoids 
In this type, there is extensive dilatation of the terminal superior rectal 
venous plexus.  It is commonly found in adults particularly in men.  
2. Mucosal Haemorrhoids  
 In this type, there is sliding down of the thickened mucous membrane, 
which conceals the underlying veins.   
 Internal Haemorrhoids – 4 degrees  
  
                                                           
36
 Clinical Surgery Pg 400  
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1stDegree 
 Haemorrhoids are those in which hypertrophy of the internal 
Haemorrhoidal plexus Remains entirely within the anal canal as the mucosal 
suspensory ligaments remain intact.  Patients in this stage usually present 
with rectal bleeding and discomfort or irritation.  Bleeding is bright red and 
occurs during defaecation as splash in the pan.  It may continue for months 
or years (Haemorrhoids that bleed but do not come out of anus)  
2nd Degree  
 Piles will descend so that they prolapsed during defaecation but 
spontaneous Reduction takes place afterwards.  
3rd  Degree 
 Haemorrhoids comes out only during defeacation and do not return by 
Themselves but need to be replaced manually and them they stay Reduced.  
4th  Degree 
 Haemorrhoids, that permanently prolapsed.  At  this stage great 
discomfort is complained of with a feeling of heaviness in the rectum.  
Etiology  
1. Hereditary  
2. Exciting cases : 
Chronic constipation  
Over pulsation & diarrhoea, dysenting colitis, enteritis. 
3. Physiological cause  
4. straining at mictuition  
5. Presence of tumours  
Gravid uterus  
Uterine fibroids  
6. Loss of sphicher  
7. Occupation 
 Prolonged standing sitting as in train drivers, traffic polic. 
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 Internal Haemorrhoids contain main terminal divisions of superior  
rectal vein and artery. 
 Left lateral (3 O’ clock) 
 Right posterior (7 O’ clock) 
 Right anterior (11 O’ clock) 
C/F 
1. Bleeding per rectum (Splash in the pan ) 
2. Constipation  
3. Prolapsed  
4. Mucous discharge  
5. Pruritus ani 
6. Anaemia – persistent & profuse bleeding  
Complictions : 
1. Profuse bleeding  
2. Thrombosis  
3. Strangulation  
4. Fibrosis  
5. Suppuration  
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LATERAL RESEARCHWORKS 
37PHYTO-CHEMICAL STUDIES: 
Two new b-sitosterol esters have been isolated from the flowers of 
PunicagranatumLinn. (Punicaceae) along with the known compounds n-
tricosane (3), nheptacosanyln-hexanoate (4), olean-5,12-dien-3b-ol-28-oic 
acid (5), and olean-12 en-3b-ol-28 oicacid (6). The structures of the new 
phytosterols have been elucidated as stigmast-5-en-3b-ol-3b-dodecanoate (b-
sitosterollaurate, 1) and stigmast-5-en-3b-ol-3b-tetradecanoate 
PHARMACOLOGICAL ACTIVITIES: 
ANALGESIC ACTIVITY: 
The extracts of flowers of Punicagranatum(Linn). (N.O. Family 
Punicaceae) were investigated for analgesic activity in mice using hot plate 
method. The flowers of Punicagranatum (Linn) were collected from the 
local market of Mumbai, Maharashtra and were in a dried condition. The 
dried powdered flowers (500 gm) were extracted in a soxhlet apparatus by 
using different solvents. Mice weighing 15-25 gm were taken for the 
experiment. The reaction time of animals in all the groups was noted at 30, 
60 and 120 min after drug administration. All data were analyzed with 
Student-t test. The various extract of the flowers of Punicagranatum (Linn) 
showed significant analgesic activity at a dose of 50 mg/kg body weight. A 
maximum analgesic activity was found at 60 min, after drug administration, 
which was equivalent to the standard drug used as morphine sulphate. 
WOUND HEALING ACTIVITY: 
The present study demonstrated that Punicagranatumextract was 
capable of promoting. Enhanced wound contraction andhistological 
observations suggest that Punicagranatumhas potential in the management 
of wound healingand suggests further study. 
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ANTI-SPASMODIC ACTIVITY: 
Our result indicated that aqueousand hydroalcoholic extracts of 
Punicagranatumflower could induce relaxant effects on uterus ofvirgin rat 
and uterine contractions were decreasedwithout involvement of β-
adrenoceptors or opioidreceptors. These results indicate that aqueous 
extractsof punicagranatumflower could inducespasmolytic effect on rat 
uterus through blockageof VDCCs. These results support the clinical 
efficacyand use of Punicagranatumflower in thetreatment of dysmenorrhoea 
and other uterinespasmodic disorders. This process appears to bethe most 
relevant physiological process andshould be the target of future research. 
ANTI-DIABETIC ACTIVITY: 
Peroxisome proliferator-activated receptor (PPAR)-gamma activators 
are widely used in the treatment of type 2 diabetes because they improve the 
sensitivity of insulin receptors. Punicagranatum flower (PGF) has been used 
as an anti-diabetic medicine in Unani medicinal literature. The mechanism 
extract diminishes cardiac fibrosis in Zucker diabetic fatty rats, at least in 
part, by modulating cardiac ET-1 and NF-kappaB signaling of actions is, 
however, unknown. In the current study, we demonstrated that 6-week oral 
administration of methanol extract from PGF (500 mg/kg, daily) inhibited 
glucose loading-induced increase of plasma glucose levels in Zucker diabetic 
fatty rats (ZDF), a genetic animal model for type 2 diabetes, whereas it did 
not inhibit the increase in Zucker lean rats (ZL). The treatment did not lower 
the plasma glucose levels in fasted ZDF and ZL rats. Furthermore, RT-PCR 
results demonstrated that the PGF extract treatment in ZDF rats enhanced 
cardiac PPAR-gamma mRNA expression and restored the down-regulated 
cardiac glucose transporter (GLUT)-4 (the insulin-dependent isoform of 
GLUTs) mRNA. These results suggest that the anti-diabetic activity of PGF 
extract may result from improved sensitivity of the insulin receptor. From 
the in vitro studies, we demonstrated that the PGF extract enhanced PPAR-
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gamma mRNA and protein expression and increased PPAR-gamma-
dependent mRNA expression and activity of lipoprotein lipase in human 
THP-1-differentiated macrophage cells. Phytochemical investigation 
demonstrated that gallic acid in PGF extract is mostly responsible for this 
activity. Thus, our findings indicate that PPAR-gamma is a molecular target 
for PGF extract and its prominent component gallic acid, and provide a 
better understanding of the potential mechanism of the anti-diabetic action of 
PGF. 
CARDIAC ACTIVITY: 
The diabetic heart shows increased fibrosis, which impairs cardiac 
function. Endothelin (ET)-1 and nuclear factor-kappaB (NF-kappaB) 
interactively regulate fibroblast growth. We have recently demonstrated that 
Punicagranatum flower (PGF), a Unani anti-diabetic medicine, is a dual 
activator of peroxisome proliferator-activated receptor (PPAR)-alpha and -
gamma, and improves hyperglycemia, hyperlipidemia, and fatty heart in 
Zucker diabetic fatty (ZDF) rat, a genetic animal model of type 2 diabetes 
and obesity. Here, we demonstrated that six-week treatment with PGF 
extract (500 mg/kg, p.o.) in Zucker diabetic fatty rats reduced the ratios of 
van Gieson-stained interstitial collagen deposit area to total left ventricular 
area and perivascular collagen deposit areas to coronary artery media area in 
the heart. This was accompanied by suppression of overexpressed cardiac 
fibronectin and collagen I and III mRNAs. Punicagranatum flower extract 
reduced the up-regulated cardiac mRNA expression of ET-1, ETA, inhibitor-
kappaBbeta and c-jun, and normalized the down-regulated mRNA 
expression of inhibitor-kappaBalpha in Zucker diabetic fatty rats. In vitro, 
Punicagranatum flower extract and its components oleanolic acid, ursolic 
acid, and gallic acid inhibited lipopolysaccharide-induced NF-kappaB 
activation in macrophages. Our findings indicate that Punicagranatum 
flower. 
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HEPATO-PROTECTIVE ACTIVITY: 
 PGF-treated ZDF rats showed reduced ratio of liver weight to tibia 
length, hepatic triglyceride contents and lipid droplets. These effects were 
accompanied by enhanced hepatic gene expression of peroxisome 
proliferator-activated receptor (PPAR)-alpha, carnitine palmitoyltransferase-
1 and acyl-CoA oxidase (ACO), and reduced stearoyl-CoA desaturase-1. In 
contrast, PGF showed minimal effects on expression of genes responsible for 
synthesis, hydrolysis or uptake of fatty acid and triglycerides. PGF treatment 
also increased PPAR-alpha and ACO mRNAlevels in HepG2 cells. 
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MATERIALS AND METHODS 
SELECTION OF THE DRUG: 
Madhulai poo choornam was selected with reference from  
Gunapadam Mooligai vaguppu, page no 749 and Dr.Nadkarni’sIndian 
MateriaMedica, Vol I, page no:1031. 
COLLECTION OF THE DRUG: 
Madhulai poo were freshly collected from the areas in and around 
palayamkottai. 
PURIFICATION OF THE TEST DRUG: 
Madhulai poo has to be clean and washed thoroughly with fresh 
water.Then they should be kept under shade.                                                           
PREPARATION OF THE TEST DRUG:                
 The purified madhulai poo has to be made into fine powder and 
filtered by a clean white cloth .(Vasthirakayam).Then it should be collected 
and preserve in air tight container.  
ROUTE OF ADMINISTRATION: 
Enteral or Oral route 
DOSE: 
One gram twice a day with lukewater taken after food for 3 to 7 days. 
The prepared Madhulai poo choornam was analyzed on its 
haemostatic activity by the following methods: 
 PHYSIO-CHEMICAL ANALYSIS 
 CHEMICAL ANALYSIS 
 PHARMACOLOGICAL STUDY  
 MICROBIOLOGICAL ANALYSIS 
 FTIR ANALYSIS 
 SEM ANALYSIS 
 CLINICAL ASSESSMENT 
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38LUKE WARM WATER 
Definition: 
"Lukewarm" generally means between 98 and 105 degrees Fahrenheit, 
36.5 to 40.5 Celsius. When you run the water on your wrist and it feels 
warmer than your body temperature, but not hot, that should be just about 
right. If you've ever tested the temperature of warm formula or milk in a 
baby's bottle, that's lukewarm!  
Improve Digestive and Bowel Function: 
Drinking lukewarm water during a meal can aid in the digestive 
process; it helps break down food in the stomach. Hot water also breaks 
down old food left behind in our digestive tracks --- colon cleanses flush the 
digestive track with warm water from the inside. Drinking it, however, can 
also help remove that fermenting waste. Warm water with lemon, according 
to Free Drinking Water, can help the body remove waste, too; smoother 
bowel functions are the result. Constipation and diarrhea can even be 
prevented. 
Detox the Mind and Body: 
Drinking warm water a few times per week has purification benefits, 
according to Healthy Drinking Water Blog. As you drink hot or warm water, 
you body temperature rises. This results in perspiration, a natural process of 
cooling, which has an added bonus of removing toxins. This helps cleanse 
the bloodstream. It's like a sauna in beverage form. Because toxins are being 
removed from the body, many natural health practitioners believe warm 
water can also improve mental clarity. 
  
                                                           
38Greekfood.about.com 
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39Clear the Nose and Throat: 
Drinking warm or hot water can be an effective way to clear up nasal 
congestion from a cold, allergy or flu. The water vapor can loosen the mucus 
buildup in the nasal cavity. The logic of drinking the water alone is that it 
removes the dehydrating effects of caffeine in other hot beverages, such as 
tea and coffee, which should be avoided when ill. Additionally, warm water 
can help fight coughs by removing phlegm from the airways. 
Warm Water Drinking Tips: 
Do not drink hot or warm water from your tap. Instead, boil the water 
in a teapot and let it cool until it is a lukewarm, comfortable-to-the-touch 
temperature. This will make your water clean and safe and prevent burns. If 
drinking warm water leaves a lot to be desired in the taste area, add lemon or 
honey or both. Not only do those additives make the water more flavorful, 
but they also add health benefits. 
 
 
fha;e;jhwpa ePhpd; Fzk; : 
 ‘cz;lgpd;G nte;ePnuhU jukhf; nfhz;lf;fhy; 
 kPz;LRuk; thjk; tpjhfke;j - kz;Ljuj; 
 jhh;e;j nghUkYk;Ngh khASz;lh khjh;jikr;  
Nrh;e;jizaj; jhJTkhe; Njh;” 
- gjhh;j;j Fz rpe;jhkzp. nra;As; 
1398. 
jpUg;jpahFk;gb nte;ePiu xU Kiwahf cz;lhy;> Nghrdf; 
Fw;wj;jhYz;lhFk; myrk;> tapw;Wg;gprk;> tpjhfk;> thjhjpf;fk;> 
&l;ir ,it NghtJky;yhky;> MASk; Rf;fpyKk; tpUj;jpahFk;. 
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STANDARDIZATION OF THE DRUG 
PHYSICO-CHEMICAL ANALYSIS 
ASH AND ACID INSOLUBLE ASH: 
To the ash add 1:5 Hcl: Distilled water 15 ml boil, cooled and then 
filtered usingwhatman filter paper (No.41) repeat 3 to 4 times till the yellow 
colour disappear orcolourless, then remove the filter paper and add to the 
filter to the original dish and keepit in the muffle furnace at 600o C and take 
constant weight and calculate the acidinsoluble ash value. 
Weight of acid insoluble residue x 100 
Acid insoluble ash (%) 
Weight of the sample 
Acid insoluble residue = Acid insoluble ash value – Empty weight of 
the dish 
LOSS ON DRYING: 
3gm of the drug is heated in a hot oven at 1050 c to constant weight. 
The % of  weight was calculated. 
Loss on drying value at 1050 c - 10.96 %w/w 
POTENTIAL OF HYDROGEN (pH): 
The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 being 
neutral. Readings less than 7.0 indicate acidic solutions, while higher 
readings indicate alkaline or base solutions. 
THIN LAYER CHROMATOGRAPHY: 
4gms of the sample was soaked in 40 ml of Ethyl alcohol, kept 
overnight, boiled for ten minutes and filtered. The filtrate was concentrated 
to 10 ml and made up to the mark in a 10 ml and standard flask.10µl of this 
solution was applied on Merck aluminium plate 60 F 254 precoated with 
silica gel of 0.2 mm. thickness and the plate was developed in Toluene: 
Ethyl acetate 6:1.5. After drying the plate was visualized under UV 254 and 
366 nm and photographs were taken. The plate was dipped in vanillin-
sulphuric acid reagent and kept in oven at 1050c till the colour of the spots 
appeared. 
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BIOCHEMICAL ANALYSIS OF MADHULAI 
POOCHOORANAM PREPARATION OF THE EXTRACT 
 5gms of the drug was weighed accurately and placed in a 250ml clean 
beaker.  Then 50ml of distilled water is added and dissolved well.  Then it is 
boiled well for about 10minutes.  It is cooled and filtered in a 100ml 
volumetric flask and then it is make up to 100ml with distilled water.  This 
fluid is taken for analysis.   
QUALITATIVE ANALYSIS 
S. NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above 
prepared extract is taken 
in a clean test tube.  To 
this add 2ml of 4 % 
Ammonium oxalate 
solution 
A white 
precipitate is 
formed 
Indicates the 
presence of 
Calcium 
2.  TEST FOR 
SULPHATE: 
2ml of the extract is 
added to 5% barium 
chloride solution. 
A white 
precipitate is 
formed 
Indicates the 
presence of  
Sulphate 
3.  TEST FOR 
CHLORIDE 
The extract is treated 
with silver nitrate 
solution 
No white 
precipitate is 
formed  
Absence of 
Chloride 
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4.  TEST FOR 
CARBONATE 
The substance is treated 
with concentrated Hcl 
No brisk 
effervescence is 
formed 
Absence of 
Carbonate 
5.  TEST FOR STARCH 
The extract is added with 
weak iodine solution. 
No blue colour is 
formed 
Absence of  
Starch. 
6.  TEST FOR FERRIC 
IRON 
The extract is acidified 
with Glacial acetic acid 
and potassium ferro 
cyanide. 
No Blue colour is 
formed. 
Absence  of 
Ferric Iron 
7.  TEST FOR FERROUS 
IRON 
The extract is treated 
with concentrated Nitric 
acid and ammonium 
thiocyanate solution. 
Blood red colour 
is formed 
Indicates the 
presence of 
Ferrous Iron. 
8.  TEST FOR 
PHOSPHATE 
The extract is treated 
with ammonium 
molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed 
Absence of 
Phosphate. 
9.  TEST FOR ALBUMIN 
The extract is treated 
with Esbach’s reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
Albumin 
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10. TEST FOR TANNIC 
ACID 
The extract is treated 
with ferric chloride. 
Blue black 
precipitate is 
formed. 
Indicates the 
presence of 
Tannic acid 
11. TEST FOR 
UNSATURATION 
Potassium permanganate 
solution is added to the 
extract 
It gets 
decolourised 
Indicates the 
presence of 
Unsaturated 
compound. 
12. TEST FOR THE 
REDUCING SUGAR 
5ml of Benedict’s 
qualitative solution is 
taken in a test tube and 
allowed to boil for 2 mts 
and added 8-10 drops of 
the extract and again boil 
it for 2 mts. 
Colour change 
occurs. 
Indicates the 
presence of 
Reducing 
Sugar. 
13. TEST FOR AMINO 
ACID 
One or two drops of the 
extract is placed on a 
filter paper and dried it 
well.  After drying, 1% 
Ninnydrin is sprayed over 
the same and dried it 
well. 
No Violet colour 
is formed 
Absence of 
Amino Acid. 
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14. TEST FOR ZINC: 
The extract is treated 
with potassium ferro 
cyanide 
No white 
precipitate is 
formed 
Absence of 
Zinc.  
 
Inference: 
The given sample of “Madulai poo chooranam” indicates the 
presence of Calcium, Sulphate, Ferrous Iron, Tannic acid, unsaturated 
compound and reducing sugar. 
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PHARMACOLOGICAL EXPERIMENT TO STUDY THE 
HAEMOSTATIC ACTIVITY OF 
MADHULAI POOCHOORNAM IN ALBINO – RATS 
Aim: 
To study the haemostatic activity of Madhulai Poo Choornam in 
Albino rats. 
Preparation: 
Madhulai Poo Choornam was taken as a fine powder. 
Procedure: 
In the method of Thieneset. Al 1957, rats anaesthetised by means of 
phenobarbitone sodium with an usual intraperitoneal dose of 6mg/100gm of 
body weight. The abdomen was opened by a cruciate incision and the liver 
was gently lifted out. A piece of liver was cut from a portion of the edge 
with sharp scissors having a cut surface of 10mm length and 3 to 6mm 
width. 
To obtain control values, one group of animals received distilled water 
applied to the cut surface and bleeding time was taken and determined. 
The length of bleeding time was determined by gently blotting with 
pieces of filter paper at 2 to 3 seconds intervals. The end point was rather 
sharp and was indicated by a blood clot changing to the filter paper 1 or 2 or 
no blood wetting it. The same procedure was repeated with the standard and 
the test drug Madhulai pooChoornam. The mean differences between 
bleeding times of both the groups were determined. 
Result: 
The mean bleeding time in the filter paper applied group was 4 
minutes 55 seconds, vit k treated group was 2 minutes 55 seconds and the 
drug treated group it was 1minute 30 seconds. 
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THE VALUES ARE GIVEN IN THE TABLE: 
S.No Groups Dose Mean Bleeding time 
1. Control 2 ml 4.55 Min 
2. Standard(vitamin k) 5 mg 2.55 Min 
3. Madhulai poo Choornam 100mg 0.58 Min 
 
Inference : 
The test drug “MADHULAI POO CHOORNAM” has significant 
haemostatic action. 
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ANALGESIC STUDY OF MADHULAI POO CHOORNAM 
BY TAIL-FLICK METHOD IN 
ALBINO RATS. 
Aim : 
To study the analgesic effect of Madhulai pooChoornam in 
albinoratsby tail flick method. 
Preparation Of The Test Drug : 
1gm of Madhulai pooChoornam was suspended in 10ml of 
distilledwater using as suspending agent. This 1ml contains 100mg of the 
test drug. 
Requirements: 
 Distilled Water 
 Standard Drug (Paracetamol) 
 Test drug Madhulai pooChoornam 100mg/100gm of body weight. 
Instrument: 
Hot water bath maintained at 550C ± 0.50C was used as the sourceof 
stimulus. 
Procedure: 
Healthy albino-rats weighing 100-200 grams of both sex were 
selected. The tail of each rat was dipped in the hot water bath and time taken 
for the rat to remove the tail from the water bath was noted. The rats that 
take more than 5 seconds to remove the tail were excluded from the 
experiment. 
The rats were divided into 3 equal groups. Each group having 2 rats 
the first group was given the solvent used to suspend the drug and kept as 
untreated control. 
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The second group was given the standard drug and kept as treated 
control. The third group was given the test drug 100mg /100gm of body 
weight. Half an hour and one hour after drug administration the rats were 
again tested by dipping the tail in the hot water bath. The time taken for the 
rat to remove the tail was noted as done initially. 
The results of control group, standard group and drug treated group 
were tabulated and compared. 
ANALGESIC EFFECT OF MADHULAI POO CHOORNAM 
S.No 
DrugDose/100g 
By bodyweight 
ofthe rat 
Initialread
ing 
Inseconds 
 
Reading after 
drugAdministration 
inSeconds Mean 
Difference After 
30 
Min 
After 
60 
Min 
After 
180 
Min 
1 
 
Control 
(Water) 2ml 2.0 2.0 2.0 2.0 
2 
 
Standard 
(Paracetamol) 20mg 2.0 2.5 4.5 6.5 
3 
 
Madhulai poo 
Choornam 100mg 2.0 2.75 4.0 4.5 
 
INFERENCE 
The test drug MADHULAI POO CHOORNAM has good analgesic 
action 
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MICROBIOLOGICAL ANALYSIS 
ANTI – MICROBIAL ACTIVITY BY KIRBY BAUER METHOD 
Aim: 
To determine the Antimicrobial activity of “Madhulai poo 
Choornam” 
Components Of Muller Hinton Agar Medium: 
Beef Extract  -  300 gms /lit 
Agar    -  17 gms /lit 
Starch   -  1.5 gms / lit 
Casein Hydroxylate  -  17.5 gms/lit 
Distilled water  -  1000 ml. 
PH    -  7.6 
Procedure: 
The method of antimicrobial activity study is UPS 
DiffusionMethod. 
Antibiotic discs are prepared with known concentration of 
antibiotic and placed on agar plates that has been inoculated with the 
known pathogenic micro organism. The antibiotic diffuses through the 
agar producing an antibiotic concentration gradient, antimicrobial 
susceptibility is proportional to the diameter of the inhibitory zone 
around the disc. If the micro organism which grows upto the edge of the 
disc are resistant to the antimicrobial agent. 
The recommended medium in this method is Muller Hinton Agar, 
its pH should be between 7.2 – 7.6 and should be poured to uniform 
thickness of 4mm in the petri plate (25ml) 
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Methodology: 
Muller Hinton Agar plates are prepared and Escherichia coli, 
Candida albicans, Staphylococcus aureus, Streptococcus pneumonia, 
Pseudomonas aeruginosa are inoculated separately. 
The prepared discs of Madhulai poo Choornam are placed over 
the incubated plate using sterile forceps and incubated for 24 hours at 
37o celcius. 
The plates after 24 hours incubation are observed for the zone of 
inhibition. 
S.No Test Drug 
Organisms 
(Culture) 
Susceptibility 
Zone size 
(mm) 
1. 
Madhulai Poo 
Choornam 
Escherichia coli Resistant - 
2. 
Staphylococcus 
aureus 
Moderately 
sensitive 
10mm 
3. 
Streptococcus 
pneumoniae 
Resistant - 
   4. Pseudomonas 
aeruginosa  
Resistant  - 
   5. Candida albicans Resistant - 
 
Result: 
           The test drug Madhulai poo chooranam is moderately sensitive to 
Staphylococcus aureus. 
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FOURIER TRANSFORM INFRARED  
SPECTROSCOPY (FTIR): 
 Also quantitative estimation is possible in certain cases forchemicals, 
pharmaceuticals, petroleum products, etc. Resins from industries, water 
andrubber samples can 
INSTRUMENT DETAILS: 
Model : Spectrum one: FT-IR Spectrometer 
Scan Range : MIR 450-4000 cm-1 
Resolution : 1.0 cm-1 
Sample required : 50 mg, solid or liquid. 
Fourier Transform Infrared Spectroscopy (FTIR) is an analytical 
technique usedto identify mainly organic materials. Infrared Spectroscopy 
gives information on the vibrational and rotational modes of motion of a 
molecule and hence an important technique for identification and 
characterisation of a substance.. The Infrared spectrum of an organic 
compound provides a unique fingerprint, which is readily distinguished from 
the absorption patterns of all other compounds; only optical isomers absorb 
in exactly the same way. Hence FTIR is an important technique for 
identification and characterization of a substance 
Infrared spectrum is useful in identifying the functional groups like –
O-H,C-H,-N-H,-NH2,, etcbe analyzed. 
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SP  3601  4000.0  400.0  3.1  100.0  4.0  %T  4  2.0 
PT 
REF 4000 98.6 2000 99.2 600 
3391.7  3.1    2929.5  19.3   2357.5  67.6   2341.8  74.0   1629.1  33.3    
1346.4  39.8   1232.1  43.1   1049.5  37.1   921.8   82.8   867.7   90.8    
616.2   85.2 
COMMENT: 
3391cm-1 –is due to O-H of β-sitosterol, 2929cm-1- is due to C-H 
stretching or alkanes , the two bands near 2357cm-1 and 2341cm-1 due to the 
presence of  acid, 1629cm-1 is due to the amide band, 1346cm-1 weak 
alkanes, 1232cm-1- is due to the C-O stretching of the phenol.   
  
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 400.0
0.0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100.0
cm-1
%T 
3391.7
2929.5
2357.5
2341.8
1629.1
1346.4
1232.1
1049.5
921.8
867.7
616.2
54 
 
SEM-Micro graph particle size average range is 60nm 
SCANNING ELECTRON MICROSCOPE (SEM) 
The Scanning Electron Microscope (SEM) is a microscope that was 
electronsrather than light to form an image. There are many advantages to 
using the SEM insteadof a light microscope. 
Resolution : 
1.2 nm gold particle separation on a carbon substrate 
Magnification : 
From a min of 12 x to greater than 1, 00,000 X 
A scanning electron microscope (SEM) is a type of electron 
microscope that produces images of a sample by scanning it with a focused 
beam of electrons. The electrons interact with electrons in the sample, 
producing various signals that can be detected and that contain information 
about the sample's surface topography and composition. The electron beam 
is generally scanned in a raster scan pattern, and the beam's position is 
combined with the detected signal to produce an image. SEM can achieve 
resolution better than 1 nanometer. Specimens can be observed in high 
vacuum, low vacuum and in environmental SEM specimens can be observed 
in wet condition. 
SEM Picture of Madhulai Poo Chooranam 
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CLINICAL ASSESSMENT 
The study was conducted to assess the haemostatic activity of 
‘Madhulai poo Choornam’. Clinically, the study was carried out in In- 
Patients and Out-Patients of both sex and varying age groups at Post 
Graduate Department of Gunapadam, Govt. Siddha Medical College, 
Palayamkottai. They were clinically diagnosed according to the Siddha 
parameters. 
The diseases selected for this activity were Kuruthimoolam (Bleeding 
piles). 
Kuruthimoolam is characterized by bleeding through anus during 
defecation. Due to excessive loss of blood, anemia, lassitude, malaise and 
giddiness may occur. 
DESIGN OF THE STUDY: 
Open clinical trial, phase II B 
SELECTION OF THE PATIENTS: 
Clinically the patients selected for this study had either Bleeding per 
anum during defecation. 
Cases were selected for the study in both sex. Of these 10 cases were 
studied as In-Patients and 30 cases were studied as Out-Patients. 
Routine blood and urine investigations along with determination of 
bleeding time (BT) and clotting time (CT) were done before and after 
treatment to assess the clinical status of the patient. Blood pressure was 
recorded in all cases. 
Proctoscopic examination was done in the case of Kuruthimoolam. 
During the course of the clinical study, other ailments which occurred 
were treated with conventional Siddha medicines. 
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INCLUSION CRITERIA IN THE CASE OF KURUTHIMOOLAM: 
1. Age group between 25-50yrs. 
2. First degree haemorrhoids. 
3. Bleeding per anum during defecation. 
4. Non-hypertensive patients 
5. Patients with normal bleeding time and clotting time. 
6. Proctoscopic examination – 3’o clock, 7’o clock, 11’o clock 
positionsof internal pile masses. 
7. Other symptoms like tiredness, giddiness, malaise etc. 
EXCLUSION CRITERIA IN THE CASE OF KURUTHIMOOLAM: 
1. Age above 50yrs. 
2. Second, Third degree haemorrhoids. 
3. Symptomatic haemorrhoids appear in 
                a) Carcinoma of rectum. 
                b) Pregnancy 
                c) Stricture urethra. 
                d) Enlarged prostate. 
4. Fissure in - ano patients. 
5. Hypertensive patients 
6. Tumours of rectum and anus. 
7. Haemangioma of superior rectal veins 
DRUG AND DOSAGE: 
The drug Madhulai poo Choornam was administered orally in the dose 
of 1gm twice daily with water after food, for a period of 3-7 days. 
The duration of treatment varied from patient to patient. 
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LAB INVESTIGATION: 
Blood: 
TC (cells/cu.mm) : 
DC(%) : 
1/2hr (mm) : 
ESR 
1hr (mm) : 
Hb (gm %) : 
Sugar (R) (mg %) : 
Urea (mg %) : 
Cholesterol (mg %) : 
Bleeding Time(sec) : 
Clotting Time(sec) : 
Urine: 
Albumin : 
Sugar : 
Deposits : 
Motion: 
Ova : 
Cyst : 
Occult blood : 
Proctoscopic Examination: 
DIET AND MEDICAL ADVICE FOR KURUTHIMOOLAM: 
1. Advised to take rich fibre diet and easily digestible foods e.g.spinach, 
pirandai thuvaiyal etc. 
2. Advised to avoid tubers. 
3. Advised to avoid smoking, alcohol, excess intake of tea and coffee 
4. Advised to avoid food which increases pitha humour e.g. chicken, 
mutton, pickles etc. 
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5. Advised to avoid hot, spicy diet. 
6. Advised to avoid hot weather. 
7. Advised to avoid sedentary habits. 
8. Advised to avoid heavy work like lifting heavy objects. 
9. Advised to avoid constipation. 
PRANAYAMA THERAPY: 
Patients are advised to follow kabalabhati. The technique is as 
follows: 
The posture is padmasana, first the abdominal muscles are relaxed and 
anus is contracted. Then, suddenly the lower abdomen below navel is 
contracted. This is held for twenty seconds and then abdomen is relaxed. 
This process is repeated up to the level that one feels comfortable. 
There should be half a minute rest between each round. Three rounds 
are enough at a time in the beginning.  
This pranayama corrects the whole system and normalizes the affected 
vayus. This helps in avoiding congestion and varices of lower rectal veins 
and promotes better circulation. 
YOGA THERAPY: 
The following four asanas are prescribed to prevent the recurrence of 
kuruthimoolam. 
1. SARVANGASANA: 
It vitalizes all internal organs. It promotes better venous circulation 
and reduces rectal venous congestion. 
2. MAYURASANA: 
This relieves constipation, regularizes bowel habits and thereby prevents 
the recurrence of kuruthimoolam. 
4. SIRASAASANA: 
It vitalizes brain, reduces anxious states, promotes better venous 
circulation 
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OBSERVATION: 
The results were observed on the basis of relief of symptoms and 
routine lab investigations. In all patients, the bleeding started reducing from 
the next day onwards. 
Among 40 cases, 29 cases showed good response, 9 cases showed fair 
response and 2 cases showed poor response. 
RESULT: 
In all the cases, bleeding was arrested. 
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BIO STATISTICAL ANALYSIS 
The clinical trials of the drug Madhulai Poo Choornamwere 
differentiated according to the sex and age in terms of percentages and 
averages. The sex and age wise distribution was analyzed and interpreted by 
students‘t’ test (unpaired). The effectiveness of the drug was analyzed and 
interpreted by students paired‘t’ test. The responses of the patients to the 
drug are analysed in terms of percentages. The above statistical procedures 
were performed by the statistical package S.P.S.J (13.0) The P-values<0.05 
were taken as significant. 
Results and observation: 
Drug: Madhulai Poo Choornam 
Description of the Clinical trials: 
 The clinical trials were described and compared  according to their sex 
and age as follows. 
Table – 1 Sex and age wise percentage distribution of the study subject: 
Age group 
(Years) 
Males Females Total 
No % No % No % 
20-29 1 5.88 2 8.70 3 7.5 
30-39 2 11.77 4 17.39 6 15 
40-49 8 47.05 13 56.52 21 52.5 
50-59 6 35.30 4 17.39 10 25 
 17 100 23 100 40 100 
  
The above table -1 describes thesex and age wise distribution of the 
clinical trials. The male participation was 42.5% and the same of the female 
was 57.5% 
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Table -2Comparison of males and females according to their age. 
Sex 
Age (Years) Difference 
of means 
‘t’ d.f Significance 
Mean S.D 
Male 45.18 6.65 
2.39 0.1078 38 P>0.05 
Female 42.79 7.18 
 
The above table – 2 compares the age between the male and female 
subjects in the study. The mean age of male was 45.18±6.65years and the 
same of the female was 42.79±7.18. The difference of mean ages between 
the two sex was not statistically significant (P>0.05). 
Assessment of bleeding, clotting time and arrested time of bleeding: 
The bleeding and clotting time were assessed before and after 
administration of the drug Madhulai poo Choornam.  The bleeding arrested 
days were also assessed as follows. 
Table – 3: Assessment of bleeding and clotting time before and after the 
drug administration: 
 
Time 
(in Sec) 
Bleeding time Clotting time 
Before After  Before After  
No % No % No % No % 
61-120 2 5 13 32.5 - - - - 
121-180 25 62.5 25 62.5 - - 2 5 
181-240 13 32.5 2 5 6 15 11 27.5 
241-300 - - - - 19 47.5 24 60 
301-360 - - - - 15 37.5 3 7.5 
Total 40 100 40 100 40 100 40 100 
  
The above table – 3 describes the bleeding and clotting time of before 
and after treatment.  Before treatment the bleeding time of 32.5% of subjects 
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was 181-240 seconds and after treatment the bleeding time was reduced as 
61-120 seconds to 32.5% subjects.  The clotting time before treatment of 
47.5% and 37.5% subjects were in between 241-300 seconds and 301-360 
seconds respectively.  After treatment the clotting time of 60% and 27.5% of 
subjects were in between 241-300 seconds and 181-240 seconds 
respectively.  
Table – 4Assessment of bleeding arrest: 
Duration 
(days ) 
Persons Mean Standard deviation 
2-3 2 5  
 
5.1 days 
 
 
1.43days 
4-5 27 67.5 
6-7 9 22.5 
8-9 1 2.5 
10-11 1 2.5 
Total 40 100 
 
The bleeding arrest after the treatment was shown in the above table – 
4. The maximum (67.5%) persons had arrested theirbleeding  in4 to 5 days. 
The mean days of arrest of bleeding was 5.1± 1.43 days. 
Effectiveness of the drug in arrest of bleeding: 
The effectiveness of the drug was analysed and interpreted by 
studying the bleeding and clotting time before and after treatment.   
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Table – 5. Comparison of the effectiveness of the drug: 
Variables 
Before After Difference 
‘t’ df Significance 
Mean S.D Mean S.D Mean S.D 
Bleeding 
time (sec) 
179.1 23.53 147.1 26.86 32 15.59 13.008 39 P<0.001 
Clotting 
time (sec) 
295.7 36 259.2 35.0 36.5 26.03 8.88 39 P<0.001 
 
The above table – 5 reveals the effectiveness of the drug in reducing 
bleeding time and clotting time from before treatment  to after treatment. 
The mean bleeding times of before and after treatments were 179.1±23.53 
and 147.1±26.86 seconds respectively with reduction of mean seconds of 
32±15.59 
The mean clotting times of before and after were 295.7±36 and 
259.2±35 seconds respectively. The reduction was 36.5±26.03 seconds. The 
reduction of bleeding and clotting times were very highly statistically 
significant (P<0.001).  
Assessment of the response of the drug: 
The response of the drug was assessed by all factors of relief in the 
arrest of bleeding after treatment.  The responses were graded into three 
categories namely good, fair and poor and are tabulated as follows. 
Table -6Response of the patients to the drug: 
S.No 
Category of 
Response 
No of 
persons 
Percentage 
% 
1. Good  29 72.5 
2. Fair 9 22.5 
3. Poor 2 5 
 Total 40 100 
64 
 
The above table – 6 shows that the response of drug was good to 29 
(72.5%)  cases, fair to 9 (22.5%) cases and poor to 2 (5%). 
Inference: 
 The drug is very effective in controlling  Kuruthi moolam, good 
response (72.5%)is shown among the clinical trials. 
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RESULT &DISCUSSION 
The drug Madhulai poo Choornam is selected to study its therapeutic 
efficacy in the control of bleeding in Kuruthimoolam as per Siddha Literature. 
The drug is studied physiochemical, biochemical,SEM,FTIR, 
pharmacologically and clinically. 
According to Siddha Medicine, the main anamoly in haemorrhage or 
bleeding is vitiation of pitha humour. Based on the interaction between seven 
physical constituents and tridoshas, it is inferred that one of the representations 
of pitha in the body is blood.  Any change in the blood tends to derange the 
pitha humour and vice – versa. 
 40“gpj;jkjp fhpg;gpd; NgRk; ghpfhuk; 
Rj;jj; JtNuhL nrhy;ypdpg;Gr; Rj;jhFk; 
 ifg;Gr; RitNa fUJtjd; tPW  
va;g;gilA nkd;Wiuj;jh hpq;F” 
-fz;Zrhkpak;; ;; ;; ; 
JtHg;G> ,dpg;G> ifg;G ,k;%d;W RitfSk; gpj;j kpFjpiar; 
rkg;gLj;Jk;. 
The use of Madhulai poo Choornam helps to restore the vitiated Pitha 
humour to its original status because Madhulai poo possesses astringent taste 
(Thuvarppu Suvai) and astringent action. 
JtHg;gpd; nra;if:; ; ;; ; ;; ; ;  
 “FUjp Rj;jp ahf;Fk; 
 nfhba gpj;jk; Nghf;Fk; 
 nghUJg; Gz;iz ahw;Wk; 
 nghy;yh itak; khw;Wk; 
 kUT ke;jk; Njf;Fk;  
 tsHf;F khkk; ahHf;Fk; 
 FUtpd; Fzj;j jhNy 
 FspHe;j JtHg;gpd; Ntiy” 
-(kUj;Jtj; jdpg;ghly;); ; ; ;; ; ; ;; ; ; ;  
                                                           
40
Neha; ehly; Neha; Kjy; ehly; jpul;L> gf;f vz;: 24 
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Nkw;fz;l ghlypypUe;J Jth;g;G nra;ifahdJ nfhba gpj;jj;ijg;   
Nghf;Fk; jd;ikAk;> ,uzq;fis Mw;Wk; jd;ikAk;> FUjp 
Rj;jpahf;Fk; jd;ikAk; nfhz;lJ. 
1. The astringent activity helps to control bleeding by producing contraction 
of the blood vessels. 
2. The astringent activity moreover helps to purify the blood, there by 
restoring the  pitha humour to its original status. 
3. Astringent taste of the medicine basically from earth and air element 
(manbootham and vayu) 
4. Earth element has the general property in helping evacuation of faeces 
from analcanal. 
Biochemical analysis showed the presence of Calcium,Sulphate, 
Ferrous Iron, Tannic acid,Unsaturated compound and Reducing sugar. 
41Calcium: 
 Calcium ions are necessary for vascular smooth muscle contraction and 
promotes haemostasis.  
 
42Calcium takes part a major role in all steps of blood clotting 
mechanism. 
Sulphate: 
 Sulphate prevents all type of infection. 
43Ferrous Iron: 
 Ferrous Iron is essential for the synthesis of Hemoglobin.  Bleeding per 
anum causes anemia, which is managed by the trial medicine.  In the trial 
medicine, iron is present in ferrous form, which is soluble and readily 
absorbed in the intestinal lumen.  
  
                                                           
41
 Fundamental s of  Bio chemistry by Dr. Ambika Shanmugam, Page No: 666 
42
 Essentials of Medical Physiology by K. Sembulingam, Page No: 120 
43
Bio-Chemistry by Dr.U. Satya Narayana, Page No: 414 
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44Tannic acid: 
 Tannic acid possess astringent property and arrest the over bleeding. 
From the Organolepticcharacters of Madhulai poo chooranam it has 
Haemostatic activity.  
The biochemical analysis also showed that it has Haemostatic activity 
and also it manages the complication of Bleeding piles. 
All these form a strong base for excellent relief of symptoms. 
Pharmacological studies showed that the drug has more haemostatic 
activity compared with Vitamin K. It also has good analgesic activity through 
this it relieves tenesmus. 
Microbiological studies revealed that the test drug is moderately sensitive 
against Staphylococcus. 
Physico chemical analysis, The analytical parameters like total Ash value, 
Acidinsoluble ash value, Loss on drying values are helping us to interpret the 
digestion andsolubility capacity of the crude extract. As per the result the tested 
sample contains goodpercentage of solubility as well as digestive capacity. 
In FTIR,it showed the functional groups related 
toamides,phenols,alcohols,alkanes and carboxyl groups. 
SEM picture shows Nano particle (Micro level) size of the sample is 
60nm. Which is within the normal limit. The extremely small size of 
nanoparticles allows them topenetrate cells and interact with cellular molecules. 
Due to nanoparticle size a low dose of thedrug can cure the diseases. 
For clinical study, 40 patients were selected of both sex.  They were 
either of Kuruthimoolam . Among these 40 cases, 29 cases (72.5%) showed 
good response, 9 cases (22.5%) showed fair response and 2 cases (5%) showed 
poor response. 
                                                           
44
 Pharmacology by K.D.Tripathi, Page No: 846 
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Those who had arrest of bleeding within 3-5 days were categorized under 
good response, 6-7 days were under fair response and more than 7 days were 
under poor response. 
Bio - statistical analysis also revealed that this drug has significant effect 
in treating Kuruthimoolam . 
No untoward effects were observed during clinical trial. 
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SUMMARY 
In this dissertation, the test drug ‘Madhulai poo Choornam’ is selected to 
find out its efficacy in treating kuruthimoolam based on its haemostatic activity. 
The dose of the choornam is 1 gm twice a day with water after food.  
The review of literature about the drug and their significance in Siddha 
aspect were done.  Information about the drug was collected from various 
literature which have been documented. 
Bio – chemical analysis showed the presence of Calcium,Sulphate, 
Ferrous Iron and Tannic acid and their biological significance has been 
discussed.   
Pharmacological analysis revealed that the test drug has significant 
haemostatic activity and good analgesic activity. 
Micro-biological analysis revealed that the test drug is moderately 
sensitive against Staphylococcus. 
Bio-statistical analysis also revealed that the test drug has significant 
effect in treating kuruthimoolam . 
For the clinical assessment, 40 patients were selected.  Among these 29 
cases (72.5%) showed good response, 9 cases (22.5%) showed fair response and 
2 cases (5%) showed poor response.  From this, it is inferred that the test drug 
has effective and potent haemostatic activity and has no untoward effects. 
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CONCLUSION 
With the above results, it can be concluded that the test drug “Madhulai 
poo Choornam” has significant haemostatic activity and it has no untoward 
effects in the clinical trial.  
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INTRODUCTION 
The siddha  system of medicine is most predominant in tamil 
nadu.Outside of india  the siddha system common in sri lanka ,Malaysia 
and Singapore,where the dravidian civilisation had taken roots.   
In the siddha system kaayakalpa has a very conspicuous 
place.Inherent in kaayakalpa is the belief  of the siddha physicians that 
the human body consists of 72000 veins and nerves ,6 vital centres,10 
vital airs and 10 vital pulses .These appear to relate to tantrik and yogic 
concepts .One of the notable characteristics of kaayakalpa is the intake of 
muppu ,the three salts ,besides the administration of meticulously 
processed minerals and other rejuvenating compositions ,use of potent 
herbal extracts breathing regulations ,conservation of sperm ond 
others.Muppu is believed to enhance the efficacy of any siddha medicine 
,but its preparation ,and even the composition are a closely guarded secret 
.In fact a very considerable part of the siddha system appears to be 
shrouded in a cloak of secrecy ;the texts being only in tamil and the 
formulations being referred mostly by  numbers ,promotes security.. 
 India is one of the countries having highest number of cases of Anaemia in 
world. 
 Over 90% of indianwomen ,adolescent girls and children are anaemic. 
 Anaemia adversely affects a child’s mental and motor development. 
  So control of iron deficiency anaemia in young children and adolescent is 
necessary to improve the quality of life for youngsters. 
  So the author has taken Ayachenduram to test its efficacy through 
Haematinic action.  
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AIM AND OBJECTIVES 
 The aim of this dissertation is to study the effect of 
“Ayachenduram” for the treatment of paandunoi on the basis of 
Haematinic action. 
In our Siddha system metal and mineral therapy was introduced by 
our Siddhars which is easy to preserve, smaller in dosage and longer in 
Shelf life.  Paandunoi can be correlated with Iron deficiency Anaemia. 
Eventhough our country is developing one,even now some of our 
people are in poverty line,under poor socio-ecnomicstatus.They have 
been suffering from various diseases. 
In our siddha system there are lot of medicines for 
pandunoi.Among them “ Ayachenduram” is selected for this 
dissertation.Thischenduram was prepared based on the reference in the 
siddha literature Kannusamiyamvaithyiasegaram .page no.122 
In this dissertation the analysis of ‘Ayachenduram’ is done in all 
aspects like, 
 Botanical aspect 
 Chemical aspect 
 Gunapadam aspect 
 Siddha aspect of the disease 
 Modern aspect of the disease 
 Bio chemical analysis 
 Pharmacological analysis 
 Microbiological analysis 
 Geo Chemical  analysis 
 Acute toxicity study 
 Clinical assessment 
 Bio statistical analysis 
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GUNAPADAM ASPECT 
mak;;;; FERRUM 
1Vernacular Name 
Tam    :  Irimbu 
Eng    :  Iron 
Sans    :  Lauha; Hyam 
Tel    : Irumu 
Hindi, Ben, Duk  : Loha 
Huj    : Lodhum 
Mah & Kon   : Lokharrd 
Arab    : Hadida 
Pers    : Ahana 
Urdu    : Lohchum 
Can    : Kabbina 
Sinh    : Yekada 
Burm    : Than 
Malay   : Basi 
2NtW ngaHfs;;;; 
1. Mfp 
2. maR 
3. mapy; 
4. ,b 
5. ,Uk;G 
6. <rnrak; 
7. fUf;nfhy; 
8. fUk;gp 
                                                 
1Indian Materia Medica. P.No.54 
2Fzghlk; jhJ rPt tFg;G gf;f.vz; 64 
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9. fUk;G 
10. fUkzy; 
11. fUg;G 
12. fUk;nghd; 
13. faR 
14. fpU\;zitak; 
15. fhypy; nefpsk; 
16. Mjp 
17. rj;J 
18. rpNuhruk; 
19. rpl;lk; 
20. jpUk;gp 
21. Jz;lk; 
22. gpz;lk; 
23. nghd;kzy; 
24. Nyhfk; 
25. ehjk; 
26. tho;G+kp 
27. fUe;jhJ 
3‘mj;jnkd;w> thjpg; gr;irf;F fUk;nghd; ndd;Wk; NgU 
mlyhd> epSk;nghd; ndd;W kjw;Fg; NgU 
mj;jnkd;w> fUk; nghd;ndd;wjw;Fg; NgU 
trdpj;Njhk;> JUk; nghd;ndd;Wk; jw;Fg; NgU 
epjnkd;w khrw;w rjf nkd;Wk; NgU 
epiyahd> jhk;gu rq;fnkd;Wk; NgU 
mjPjnkd;Wk; jpUk;gngdd;W kjw;Fg; NgU 
rhw;wpNdhk;> mjPjg;NgH ,Uk;gpd; NgNu” 
                                                 
3gQ;r fhtpa epfz;L g.109 
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thj gr;ir fUk;nghd;> epUk;nghd;> fUk;nghd;> JUk;nghd;> 
fjfk;> jhk;gurq;fk;> jpUk;gd; vd;gd ,Uk;gpd; ngaHfs;. 
4nrakhFk; rj;J 
mak; 
fUg;gp 
kjpapd; tho; 
G+kpehjk; 
fWg;gp 
Nyhfk; 
gpz;l Jj;jk; 
Nuhrkhd;fhup 
Nefpsk; 
,Uk;gpd; fpl;lk; 
fpU\;zitak; 
5‘,Uk;gpDl NgH jidNa ,aw;wf; NfS 
 ,NaRtpl nrakhFe; rj;JkhFk; 
kUk;khd marhFq; fWg;gpahF 
 khjpah tho;G+kp dhjkhFq; 
fUk;gpnad;Wk; Nyhfnkd;Wk; gpz;lJj;j nkd;Wk; 
 faRr;r Nuhr ukhzf;fhup nefpsj;jhd; 
jpUk;gpDk; fpl;lkhq; fpU\;z makhFk; 
 nrg;gpaNjhH Ngnuy;yh kpUk;Gf;fhNk” 
fpilf;Fkplq;fs; ;; ;; ; ; 
 mak; vy;yh kiyfspYk;> epyq;fspYk; mNefkhf fe;jfk; 
Nghd;w rpy nghUs;fSld; fyg;Gw;Wf; fpilf;fpd;wJ.  ,J jhJ> 
jhtu [Ptg; nghUs;fspy; rpwpJ fye;Jk; ,Uf;fpd;wJ. 
  
                                                 
4NghfH epfz;L g.84 
5NghfH epfz;L g.73 
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6Sources 
Rarely met with free in nature, though very widely distributed in 
both the organic and inorganic kingdom.  Found in nearly all rocks soils 
etc.  Variously combined with oxygen as haematite, magnetic iron etc. Or 
with sulphur as iron-pyrites and as carbonate of iron, in spathi iron in the 
ashes of plants and even the blood (red corpuscles of the blood) of 
animals also in the bile, chyle, gastric, juice, lymph, milk, pigment of the 
eye and in the urine. 
7el;G ;;; - gifr; ruf;Ffs;; ; ;; ; ;; ; ; 
el;G    gif 
,uh[tHj;jk;  mz;lNthL 
fhe;jk;   mg;gpufk; 
nfe;jpr; nrk;G  fe;jp 
#ld;   fpspQ;rNyhL 
nrk;G   nfsup 
jq;fk;   rt;tPuk; 
ehfk;    rhuk; 
G+ehfk;   rpq;fp 
G+uk;    rpyhrj;J 
kA+ur; nrk;G  rpiy 
nts;sp   juh 
    epkpis 
    G+epW 
    tq;fk; 
    ntq;fhuk; 
    ntz;fyk; 
    nts;isg;ghlhzk; 
                                                 
6Indian Materia Medica. P.No. 54 
7Fzghlk; jhJ - rPt tFg;G g.64 
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8mar; nre;J}uj;jpd; kfpik; ; ; ;; ; ; ;; ; ; ;  
 ‘kz;lyq; fhypy; Neha; Nghk;;;;; kw;nwhd;wpy; typTz;lhFk;. 
 mz;L Kf; fhypd;gk;;; mg;Gw nkz;zq; fpl;Lk;; 
 nfhz;ltH jk;ikf; fz;L nfhz;l NgH gupr nka;Al; 
 nfhz;l NgH jkf;F Kz;lhk; $nwhzhr; rpj;jp jhNd” 
nghUs;;;; 
 mar; nre;J}uj;ijf; fhy; kz;lyk; cz;lhy; Neha; NghFk;. 
 Miu kz;lyk; cz;lhy; td;ik cz;lhFk;. 
 Kf;fhy; kz;lyk; cz;lhy; clYf;Fk;> kdJf;Fk; 
,d;gKz;lhFk; 
 xU kz;lyk; cz;lhy; vz;zpa vz;zk; if$Lk;NkYk; 
mar;nre;J}uj;ij tpjpg;gb cz;ltHfisghHj;jtHfSf;Fk; 
mtHfs; cly; guprj;ij nfhz;l 
NgHfSf;Fk;nrhy;yKbahj clw;rpj;jpfs; cz;lhFk; vd;W 
$wg;gl;Ls;sJ. 
gQ;r G+jj; jd;ik; ; ;; ; ;; ; ;  
,Uk;G- thA G+j cNyhfk; 
 ‘G+jnkd;w nrhd;dkJ G+kp ahr;R; 
  Gfohd fhupae; jz;zPuhr;R; 
 ehjnkd;w nrk;gJNt jPA khr;R; 
  eykhd tpUk;gJNt thA thr;R 
 Ntjnkd;w ehfkJ thD khr;R” 
,aw;if cNyhfk;; ;; ;; ; 
 ‘cw;Wg;ghH jq;fk; nts;sp nrk;G ehfk; 
  cUf;fpUk;G ntz;fyk; gpj;jis juhTk; 
 ej;jpg;ghH fhuPak; nts;sP ae;jhd; 
  eykhfg; gjpndd;wha;g; gpupe;j ijah “ 
,jpy; vl;L cNyhfq;fs; kl;Lk; ,aw;if cNyhfkhFk;.  
mjpy; ,Uk;G ,aw;if cNyhfg;gpuptpy; mlq;Fk;. 
  
                                                 
8NghfH fhu rhuj;Jiw 
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9Rit 
ngUk;ghd;ik; ;; ;; ;  
 JtHg;G 
rpWghd;ik;;;  
 Gspg;G 
 ifg;G 
nra;if;;;  
 grpAz;lhf;fp 
 cly; cukhf;fp 
 FUjpg;ngUf;fp 
 cly; Njw;wp 
nghJf;Fzk;; ;; ;; ; 
 ‘ghz;L ntz; Fl;;lk; gUe;J}y Neha;Nrhia 
 Khz;bbr;nra; ke;jq;fh khiyFd;kk; G+z;l 
 ngUe;jhJ el;lKk;Nghk; Ngjpgrp Az;lhq; 
 fUe;jhJ el;lkpLq; fhy;” 
,Uk;gpdhy; gpj;jghz;L> ntz;Fl;lk;> mjpJ}yNeha;> 
Nrhig> ke;jk;> fhkhiy> Fd;kk;> Rf;fpel;lk;> fopr;ry; ,it 
ePq;Fk;.  grp cz;lhFk; kw;Wk; 
‘,isj;jtH ,Uk;ig cz;z Ntz;Lk;” vd;w tpjpapid 
‘va;g;Glw; ,Uk;ig Az;kpd;” vDk; gonkhopahy; mwpf. 
10Njhlq;fs;; ;; ;; ; 
maj;jpw;F Itifj; Njhlq;fs; cz;nld;Wk; mtw;iw 
ePf;Fk; tif ,d;dntd;Wk; $wg;gl;bUf;fpwJ.  mjidf; 
fPo;tUk; nra;Al;fs; czHj;Jk;. 
 thWNf dpUk;Gf;ifq; Fzq;f Sz;L 
  tifahfr; nrhy;YfpNwd; ed;wha;f; NfSk; 
 jhWNfs; jpiurtpL Tilr;r Y}wy; 
                                                 
9Fzghlk; jhJ rPt tFg;G - g.64 
10Fzghlk; jhJ - rPt tFg;G g.66 
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  NgWNf spij ePf;f twpe;Njd; thjp 
 gpupj;jjpid ePf;fhjhd; gpze;jhd; ghNu 
  thWNfs; Fsk;ntl;l T+w;wg; Nghy 
 tk;kk;kh tpUk;G+wy; mUfh njd;Nd” 
 ‘mUfhj tUk;G+w yWf;ff; NfSk; 
  Milthd rhukpb yUF %wy; 
 jUfhj rtplWf;F rhw;wf; NfSk; 
  jaq;fhj fy;Yg;ghy; rtpL NghFk; 
 kUfhj jpiuNahf tupir NfSk; 
 
  tskhd tPukpbld; kzpNgh yhFk; 
 cUfhj [Puzpg;G Nghf ntd;why; 
  XNfhNfh #jkpl;Nl cUf;fpg; ghNu” 
 ‘ghug;gh Tile;jnjd;why; ehdj; J}J 
  gUtKl dQ;Rf;Fk; gaDe; nrhd;Ndd;”. 
 
 Cwy;   - rhuj;jpd; %yKk; 
 jpiu   - tPuj;jpd; %yKk; 
 rtpL   - fy;Yg;G %yKk; 
cilr;ry;  - Rf;F %yKk; 
rurk;   - #jj;jpd; %yKk; ePf;f Ntz;Lk; 
Grpf;f Vw;w khjq;fs;; ; ; ;; ; ; ;; ; ; ; 
 ij> khrp> gq;Fdp  - cj;jkk; 
 rpj;jpiu> itfhrp> Mdp - kj;jpkk; 
 Mb> Mtzp> Gul;lhrp  - mjkk; 
 Ig;grp> fhHj;jpif> khHfop - mjkhjkk; 
Grpr;f Vw;w epyk;; ; ;; ; ;; ; ; 
thj NehapdHf;F;;;  
 Ky;iy - cj;jkk; 
 FwpQ;rp - kj;jpkk; 
 nea;jy; - mjkk; 
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gpj;j NehapdHf;F; ;; ;; ;  
 nea;jy; - cj;jkk; 
 FwpQ;rp - kj;jpkk; 
 Ky;iy - mjkk; 
fgNehapdHf;F;;;  
 nea;jy; - cj;jkk; 
 FwpQ;rp - kj;jpkk; 
 Ky;iy - mjkk; 
thj> gpj;j> fgk; Mfpa %tif NehapdHf;F; ; ;; ; ;; ; ;  
 kUjk; - cj;jkj;jpy; cj;jkk; 
 ghiy - mjkj;jpy; mjkk; 
11Rj;jp Kiwfs;; ;; ;; ; 
xU gyk; (35 fpuhk;) mag;nghbf;F> 6 gyk; (210 fpuhk;) 
,Yg;igg;G+r; rhWtpl;L fhiy Kjy; khiy tiu ntapypy; itf;f 
Ntz;Lk;.  ,t;tpjk; MWehs; nra;J ,uz;Lehs; rhWtplhky; 
cyHj;jp gpd;Dk; ,ijg;Nghy ,Ukiw nra;J 25k; ehs; Kjy; gj;J 
ehl;fs; ,iltplhky; Nkw;gb rhWtpl;L ntapypy; itj;Jg;gpd;G 
rhWtplhky; ,uz;L ehs; cyHj;jp ePHtpl;Lf; fOtp vLf;fr; 
Rj;jpahFk;. 
xU gyk; maj;ij xU ghz;lj;jpypl;L mj;Jld; my;ypNtH 
vl;LgyKk; (280 fpuhk;) Gd;idNtH vl;LgyKk; (280 fpuhk;) 
,bj;Jg; Nghl;L gjpdhW gyk; (560 fpuhk;) fhbtpl;L ,uT gfYk; 
jPghf;dpaha; vupf;f Ntz;Lk;.  mg;gb vupj;jhy; mak; Rj;jpahFk;. 
maj;ijf; nfhy;yd; ciyapypl;L rptf;ff; fha;r;rp MWkhj 
md;df;fhb> vz;nza;> Mtpd;ePH> nfhs;FbePH ,e;ehd;fpYk; 
Kk;%d;W Kiw Njha;j;Jj; Njha;njLj;Jf; fOtpf; nfhs;sr; 
Rj;jpahFk;.  myk;Gjw;F xt;nthU KiwAk; Gjpa ePiuNa 
cgNahfpf;f Ntz;Lk;. 
                                                 
11Fzglk; jhJ - rPt tFg;G g.66 
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,Uk;gpd; mug;nghbia vYk;kpr;ir gor;rhW> fhb> ehl;L 
fhl;lhkzf;F ghy; ,it xt;nthd;wpYk; %d;W ehs; 
Cwitj;Jf; fOtpnaLf;fr; Rj;jpahFk;. 
mag;nghbf;F ehtw;gor; rhw;iw %o;Fk;gb tpl;L> rhW 
Rz;Lk; tiu ntapypy; itj;Jf; fOTf.  ,t;tpjk; MWKiw 
nra;a mak; Rj;jpahFk;. 
mag;nghbia fy;YUtpr; rhW (m) vYkpr;rk;go rhw;wpy; 
miuj;J gpd; fOtp vLf;f Rj;jpahFk;. 
12mag;nghbf;F vs;spd; nea;tpl;L 60 ehopif fopj;J 
tWj;njLj;J gPq;fhdpypl;L gor;rhW tpl;L fpz;b itj;jpUe;J 
ehd;F ehs; fopj;J gpd;G fOtpf; nfhs;s Rj;jpahFk;. 
13mag;nghbia vYkpr;rk;gor;rhw;wpy; 3 ehs; Cwitf;f 
Ntz;Lk; gpd; mij curp fOt Ntz;Lk;. 
14PURIFICATION 
Iron is purified by the following methods. 
It is first of all beaten into thin plates which are then heated in fire 
and when red-hot, plunged into the following liquids one at a time oil 
when conjie, cows urine and a decoction of dolichos uniflorus.  This is 
repeated three times in sucession. 
(OR) 
To get rid of impurities, boil one and half seer of water, reducing to 
quarter and then soaking in it half a seer of thin plates of cast iron which 
have been previously heated.  Repeat the process seven times. 
(OR) 
Powdered iron is to be meceratewd a while in the decoction of the 
three myrobalans (triphala), in cows urine and then to be mixed up with 
                                                 
12itj;jpa rpe;jhkzp g.237 
13mfj;jpaH Nyhf khuzk; g.110 
14Indian Materia Medica Pg140 
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butter and fired in an earthen vessel and stirred with an iron rod until a 
blade of straw thrown over catches fire. 
The iron powder is to be pounded and the above process  repeated 
five times.  One iron is roasted four times in a covered crucible with the 
decoction of the Myrobalan and is reduced to fine powder.  Leaves of 
Tikshna iron (steel or castiron) are repeatedly to bhe heated and plunged 
into water and then to be powdered in a stone mortar with an iron.  The 
powder of iron thus obtained is to bge roasted 20 times in a covered 
crusiable in combination with mercury and sulpher and after each 
roasting the powder of iron is to be pounded as directed above iron thus 
reduced to ashes is to be used in Medicine. 
15mak; NrUk; ghz;L Neha;f;fhd gpw kUe;Jfs;; ; ; ; ; ; ;; ; ; ; ; ; ;; ; ; ; ; ; ; 
mar;nre;J}uk;; ; ;; ; ;; ; ; 
 Rj;jp nra;j xU gyk; (35 fpuhk;) mag;nghbf;F fPo;g;gl;bay; 
fhZk; rhWfis Kiwg;gb tpl;L miuj;J tpy;iyjl;b cyh;j;jp 
Glkpl;L miuj;J vLf;fr; nre;J}ukhFk;. 
rhw;wpd; ngaH; ;; ;; ;  
msT 
gyk;;;; 
miug;G ;;;
ehs;;;; 
tpy;iy ;;;
cyHj;Jk; ; ;; ;; ;
ehs;;;; 
ftrk; ;;;
cyHj;Jk; ; ;; ;; ;
ehs;;;; 
Glk; ;;;
tul;b;;;  
rPNjtp nrq;fOePHr;rhW 5 5 4 1 30 
Miwapiyr; rhW 5 5 4 1 30 
KUf;fpiyr;rhW 5 5 4 1 30 
njd;dq;FUj;Jr; rhW 5 5 4 1 30 
gdq;FUj;Jr;rhW 5 5 4 1 30 
MlhNjhilr;rhW 5 5 4 1 30 
rPe;jpy; rhW 5 5 4 1 30 
J}JNtisr;rhW 5 5 4 1 30 
 
thiog;goj;jpy; cz;z ghz;L FzkhFk; 
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NtW 
 mag;nghbf;F vs;spd; nea;tpl;L 14 kzpNeuk; 40 epkplk; (60 
ehopif) fopj;J tWj;njLj;J> gPq;fhdpypl;L> gor;rhW tpl;L 
fpz;b itj;jpUe;J> ehd;F ehs; fopj;J gpd;G fOtpf; nfhs;sr; 
Rj;jpahFk;.  ,g;gb Rj;jp nra;j mak; 35 fpuhk;> nfe;jp 35 fpuhk;. 
,t;tpuz;ilAk; fy;tj;jpypl;L gor;rhw;wpdhy; 4 rhkKk; (12 
kzp) nghw;wpiyf;ifahd; rhw;why; 4 rhkKk; (12 kzp) miuj;J 
tpy;iy nra;J cyH;j;jp rpy;ypl;L gpd;G Nkw;Fwpg;gpl;l rhWfspdhy; 
,uz;lhk; Kiw miuj;J Kd;NghyNt Glkpl;nlLf;fr; 
nre;J}ukhFk;. 
msT 
 gzntil (488 kp.fpuhk;) 
Njdpy; nfhs;s ghz;L;;; >gpj;jntl;il> gpj;jthA> mNuhrfk;> 
kaf;fk;> the;jp ePq;Fk;. 
NtW 
 16‘Jg;gw; wag;nghbAk; Njhjhq; nfhbrPe;jpy; 
 nrg;Ge; jpupgiyAe; NrH tPjk; - xg;g 
 tpbj;Nj xUkpf;f ,l;L flj;jpy; 
 kbf;f tpLePiu thq;F 
 thq;Fehd tw;goKk; thlh jjd;gl;il 
 jhq;F kjd;rhw;iwj; jhdpl; - Vq;fhNj 
 jpq;fsh Nkhupuz;L Njd;nkhopNa! tpl;bUf;fpy; 
 jq;fpf; fiue;jpLNk jhd; 
 jhdh kUe;ijf; jfu tWj;jplNt 
 tPdh kjd;khR tpl;lfd;W -  Nfhdha; 
 tUk;gjj;jp yhtpd;nea; thh;j;njupf;fg; ghup 
 VWk;gjNkh ew;rptg;ngd; W}z; 
 cz;z kJNkfk; CJfh khiyAld; 
 ez;Zk; ngUQ;Nrhif ehlhNj - jpz;zkpJ 
 ghz;L;;; ngUk;ghL gw;wp tUk; gpj;jk; 
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 <z;L ahunjd;wh upq;F 
 ,q;F rrGlj;Nj apl;ltl nkd;wpbDk; 
 gq;FKW Kd;dpjw;Fg; gz;bjNu – rq;ifapiy 
 ghfKld; nra;J gUfg; gzntilNa 
 Mfk; tYf;F kwp” 
Gjpjhf ,uhtpa mag;nghb> rPe;jpy; nfhb> fLf;fha;> 
ney;ypf;fha;> jhd;wpf;fha; ,itfspd; #uzk; xt;nthd;Wk; 280 
fpuhk; (xU NrH tPjk;) xU kl;flj;jpy; Nghl;L> 1.32 yp (xU gb) 
ehty; gor;rhWk;> 1.32 yp (xU gb) ehfg;gl;ilr;rhW my;yJ mjd; 
fpahok; tpl;Lf; fyf;fp 2 khjk; tiuapy; mirahky; epoypy; 
itf;f mag;nghbahdJ cld; NrHf;fg;gl;Ls;s Jtuhd 
jputj;Jld; rk;ge;jg;gl;Lf; fiue;J gf;Ftg;gLk;.  gpd;dH <uk; 
tws> utpapy; cyHj;jp xU ,Uk;Gr; rl;bapypl;L nre;epwkhFk; 
tiu tWf;fTk;. 
tWf;Fk; gjkhdJ mag;n;ghbAld; Nrh;f;fg;gl;Lsls 
ruf;Fs; vy;yhk; rhk;gyhfpf; fhw;Wld; rk;ge;jg;gl;L ntspahfTk; 
makhj;jpuk; epd;wjhfTk; ,Uj;jy; Ntz;Lk;.  mj;jUzj;jpy; 
kPz;Lk; mjpfj; jPapl;L mak; rpte;jpUf;Fk; jUzj;jpy; (280 kp.fp) 
xU NrH nea;ia Cw;wp vupj;Jj; jhNd jzpAk;NghJ makhdJ 
khJsk;G+ epwj;jpw;F xg;ghfr; rpte;jpUf;Fk;.  mjid Mwtpl;Lg; 
nghbj;Jg; rPthtpypLf.  ,jidNtisf;F 488 kp.fpuhk; tPjk; nea;> 
Njd; Kjypaitfspy; nfhLf;f kJNkfk;> fhkhiy> 
Nrhif>ghz;L;;; > ngUk;ghL> gpj;jg;ghz;L Kjypa gy gpzpfisAk; 
eptHj;jp nra;tJld; NjfkhdJ tYf;Fk;.  MAs; tpUj;jpahFk;. 
NtW 
 ‘,r;ir aag;nghbia ,l;Lf;fh Nuhl;bdpy; 
 nkr;Rq;Nfh tpd;ePH kpjf;fpl;L – jr;Rfw;wp 
 tl;lg; gor;rhw;iw thH;j;Jld; Nky; %b 
 ,l;lg; gupkyj;J spq;F 
 ,q;fpU gj;Njh bUehSk; ePfhj;Jj; 
 jq;Fe;j jpupgiyapd; rhwpl;Lg; - nghq;fKld; 
85 
 
 Ml;b tiyjl;b> MFKO khnkUtpy; 
 ehl;b naLj;jplNt ed;W 
 ed;Nw Glike;J ehjhf;fs; $Wnkhop 
 nad;W kdk; nghWj;Nj Vw;ftiu - Ud;wpas 
 Tz;z kpUe;jhYk; Xj tpuj;jkpfk; 
 jpz;z kpJntd;Nw NjH” 
175 fpuhk; maj;J}is xU gPq;fhd; ghj;jpuj;jpy; Nghl;L 
%o;f gRePH tpl;L %d;W ehs; itj;J> ehd;fhtJ ehs; gRePiu 
tbj;J myk;gp epuk;gg; gor;rhW tpl;L Nky; mfy; %b ,uz;nlhU 
kz;rPiy nra;J itj;Jf; nfhs;f.  G+kpapy; xU Kok; MoKs;s 
rJukhd FopNjhz;b mjdpy; ghjpf;Fop tiuapy; Fjpiu 
yj;jpiag; Nghl;L mOj;jp mjd; Ngupy; Kd; Nfhg;igia itj;J 
NkYk; Fop epuk;gf; Fjpiu yj;jpiag; Nghl;L mOj;jp Nky; kz; 
NkbLk;gbahfr; nra;f.  ,q;qdk; %d;W thuk; itj;J vLj;J 
maj;J}isf; fy;tj;jpypl;L jpupgiyapd; fpahoj;jpdhy; 108 kzp 
NeuKk; rhkk; ed;F miuj;J tpy;iy nra;J fha;e;jgpd; mfypy; 
mlf;fp rPiy nra;J cyHe;jgpd; Gspak;Gwzp fhl;nlU$l;b 
miuf;f[f; Fopg;GlkplTk;.  ,q;qdk; 5 Glkpl;nlLj;Jf; 
fy;tj;jpypl;liuj;J rPrhtpy; itf;fTk;.  Njf jplj;jpw;F jf;fthW 
65kp.fp. Kjy; 10 kp.fp. tiu Njd;> nea; Kjypa mDghdq;fspy; 
jpdk; ,UnghOJ nfhLj;J tu ,uj;j tpUj;jpAk;; ; ;; ; ;; ; ;>ey;y Nj[Rk; 
cz;lhFk;.  Gsp js;sp ,r;rhgj;jpak; ,Uj;jy; ed;W. 
NtW 
 17‘maj;J}sp dpuz;L kzy;nfe;jp ahW 
 eag;ghd fy;tj;Nj ehl;b - af;fKw 
 Rz;zePH nfhz;bq;Nf nry;NyO ehsiuj;J 
 ,d;dywf; fha;e;jplNt apl;L 
 ,l;l taKs <d;W kz; Nzhl;ljdpy; 
 tl;lr; rpWjPapy; thl;lKwh - jpl;L 
 tWj;Jg; Gifg;Nghf;fp thq;FQ;rpe; J}uk; 
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 rWf;fh jjd;td;ik rhw;W 
 rhw;wq; fuprhiy rj;jjpdp xl;nfhs;sj; 
 Njhw;W q;fhkhiy Kjy; Nrhifnayhk; khw;wpLNk 
 ntg;ghiyr; rPufKk; Ntftpl;l ePujdpy; 
 fg;GQ;Q iyg;NghLq; fhz; 
 fhZk; gpuNkfk; fz;bf;Fk; ghyjdpy; 
 fhZq; fpuhzp eWe;Njdpy; - NtWk;eP 
 ej;Jk; GifGspAk; ehl;bw;ngz; zpr;irANk 
 gj;jpae;jhd; ePf;fplNt ghH”. 
Rj;jkhd ,Uklq;F mag;nghbf;F MW gq;F rpiy 
nfe;jfj;ijf; $l;bf; fy;tj;jpy; Nghl;Lf; fw;Rz;zj;ij ehd;F 
klq;F jz;zPH tpl;L fiuj;Jf; njspntLj;j jz;zPiu tpl;L 
VOehs; ed;wha; miuj;J utpapy; cyHj;Jf.  gpd;dH ,jidg; 
nghbj;J xU kz;Nzhl;bNyDk;> ,Uk;G thdhtpNyDk; ,l;L 
Gif Nghf tWj;J vLf;f ey;y nre;J}ukhFk;.  ,jidf; 
fy;tj;jpypl;L ed;wha; 12 kzp Neuk; miuj;Jr; rPrhtpyplTk;.  
,e;jr; nre;J}uj;jpy; (gzntil) 488 kp.fp. fuprhiy Nyfpaj;jpy; 
cl;nfhs;s fhkhiy>ghz;L;;; > Nrhif FzkhFk;. 
NtW 
mag;nghbia vYkpr;rk; gor;rhw;wpy; 3 ehs; Cwitf;f 
Ntz;Lk;.  gpd; mij curp fOt Ntz;Lk;.  gpd; rhag;nghbia 
vLj;Jf; nfhz;L thNye;jpug;gl;il> ehty;gl;il> 
fuprhyq;fz;zp> fw;whio ,tw;wpd; rhw;wpy; jdpj;jdpNa 
xt;nthU ehs; Cwitf;f Ntz;Lk;.  gpd;dH cyh;j;jp ciyapy; 
,l;L Nky; %b f[Glk; 3 juk; Nghl;L vLj;Jf;nfhs;sTk;. 
mDghdk;  : Njd;> jpupfLF nghb 
jPUk;gpzpfs; : ghz;L;;; > Nrhif> ,isg;G> ,Uky;> 
ml;lFd;kk;>gpj;jk;> fpuhzp 
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18NtW 
mak; 87.5 fpuhk; Rj;jp nra;j ney;ypf;fha; fe;jfk; 87.5 fpuhk; 
gyk; fy;tj;jpypl;L gor;rhW tpl;L jpdKk; 6 kzp Neuk; tPjk; 8 
ehs; miuj;J tpy;iy nra;J cyHj;jp XH rl;bapypl;L Nky; rl;b 
%br; rPiy nra;J mLg;gpNyw;wp Kj;jPahf 12 kzpNeuk; 
vupj;njLf;f nre;J}ukhFk;.  ,ij vLj;Jg; nghbj;Jf; 
fy;tj;jpypl;L fuprhiyr; rhW tpl;L jpdKk; 6 kzpNeuk; tPjk; 5 
ehs; miuj;J tpy;iy nra;J cyHj;jp rl;bapypl;L Nky; rl;b %b 
rPiy nra;J mLg;gpNyw;wp vupj;J vLf;f ey;y nre;J}ukhFk;. 
msT  : Fd;wp vil 130 kp.fp. ,Untis fuprhiy   
                               fw;fj;Jld; Njd; NrHj;Jf; nfhLf;fTk;. 
jPUk; gpzpfs; : ghz;L> Nrhig> fhkhiy> ,uj;j tpUj;jp  
cz;lhFk;. 
mankOF 
 mag;nghb   - 70 fpuhk; 
 nghupj;j ntq;fhuk; - 35 fpuhk; 
 ethr;rhuk;   - 8.75 fpuhk; 
 Gspg;G khJis ,urk; - 700 fpuhk; 
,tw;Ws; Kjy; %d;W ruf;FfisAk; fy;tj;jpypl;L rhW 
tpl;L miuj;J> ,Uk;Gr; rl;bapypl;L mLg;Ngw;wp rpWjPahy; vupj;J 
Nkw;gb rhw;wpy; nfhQ;rk; nfhQ;rkha; tpl;Lf; fpswpf;nfhz;Nl 
rhW KOtJk; KbAk;tiu vhpj;J nkOFg;gjj;jpy; ,wf;fpf; 
nfhs;sTk;.  gjk; tUk;tiu rhw;iw cgNahfpf;f Ntz;Lk;. 
msT  : 2 Kjy; 4 fpuhk; 
jPUk; gpzpfs; : vz;tifg; ghz;L;;; > gpj;jntl;il> Nrhig> 
fhkhiy 
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19magpUq;fuh[ ghzpjk;; ;; ;; ; 
‘ght Nktpa fUe;jh jpd;nghb gilKe; fdpkuprk; 
ghzk; jd;Kjy; fWntz; KiwNa gyk;gj; jiuNafk; 
NktpL k‡j‡ njhd;wiunahd;wiu tpsk;nghd;wiuahFk; 
tpiuNjd; gidnty; yk;gpU ghdJ kpsHif ahd; gbahk; 
 
ghtfd; itj;jpL Ghpgh zpjkha;g; gfupj dgpjhdk; 
ghua gpUq;f uh[k njd;g gz;Ls tpidahNy 
jhtuj; jf;Fiu thnyL ghz;Lit jow;fh kpiyNrhig 
jzpah Tju kf;fpdp khe;jpak; jg;gh njhopANk” 
 
fhprhiyr; rhw;wpYk; ney;ypr;rhw;wpYk; ghtdQ; nra;ag;gl;l 
mug;nghb gyk; 10 (350 fpuhk;)> Rf;Fgyk; ½ (17.5 fpuhk;)> fLf;fha; 
gyk; 1 (35 fpuhk;)> kpsF gyk; 1 ½ (52.5 fpuhk;)> jpg;gpyp gyk; 1 ½ 
(52.5 fpuhk;)> jpg;gpyp %yk; gyk; 1 ½ (52.5 fpuhk;)> Njd; gyk; 20 
(700 fpuhk;)> gidnty;yk; gyk; 20 (700 fpuhk;)> Gjpa ifahd;rhW 
1 gb (1.32 yp.) ,itfisr; fye;J jPapl;L vhpj;J kzg;ghF nra;J 
nfhs;sTk;.  ,jidj; jf;f msTld; nfhLj;Jtu ,uj;jf; 
Fiwtpdhy; cz;lhFk; ghz;L;;; > gpj;jk;> fhkhiy> Nrhig> ePq;fha; 
ngUtapW mf;fpdpkhe;jk; Kjypad ePq;Fk;. 
mark;gPu fw;gk;; P ; ;; P ; ;; P ; ; 
‘Ml;Lj; Jfs;fhp jphpnjhb gg;gj; jiuia nahz;aUisf; 
fhl;Lf; fdpAs;sit iak;G+ jj;njhU fyKs; dpLjynea; 
$l;Lj;njhifKd; $wpU rpy;ypL FioapL kz;lyNk 
xl;Lg; gpsnthd; wpUNgh JZghz;nlhL nghLNrhgAkWNk” 
mag;nghb gyk; 10 (350 fpuhk;)> kpsFj;J}s; gyk; 10 (350 
fpuhk;)> cupj;j G+z;L gyk; 10 (350 fpuhk;) Mfpa ,k;%d;iwAk; 
miuj;J ehw;gJ gq;fhf;fp vYkpr;rk;gok; 40 vLj;J> 
xt;nthd;iwAk; ehyhfg; gpse;J tpij ePf;fp> xt;nthU gq;if 
xt;nthU goj;jpy; itj;J xU kz;ghz;lj;jpy; mikj;J> mjpy; 
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60 gyk; (200 fpuhk;) vz;nza; tpl;L> xU %b nkOFr; rpiy 
nra;J jhkiuf; Fsj;Jf Fioe;j kz;zpy; Gijj;J> xU 
kz;lyk; fopj;njLf;fTk;.  ,jpy;  gpsT xd;W ,uz;L Ntis 
tPjk; cz;Ltu ghz;L;;;  NehAk;> Nrhig NehAk; ePq;Fk;. 
20MWKfr; nre;J}uk;; ; ;; ; ;; ; ; 
 ,urk; - 25 fpuhk; 
 fhe;jk; - 35 fpuhk; 
 fe;jfk; - 45 fpuhk; 
 ntq;fhuk; - 40 fpuhk;  
 ,e;Jg;G - 20 fpuhk; 
mag;nghb - 60 fpuhk; 
Nkw;$wpa ruf;Ffs; midj;ijAk; Kiwg;gb Rj;jp nra;J 
fw;whioghy; tpl;L 5 ehl;fSk;> nrk;gUj;jpg;G+ (m) nrk;gUj;jp 
,iyr;rhW tpl;L 3 ehl;fSk; ed;whf nefpo miuj;J rpW 
tpy;iyfshfj; jl;b XH thafykhd rl;bapypl;L Nky; rl;bahy; 
%b 2 kzpNeuk; fkyhf;fpdp> jPghf;fpdp> fhlhf;fpdpahf KiwNa 
vupj;njLj;Jg; ghHf;f khJsk;G+ epwj;jpy; tpy;iyfs; rpte;jpUf;Fk;.  
,e;j tpy;iyfis fy;tj;jpypl;L ed;whf nefpo miuj;J vLf;f 
caHe;j nre;J}ukhFk;. 
msT  : muprp vil 65 kp.fp. fhiy khiy  
,Untis 
mDghdk;  : jphpfLFr; #uzj;Jld; Njd; fye;J  
cl;nfhs;s Ntz;Lk; 
jPUk; Neha;fs; : ghz;L> Nrhif> fpue;jp> mjprhuk;> 
fz;lkhiy  %yk; Fd;kk;. 
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21mafhe;j nre;J}uk;; ; ;; ; ;; ; ; 
 mag;nghb  - 9  fpuhk; 
 nfe;jfk;  - 9 fpuhk; 
 ,ypq;fk;  - 9 fpuhk; 
 ntq;fhuk;  - 9 fpuhk; 
 fk;gpr;rhuk;  - 9 fpuhk; 
 cg;G   - 17 fpuhk; 
 #lk;   - 9 fpuhk; 
 gbfhuk;  - 9 fpuhk; 
 cg;G   - 9 fpuhk; 
 fhe;jk;  - 9 fpuhk; 
 Nkw;$wg;ngw;w ruf;Ffis Fopak;kpapypl;L gor;rhwpdhy; 24 
kzpNeuk; miuj;J tpy;iy nra;J fhaitj;J tuhfg;Glkpl 
KUf;fk;G+g;Nghy; rpte;j nre;J}ukhFk;. 
msT   - 65 kp.fp. fhiy khiy ,Untis 
mDghdk;   - Njd; 
jPUk; gpzpfs;  - ghz;L;;; > Nrhif 
manfe;jpr; nre;J}uk;; ; ; ;; ; ; ;; ; ; ; 
 ney;ypf;fha; fe;jfk; - 450 fpuhk; 
 ,Uk;G mug;nghb - 150 fpuhk; 
,uz;ilAk; fy;tj;jpypl;L fw;Rz;zhk;G njspePH tpl;L 
xUehs; miuj;J fhaitj;J xU GJr;rl;bapypl;L tWf;f xU 
rhkj;jpy; nre;J}uk; MFk;.  ,ijr; rPrhtpy; gjdQ; nra;aTk;. 
msT   : 130 kp.fp. fhiy khiy 
mDghdk;   : ,Q;rpr;rhW> Njd;> nea; %d;iwAk;  
rkkhfr; NrHj;J rhg;gplNtz;Lk;. 
jPUk; gpzpfs;  : #iy18> fpuhzp>ghz;L;;; > Nrhif> 
Gz;> Giu 
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magw;gk;; ;; ;; ; 
 ,Uk;Gj;J}s; (Rj;jp nra;jJ) -  35 fpuhk; 
 FUf;fj;jp G+tpd; rhW  - 250 kp.yp. 
Kjypy; ,Uk;Gj;J}is Fopak;kpapypl;L Nkw;gb G+tpd; 
rhw;iwtpl;L ed;F nefpo ,iltplhJ %d;W Kjy; 5 ehl;fs; 
miuj;J fhrsTs;s tpy;iyfisj; jl;b ntapypy; ed;F cyHj;jp 
Gspapiyia miuj;J %ir nra;J %irf;Fs; cyHj;j 
tpy;iyfis itj;J %irf;F kz;rPiy nra;J kz;rPiy ed;F 
cyHe;jgpd; 50 vUtpy; GlkplTk;.  Glk; ed;F Mwpagpd; Glj;ijg; 
gpupj;J kUe;ij vLf;f gw;k; Jk;igg;G+itg; Nghd;W ntz;ikahf 
,Uf;Fk;. 
msT  : 0.024 fpuhk; (fhiy>  khiy ,Untis) 
mDghdk;  : rHf;fiu> Njd;> ntz;nza; 
jPUk; gpzpfs; : ghz;L>;;; NkfNeha;fs;>FspHRuk;> ,Uky;> 
,iug;G>fl;bfs; FzkhFk;. 
NtW 
 mug;nghb : 420 fpuhk; 
 ,ypq;fk; : 35 fpuhk; 
,itfisr; Rj;jp nra;J fw;whior; rhw;why; 8 kzpNeuk; 
miuj;J tpy;iyjl;b xl;bypl;L rPiykz; nra;J tuhfGlk; 
NghlTk;.  mt;tpjk; 7 Kiw Glk; Nghl;L vLj;J gj;jpug;gLj;jTk;. 
msT 
 130 kp.fp. ntz;nza; nfhLj;jTld; fUq;Fuit 
muprpiaAk;> nte;jaKk;> ntq;fhaKk; NrHe;j frhak; (m) NtW 
frhaq;fSk; nfhLf;fj; jPUk;. 
jPUk; Neha;fs;P ; ; ;P ; ; ;P ; ; ; 
 ghz;L;;; > fzr;#L> Nrhig> ,isg;G> gpj;j thA FzkhFk;. 
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22,ytq;fhrtk;; ;; ;; ; 
msT   : 35 fpuhk; ,Untis 
jPUk; Neha;fs;  : ghz;L;;; > Nrhig> fhkhiy jPUk; 
23jq;f manre;J}uk;; ; ;; ; ;; ; ; 
msT   : jpdk; ,Ukiw 130kp.fp. jf;f  
mDghdj;jpYz;z Ntz;Lk;. 
jPUk; Neha;fs;  : ghz;L;;; > ePupopT FzkhFk;. 
24mafhe;j mg;gpuf nre;J}uk;; ; ; ;; ; ; ;; ; ; ; 
msT   : jpdk; ,Ukiw 65kp.yp.fp. Njdpy;  
fye;J cz;z Ntz;Lk;. 
jPUk; Neha;fs;  : ghz;L;;; > fhkhiy> mf;dpkhe;jk;  
ePq;Fk; 
25rg;jur nre;J}uk;; ; ;; ; ;; ; ; 
msT   : 130kp.yp.fp. ,Untis nea;> Njdpy;  
fye;Jcz;z Ntz;Lk;. 
jPUk; Neha;fs;  : ghz;L;;; > ghurthA> Fd;kk;  
FzkhFk;. 
26manre;J}uk;; ;; ;; ; 
msT   : 130kp.yp.fp. ,Untis Njdpy; fye;J  
cz;z Ntz;Lk;. 
jPUk; Neha;fs;  : <is> ,Uky; FzkhFk;. ,uj;j  
tpUj;jpahFk;. Gsp ePf;fTk;. 
  
                                                 
22fz;Zrhkp guk;giu itj;jpak; g129 
23rpfpr;rh uj;djPgk; vDk; itj;jpa E}y; g68 
24rpfpr;rh ud;j jPgk; vDk; itj;jpa E}y; g86 
25rpfpr;rh uj;djPgk; vDk; itj;jpa E}y; g72 
26rpfpr;rh uj;djPgk; vDk; itj;jpa E}y; g83 
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maf;fl;L nre;J}uk;; ; ; ;; ; ; ;; ; ; ; 
msT  : 200 kp.yp.fpuhk; Njdpy; cz;z Ntz;Lk;. 
jPUk; Neha;fs; : #jf typ> ghz;L> iffhy; RSf;F  
FzkhFk;.,r;rhgj;jpak; 
27mankOF 
msT  : Ntisf;F 130 kp.yp.fpuhk; ,Untis  
cz;z Ntz;Lk;. 
jPUk; Neha;fs; : jhJtpUj;jpAk;>,uj;j ngUf;fKk; ;; ;; ; ;  
cz;lhFk;. Gsp ePf;fTk;. 
jpupGtdr; nre;J}uk;; ; ;; ; ;; ; ; 
msT  : 260 kp.fp. ,Untis Njdpy; cz;z  
Ntz;Lk;. 
jPUk; Neha;fs; : ghz;L;;;  Nuhfk; NghFk;. 
28jpupNyhfr; nre;J}uk;; ; ;; ; ;; ; ; 
msT  : Ntisf;F 130 kp.fpuhk; vil nea;> Njdpy;  
cz;z Ntz;Lk;. 
jPUk; Neha;fs; : ghz;L;;; > Nrhig> fhkhiy> grpapd;ik  
FzkhFk;. 
29mafhe;j fw;fk;; ; ;; ; ;; ; ; 
msT  : 65 kp.fp. ,Untis 5 ehs;  
,Q;rpr;rhW (m) gor;rhw;wpy; 
nfhLf;f. 
jPUk; Neha;fs; : ghz;L>;;; Nrhig> fhkhiy jPUk;.  
NkhUk; md;dKk; fl;Lf. 
  
                                                 
27rpfpr;rh ud;j jPgk; vDk; itj;jpa E}y; g105 
28gjhHj;j Fztpsf;fk; g143 
29itj;jpa rpe;jhkzp g136 
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30rpQ;rhjp Nyfpak;; ;; ;; ; 
jPUk; Neha;fs;  : 5 fpuhk; 2 Ntis cz;z  
ghz;L>;;; fhkhiy jPUk;. 
gj;jpak;   : Gsp> cg;G> khkprk;> fLF> 
ey;nyz;nza; ePf;fTk;. 
 
  
                                                 
30ruNge;jpuH itj;jpa Kiwfs; 
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31vYkpr;ir;;;  
Botanical name   -   Citrus Limon 
Family         -      Rutaceae 
Eng  -  Lime 
Mal  - Cheru ,Naranga 
Hind  - Ninbu limu 
Tel  - Nimma  
Kan  - Nimbe 
Sans  - Jambira 
,J> nrb vYkpr;ir vd;Wk; nfhb vYkpr;ir vd;Wk; ,U 
tifg;gLk;. ,J ,e;jpah KOikAk; Njhl;lf;fhy; gapuhfr; 
nra;ag;gLfpwJ.  
 Rkhh; 8 Kjy; 10 mb cauk; tsUk;. ,iy> Nkw;Gwk; 
gRikAld; rpW Gs;spfisAk; cilj;jhapUf;Fk;. ,g;Gs;spfspy; 
vz;nza; epiwe;jpUf;fpwJ. ,r;nrb KOikAk; ePz;L 
gRikAs;sjhd Kl;fs; epiwe;jpUf;Fk;. ,jd;> goj;jpd; Njhy;> 
rw;W kQ;rs; epwkhfTk; vz;nza; fye;j Gs;spfisAilajhfTk; 
xU tpj ey;y kzKilajhfTk; ,Uf;Fk;. fhahf ,Uf;Fk; NghJ 
gr;ir epwkhf mUf;Fk;. 
 g -  c     ,iy> fha;> gok;> gourk;> vz;nza; 
,iy  Rit  - Gspg;G> jd;ik - ntg;gk;> gphpT - fhh;g;G. 
nra;if ;;;  
 Fsph;r;rpAz;lhf;fp 
ORGANOLEPTIC CHARACTERS:- 
fha;;;;>gok;;;;:- 
(TASTE) Rit    - Gspg;G>(Sour) 
(POTENCY)jd;ik   -  ntg;gk;>(Hot) 
(BIO TRANSFORMATION)gphpT - fhh;g;G> (Pungent) 
                                                 
31Fzghlk; %ypif g156 
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nra;if;;;  
 Fsph;r;rpAz;lhf;fp 
Njhy; ;;;  
 Rit- Gspg;G> fhh;g;G> jd;ik - ntg;gk;> gphpT -fhh;g;G 
nra;if :;;;  
 jbg;Gz;lhf;fp 
 mfl;Lthy; 
fha;;;; 
Fzk;;;; 
 ,J Kf;Fw;wk;> #iy> the;jp> Fd;kk;> ,LkUe;J> moy; 
,itfisg; Nghf;Fk;. 
‘jPnjY kpr;rq;fha; Nlh;Kj;Njh lj;ijAKs; 
thjfg #iyiaAk; khnfhba - rhjpnaDQ; 
rh;j;jpFd; kj;ijAKs; jq;fkUe; jpl;lj;ijAk; 
gpj;jntg;ig Ae;jzpf;Fk; NgR.” 
vYkpr;ir;;;  
“rjhgyf; fdpfha r%yK KzNt 
epjhdkha;g; gapj;jpa epe;ijiah afYNk” 
(ngh.s;) vYkpr;rk;gok;. vYkpr;rq;fha;> vykpr;ir Nth;> ,iy 
,itfisf; nfhs;spd;> jPf;Fw;wj;jhy; cz;lhd Neha;fSk;> 
ntwp NehAk; Nghk;. 
rk;gPuk; ; P ;; P ;; P ; - (vYkpr;ir);;;  
“ke;jphpf;F ke;jphpaha; kd;dDf;F kd;dnddj;  
je;jphpf;F kpj;jpud;Nghw; rhUNk - Ke;jtU 
fk;gPu kha;r;ruf;fpd; nfz;zpakha; thlflh;f;Fr;  
rk;gPu khnkYkpr; ir.” 
vYkpr;irgok; ke;jphp vdf; $Wk; jPf;Fw;wj;jijj; jzpf;Fk;> 
je;jhpahfpa Iaj;jpw;F md;gd;NghypUe;J mdy; tsh;f;Fk; 
(Iaj;ij kpFjpg;gLj;Jk;) 
- Njud; ntz;gh; ;; ;; ;  
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gok;;;; : 
Fzk; :;;;  
,J kaf;fk;> the;jp> tha;f;Fkl;ly;> ePh; Ntl;if> ntwp> 
fz;Nzha;> fhJ typ ,itfisg; Nghf;Fk;. efr;Rw;Wf;Fk; ed;ik 
jUk;. 
 “jhfk; FefNeha; jhohr; rpypgjNeha; 
 Ntfq;nfhs; cd;khjk; tPWgpj;jk; - khfz;Nzha;  
 fd;dNdha; the;jpAk; Nghq; fl;Lth epj;njhopypy; 
 kd;ndYkpr; rq;fdpia tho;j;J.” 
t.F : Ruj;jpy; cz;lhFk; the;jpfl;Fk; tha;f;Fkl;lYf;Fk;     
,g;gourj;jpdhy; nra;ag;gLk; rhjp rk;gPuf;Fok;G ew;gaidj;jUk;. 
,g;gourj;NjhL rh;f;fiu $l;b ePh; Nrh;j;Jg;ngUf;fp 
ePh;tplha;f;F mUe;jyhk;. 
vYkpr;rk;goj;ij> urKk; CWfhAkhff; fw;gKiwaha;g; 
gj;jpaj;JlNd MWkhjq;nfhs;s eiu> jpiu> khWk;. gpbg;G> 
ngUtapW> gf;f#iy>Klk;> ntwp> kaf;fk;> kdr;Nrhh;T 
vd;gitfSk; mbNahL ePq;Fk;. 
 “Nfhzj; JisAq; FwpAidq; nfhf;fhfpy; 
 Nfhzj; JisAq; FUisNghw; - Nfhzr;  
 rlkjpAz; khwhkw; rk;gpuf; fw;gQ; 
 rlkjpAz; khwhkw; rz;.” 
gts gw;gj;ij> ,g;gor;rhw;Wld; Nrh;j;J rPjf;fopr;ry; 
ngUq;fopr;ry;> mjprhuf; fopr;ry; ,itfSf;Ff; nfhLj;J 
tuyhk;.  
fopr;rYf;fhf kUe;Jfs; nfhLj;J mlq;fhj fopr;rYk; 
the;jpAk; Nehpl;lhy; rPufj;ijj; Njd; tpl;Lg; nghd;tWtyhf 
tWj;J> ,jd;gourj;ijr; Nrh;j;J ePh;tpl;Lf; fha;r;rpf; nfhLf;f 
clNd the;jpAk; fopr;rYk; ePq;Fk;. 
,jdpiyiaf; fhbapypl;L ePuhfhukhfg; gUFtJ ekJ 
ehl;Lg; gof;fk;. 
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GEOLOGICAL ASPECT 
IRON 
 Iron plays an important role in biology, forming complexes with 
molecular oxygen in hemoglobin and myoglobin; these two compounds 
are common oxygen transport proteins in vertebrates. Iron is also the 
metal used at the active site of many important redox enzymes dealing 
with cellular respiration and oxidation and reduction in plants and 
animals. 
32PERIODIC TABLE 
Atomic Number   : 26 
Atomic Symbol  : Fe 
Atomic Weight  : 55.847 
Electron configuration : [Ar} 4S2 3d6 
CAS No.   : 7439-89-6 
Density (near r.t.)   7.874g.cm-3 
Liquid density at m.p.  6.98 cm-3 
Melting point   1811K, 1538oC, 2800oF 
Boiling    3134K, 2862 oC, 5182oF 
Heat of fusion   13.81 kJ mol-1 
Heat of  vaporization  340kJ  mol-1 
Molar heat capacity  25.10 J  mol-1 K-1 
Vapor pressure 
P(pa) 1 10 100 1k 10k 100 k 
at  T (K) 1728 1890 2091 2346 2679 3132 
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Atomic properties 
Oxidation states  6, 5, [1] 4, 3, 2, 1[2], -1,-2 
    (amphoteric oxide) 
Electronegativity  1.83 (Pauling scale) 
Ionization energies 1st : 762.5kJ mol-1 
    2nd : 1561.9 kJ mol-1 
    3rd : 2957 kJ mol-1 
Atomic radius   126 pm 
Covalent radius   132 ± 3(low spin), 152 ± 6 (high spin) pm  
33Iron is an essential constituent of haemoglobin, cytochromes 
and other components of respiratory enzyme systems like cytochrome 
oxidase, catalase and peroxidose. 
The main functions of iron are 
1. Transport of Oxygen to the tissues 
2. Participation in cellular oxidation mechanism. 
Sources 
Rarely met with free in nature though very widely distributed in 
both organic and inorganic kingdoms found in nearly all rocks, soils 
etc. Variously combined with oxygen as haemiatite magnite iron ore 
etc, with sulphur as iron pyrites and as carbonate of iron, in spathi 
iron in the ashes of plants even in blood of animals also in bile, chyle, 
gastric juice, lymph milk, pigment of eye and in the urine. 
  
                                                 
33Indian Materia Medica Page No. 54. 89 
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34ntSg;G Neha;; ;; ;; ; 
NtWngaH 
 ntz;ik Neha;> ghz;L 
,ay;G;;;  
 ,aw;if epwkhwp> cly; ntSj;J fz;izAk; 
eff;fz;izAk; ePf;fpg; ghHf;fpd; Fujpapd;wp ntSj;jpUf;Fk;. 
Neha; Njhd;Wk; top; ; ;; ; ;; ; ;  
 FUjpapd; td;ikiaf; Fiwf;ff; $ba cg;G> GspAs;s 
nghUs;fis kpFjpahf nfhs;tjhYk; Ruk;> Ngjp> the;jp> fPy;thA 
Kjypa Neha;fSf;Fl;gLjyhYk; Fujpia msT fle;J 
ntspahf;Fk; ngUk;ghL> FUjpaoy; Neha;> 
FUjpf;fopr;ry;>KisNeha;> FUjpthe;jp Kjypait 
ntspg;gLjyhYk; ,e;Neha; cz;lhFk;. 
Kw;Fwpfs;; ;; ;; ; 
 czT Kjypa NtWghLfshy;> jPf;Fw;w kUe;J> FUjpapd; 
epwj;ijAk; viliaAk; nfLj;J> clw;F Ntz;ba Cl;lj;ijAk; 
nflhky;> cliy ntSf;f nra;Ak;. 
Neha; vz;; ;; ;; ; 
 Fw;wj;jhy; tUtd ehd;Fk;> eQ;rhy; tUtd xd;Wk; $b 
Ie;jhFk;. 
1. tsp ghz;L 
2. gpj;j ghz;L 
3. Ia ghz;L 
4. Kf;Fw;w ghz;L 
5. eQ;R ghz;L 
md;wpAk;> FUjpf;Fiwthy; clw;fl;Lfs; nkype;J> cly; 
tPq;fp> epwkhwp kQ;rs; my;yJ ePyepwk; ngw;W> kpFe;j 
ePHNtl;if>mbf;fb  kaf;fk; tUjy;> kdr;NrhHtiljy;>mwpT 
jLkhwy;> Mz;ik Fiwjy; vd;Wk; FwpfisAk; fhl;Lk;.  
,e;Nehapid 
                                                 
34nghJ kUj;Jtk; g345 
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 ePyg;ghz;L 
 myrg;ghz;L 
 mypKfg;ghz;L  
vd %tifahf toq;FtH. 
nghJf;Fwp Fzq;fs;:; ; ;; ; ;; ; ;  
 elf;f ,ayhik 
 jiy Nehjy; 
 khHG Jbj;jy; 
 jiy Rw;wy; 
 kaf;fKz;lhjy; 
 %r;Rj;jLkhwy; 
 grpj;jPf;nfly; 
 czT Ntz;lhik 
 ehntbj;Jg; Gz;zhjy; 
 ntSj;Jj; Njhy; RUq;Fjy; 
 eff; fz;fs; jbj;J ntSj;jy; 
 njhz;il fl;ly; 
Fw;w Kjypa NtWghLfs;:; ;; ;; ;  
 cly; td;ik Fiwe;J grpj;jP Nflile;J> cz;l czT 
rupahfr; nrupahkw;NghFk;.  cztpd; Nfl;lhy; ,ur FUjpfSf;F 
Cl;lk;ngwh.  mjdhy; mitfSf;F NjhYf;F epwj;ijf; 
nfhLf;Fk; moy; nkype;J> epwj;jpYk;> vilapYk; Fiwe;J> 
jPf;Fw;wj;ijg; ngUf;Fk;. 
czT: 
 fPiu tiffspy; fuprhiy> nghd;dhq;fz;zp> mWfPiu> 
rpWfPiu> kzj;jf;fhsp> jhspf;fPiu ,itfs; Fujpia ngUf;ff; 
$badthk;. 
fha;fwpfspy; fj;jpupg;gpQ;R> KUq;ifg;gpQ;R> thiof;fr;ry;> 
mtiug;gpQ;R Kjypad vspjpy; nrupf;ff;$bad. 
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35ANAEMIA 
Other names:  
 Iron poor blood  
 Low blood  
 Tired blood. 
Definition:  
 Ancient Greek meaning “without blood”.Anaemia refers to a state 
in which the level of hemoglobin in the blood is below the normal range 
appropriate for age and sex .It is also defined as a qualitative or 
quantitative deficiency of hemoglobin, a molecule found inside red blood 
cells.  
Since hemoglobin normally carries oxygen from the lungs to the 
tissues, anemia leads to hypoxia (lack of oxygen) in organs. Since all 
human cells depend on oxygen for survival, varying anemia is also 
caused by a lack of iron in the body.  
The clinical features of anemia reflect diminished oxygen supply to 
the tissues and depend upon the degree of anaemia, the rapidity of its 
development and the presence of cardio respiratory disease.  
Anemic ranges of hemoglobin: 
 Adult men: < 13.0  
 Non pregnant women: < 12.0  
 Pregnant women: < 11.0  
Grading of anemia: 
WHO grades anemia according to hemoglobin level as follows, 
 Hb between 10 gm and cut off point for age -Mild  
 Hb between 7 to 10 gm -Moderate  
 Hb under 7 gm -Severe  
 Hb under 5 gm -Very severe. 
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Classification of anaemia:  
1. Morphological classification  
A.Normocytic anemia  
B.Microcytic anemia  
C.Macrocytic anemia  
2. Pathological classification  
A.Anaemia due to blood loss  
B.Anemia due to impaired red cell production  
C.Anemia due to increased cell destruction  
Causes of anemia:  
 Lack of iron, it B12 and folate  
 Hypoplasia  
 Invasion by malignant cells  
 Blood loss  
 Hemoglobin  
 Hypersplenism  
 The three main causes are  
 Heavy blood loss  
 Lack of RBC production  
 High rates of RBC destruction.  
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IRON METABOLISM 
Human iron metabolism is the set of chemical reactions 
maintaining human haemeostasis of iron. Iron is an essential element 
for most life on Earth, including human beings. The control of this 
necessary but potentially toxic substance is an important part of many 
aspects of human health and disease. Haematological have been 
especially interested in the systems of iron metabolism because iron is 
essential to red blood cells. Infact most of the human body's iron is 
contained in red blood cells hemoglobin and iron deficiency is the most 
common cause of anemia. 
MECHANISM OF ABSORPTION AND TRANSPORT OF IRON 
 
 
 
 
 
 
 
 
 
 
A peculiar feature of iron metabolism is that only a small part of 
the dietary iron is absorbed under normal conditions because, the body 
has limited capacity to excrete iron. Apsorption of iron from intestine 
is controlled in such a way that accumulation in tissues in toxic 
amounts is prevented. Ordinally, less than 10% of the ingested amount 
is absorbed is excreted in faces. The rate of iron absorption is increased 
in children and in conditionsof iron deficiency. Prior administration 
of iron hinders subsequent absorption for 12 to 24 hours. 
Intestinal lumen    Mucosal Cell   Plasma 
Fe+++   Apoferritin    
       Apoferritin  Transferrin 
Fe +++   Ferritin     Fe +++ 
          Fe +++ 
    Fe+++  
      
 
    Fe+++  Fe+++    
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Uptake and storage 
Iron acquisition poses a problem for aerobic organisms, because 
ferric iron is poorly soluble near neutral pH. Thus, bacteria have evolved 
high-affinity sequestering agents called siderophores.  
After uptake, in cells, iron storage is carefully regulated; "free" iron 
ions do not exist as such. A major component of this regulation is the 
protein transferrin, which binds iron ions absorbed from the duodenum 
and carries it in the blood to cells. In animals, plants, and fungi, iron is 
often the metal ion incorporated into the heme complex. Heme is an 
essential component of cytochrome proteins, which mediate redox 
reactions, and of oxygen carrier proteins such as hemoglobin, myoglobin, 
and leghemoglobin. 
Inorganic iron contributes to redox reactions in the iron-sulfur 
clusters of many enzymes, such as nitrogenase (involved in the synthesis 
of ammonia from nitrogen and hydrogen) and hydrogenase. Non-heme 
iron proteins include the enzymesmethane monooxygenase (oxidizes 
methane to methanol), ribonucleotide reductase (reduces ribose to 
deoxyribose; DNA biosynthesis), hemerythrins (oxygen transport and 
fixation in marine invertebrates) and purple acid phosphatase (hydrolysis 
of phosphateesters). 
Iron distribution is heavily regulated in mammals, partly because 
iron ions have a high potential for biological toxicity. 
Some Facts of Iron 
 About 65% of iron is in the form of Haemoglobin. 
 About 4% of iron is in the form of Myoglobin. 
 About 1 % of iron is in the form haeme compunds. 
 An average diet contains about 10 to 15 mgm of iron per 
day. 
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 Normal human absorbs about 0.5 to 1 mg of dietery iron per 
day. 
 Anaemic human absorbs about 1.5 to 3 mg of dietery iron 
per day. 
 For a size of 1 % of Haemoglobin in one week the bone 
marrow needs 25 mgs of iron per day. 
Daily Iron requirements in different size groups 
Pregnant females    - 30mg/day 
Females 2 year to 30 years -  15mg/day 
Adult males    -  12mg/day 
Males 2 years to 17 tears  - 10mg/day 
Upto 10 years (m/f)  - 10mg/day 
Full term infants   - 1 mg/day  
      From 4 months of age 
LBW babies    -  2mg/kg/day 
      From 2 months of age 
Babies 1000 to 1500 gms. - 3mg/kg/day 
      From  4 months of age 
Less than 1000gms  - 4mg/kg/day 
      From 2 months of age. 
107 
 
IRON IN THE BODY 
Liver,spleen 
Kidneys 
(storage Fe) 
RBC(Hb Fe) 
Muscles 
(myoglobin Fe) 
Cells 
( Parenchyma 
Fe) 
Ferritin and 
Hemosiderin 
From break 
Down of RBC 
 
20% 
Transport iron 
in plasma 
attached to 
protein 
siderophilin 
level reflects 
58% 
Storage Fe 
Essential Fe for 
all cells not 
avilbale for the 
Hb combition 
 
15% 
 
Biological role 
Iron is abundant in biology. Iron-proteins are found in all living 
organisms, ranging from the evolutionarily primitive archaea to humans. 
The color of blood is due to the hemoglobin, an iron-containing protein. 
As illustrated by hemoglobin, iron often is bound to cofactors, e.g. in 
hemes. The iron-sulfur clusters are pervasive and include nitrogenase, the 
enzymes responsible for biological nitrogen fixation. Influential theories 
of evolution have invoked a role for iron sulfides in the iron-sulfur world 
theory. 
Structure of Heme b, in the protein additional ligand(s) would be 
attached to Fe. 
Iron is a necessary trace element found in nearly all living 
organisms. Iron-containing enzymes and proteins, often containing 
hemeprosthetic groups, participate in many biological oxidations and in 
transport. Examples of proteins found in higher organisms include 
hemoglobin, cytochrome (see high-valent iron), and catalase.  
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IRON DEFICIENCY ANAEMIA 
 Iron deficiency anemia is the most common and widespread 
nutritional disorder in the world. The numbers are staggering; 2 billion 
people over 30% of the world’s population are anaemic, many due to iron 
deficiency.  
Structure of the red corpuscles in IDA:  
 In Iron deficiency anaemia, the red blood corpuscles are decreased 
or normal in the number and hemoglobin content of the red blood 
corpuscles is reduced. In the blood smear, the red cells appear pale with a 
large central pale area and many of the RBC appears to be smaller than 
the normal. This type of anemia is called “Hypo chromic and Microcytic 
anemia”.  
Etiological factors:  
1. Increased physiological requirements  
2. Decreased iron stores  
3. Decreased iron assimilation  
4. Blood loss  
5. Increased demands.  
Pathogenesis:  
IDA develops when the supply of iron to the bone marrow is 
insufficient for the requirements of hemoglobin synthesis. It has been 
pointed out that the body is normally in a state of positive iron balance. 
When a negative balance occurs due to blood loss, increased 
requirements or impaired absorption, the deficit is made good by iron 
mobilized from the tissue stores and an adequate supply of iron for 
hemoglobin formation is maintained. It is only when the tissue stores are 
exhausted and the supply of iron to the marrow for hemoglobin synthesis 
becomes inadequate, hypochromic anemiadevelops.. 
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Stage of iron deficiency anemia:  
1. Storage iron depletion  
 Iron reserve is small or absent and is characterized by reduced 
serum ferritin or reduced iron concentration in marrow and liver tissue 
.Hemoglobin serum iron, transferritin concentration and saturation are 
within normal limits.  
2. Iron limited erythropoiesis  
 Hb may still be normal but serum iron is low and TIBC increased 
with a low serum ferritin and raised free erythrocyte protoporphyrin 
(FEP). 
3. Iron deficiency anemia  
 The flow of iron to erythroid marrow is impaired to cause 
reduction in hemoglobin concentration with a progressive microcytic 
hypo chromic anemia associated with the reduced serum iron, transferrin 
saturation and serum ferritin 
36REASONS FOR IRON DEFICIENCY 
Iron is an important topic in prenatal care because women can 
sometimes become iron deficint from the increased iron demands of 
pregnancy. 
Functional or actual iron deficiency can result from a variety of 
causes explained in more details in the article dedicated to this topic. 
These casues can be grouped into several categories. 
 Increased demand for iron, which the diet can't accommodate. 
 Increased loss of iron (usually through loss of blood) 
 Nutritional deficiency. This can either be the result of failure to cat 
iron containing foods, or eating a diet heavy in food that reduces 
the absorption of iron or both. 
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 Inability to absorb iron becasue of damage to the intestine lining. 
Examples of causes of this kind of damage including surgery 
involing the duodenum or diseases like crohn's or celiac sprue 
which severly reduce the surface area available for absorption. 
Inflamation leading to hepcidin, induced restriction on iron 
release from enterocytes. 
Symptoms  
 Weakness, Dizziness  
 Headache, Giddiness  
 Breathlessness, Tachycardia  
 Loss of appetite, Constipation  
 Angular stomatitis, Glossitis  
 Pica.  
Signs  
 Pallor of the skin, mucous membrane, palms, nails and conjunctiva 
 Tachycardia  
 Ejection systolic murmur  
 Mild peripheral edema 
 Venous hums  
 Wide pulse pressure 
Complications:  
Iron deficiency anemia may be the present finding in 
gastrointestinal cancer.  
In patients with heart disease severe anemia may precipitate angina 
pectoris or congestive heart failure.  
Infections are common in IDA, especially those of the respiratory, 
gastrointestinal and urinary tracts.  
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Investigation:  
 Hemoglobin level  
 Heamatocrit values (PCV, MCV, and MCHC)  
 Blood smear study  
 Iron binding capacity  
 Serum ferritin  
 Serum iron  
 Fecal occult blood test if present any gastro intestinal disorders. 
Prevention:  
 Cow’s milk consumption  
 Iron fortified cereal and formulas  
 Well balanced diet.  
Good choices include iron fortified grains and cereals, red meat, 
egg yolk, leafy green vegetables, yellow vegetables and fruits 
Health and diet 
Main articles: Iron deficiency (medicine) and Human iron 
metabolism 
Iron is pervasive, but particularly rich sources of dietary iron 
include red meat, lentils, beans, poultry, fish, leaf vegetables, watercress, 
tofu, chickpeas, black-eyed peas, blackstrap molasses, fortified bread, and 
fortified breakfast cereals. Iron in low amounts is found in molasses, teff 
and farina. Iron in meat (heme iron) is more easily absorbed than iron in 
vegetables. Although some studies suggest that heme/hemoglobin from 
red meat has effects which may increase the likelihood of colorectal 
cancer, there is still some controversy, and even a few studies suggesting 
that there is not enough evidence to support such claims.  
Iron provided by dietary supplements is often found as iron(II) 
fumarate, although iron sulfate is cheaper and is absorbed equally well. 
Elemental iron, or reduced iron, despite being absorbed at only one third 
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to two thirds the efficiency (relative to iron sulfate), is often added to 
foods such as breakfast cereals or enriched wheat flour. Iron is most 
available to the body when chelated to amino acids and is also available 
for use as a common iron supplement. Often the amino acid chosen for 
this purpose is the cheapest and most common amino acid, glycine, 
leading to "iron glycinate" supplements. The Recommended Dietary 
Allowance (RDA) for iron varies considerably based on age, gender, and 
source of dietary iron (heme-based iron has higher bioavailability). 
Infants may require iron supplements if they are bottle-fed cow's milk. 
Blood donors and pregnant women are at special risk of low iron levels 
and are often advised to supplement their iron intake. 
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MATERIALS AND METHODS 
The test drug “Ayachenduram” was prepared according to the reference 
found in “Kannusamiyamvaithyiasegaram .page no.122 
COLLECTION OF THE TEST DRUG: 
The raw drug (Ferrum) Ayam was identified and collected from 
GopalAasan raw drug store, Nagarcoil.  
PURIFICATION OF THE DRUG: 
Ayam powder has to be soaked in naaval fruit juice kept under sun light 
and washed thoroughly .This process has to be repeated for six more times. 
PREPARATION OF AYA CHENDURAM: 
The purified ayam powder is soaked in lemon juice for overnight and 
washed with water.Then it is taken in a mud plate and fried with the help of a 
brush made up of matured coconut leaf stalk.Then it is ground well to obtain a 
fine Ayachenduram. 
Dose: 
100 mg bd with honey 
Route: 
Enteral Route. 
The prepared  “Ayachenduram”  was used for the treatment of paandu 
and analysed by the following methods. 
 PHYSIO-CHEMICAL ANALYSIS 
 CHEMICAL ANALYSIS 
 PHARMACOLOGICAL STUDY  
 MICROBIOLOGICAL ANALYSIS 
 FTIR ANALYSIS 
 SEM ANALYSIS 
 ICP-OES ANALYSIS 
 CLINICAL ASSESSMENT 
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Why honey is effective as a medicine 
The effectiveness of honey as a therapeutic agent has been 
unequivocally demonstrated in the literature reviewed in Part 1 of this 
article published in 1999, but the biochemical explanation of these effects 
is more hypothetical. However, a rational explanation can be seen when 
one looks at the scientific literature outside that on honey. Some of the 
components of honey are substances known to have physiological actions 
that would explain many of its therapeutic effects. In addition, research 
on honey has shown directly that it has physiological actions that would 
give therapeutic effects. 
Therapeutic properties of honey: 
 Antibacterial activity 
 Boosting the immune system 
 Anti-inflammatory action 
 Antioxidant activity 
 Stimulation of cell growth 
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STANDARDIZATION OF THE DRUG 
PHYSICO-CHEMICAL ANALYSIS: 
ASH AND ACID INSOLUBLE ASH: 
To the ash add 1:5 Hcl: Distilled water 15 ml boil, cooled and then 
filtered usingwhatman filter paper (No.41) repeat 3 to 4 times till the 
yellow colour disappear orcolourless, then remove the filter paper and 
add to the filter to the original dish and keepit in the muffle furnace at 
600o C and take constant weight and calculate the acidinsoluble ash 
value. 
Weight of acid insoluble residue x 100 
Acid insoluble ash (%) 
Weight of the sample 
Acid insoluble residue = Acid insoluble ash value – Empty weight 
of the dish 
LOSS ON DRYING: 
3gm of the drug is heated in a hot oven at 1050 c to constant 
weight. The % ofweight was calculated. 
Loss on drying value at 1050 c - 10.96 %w/w 
POTENTIAL OF HYDROGEN (pH): 
The pH scale is logarithmic and runs from 0.0 to 14.0 with 7.0 
being neutral.Readings less than 7.0 indicate acidic solutions, while 
higher readings indicate alkalineor base solutions. 
THIN LAYER CHROMATOGRAPHY: 
4gms of the sample was soaked in 40 ml of Ethyl alcohol, kept 
overnight, boiledfor ten minutes and filtered. The filtrate was 
concentrated to 10 ml and made up to themark in a 10 ml and standard 
flask.10µl of this solution was applied on Merck aluminiumplate 60 F 
254 precoated with silica gel of 0.2 mm. thickness and the plate was 
developedin Toluene: Ethyl acetate 6:1.5. After drying the plate was 
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visualized under UV 254 and366 nm and photographs were taken. The 
plate was dipped in vanillin-sulphuric acidreagent and kept in oven at 
1050c till the colour of the spots appeared. 
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BIO – CHEMICAL ANALYSIS OF AYA CHENDURAM 
PREPARATION OF THE EXTRACT 
 100 mgs of Chenduram is weighed accurately and placed into a 
clean beaker and added a few drops of conc. Hydrochloric acid and 
evaporated it well.  After evaporation cooled the content and added a few 
drops of conc.  Nitric acid and evaporated it well.  After cooling the 
content add 20ml of distilled water and dissolved it well.  Then it is 
transferred to 100 ml.  Volumetric flask and made up to 100ml with 
distilled water. Mixed well. Filter it.  Then it is taken for analysis.   
QUALITATIVE ANALYSIS 
S. NO EXPERIMENT OBSERVATION INFERENCE 
1.  TEST FOR CALCIUM 
2ml of the above prepared 
extract is taken in a clean test 
tube.  To this add 2ml of 4 % 
Ammonium oxalate solution 
A white 
precipitate is 
formed 
Indicates the 
presence of 
Calcium 
2.  TEST FOR SULPHATE: 
2ml of the extract is added to 
5% barium chloride solution. 
No white 
precipitate is 
formed 
Absence of 
Sulphate 
3.  TEST FOR CHLORIDE 
The extract is treated with silver 
nitrate solution 
A white 
precipitate is 
formed  
Absence of 
Chloride 
4.  TEST FOR CARBONATE 
The substance is treated with 
concentrated Hcl 
No brisk 
effervescence is 
formed 
Absence of 
Carbonate 
5.  TEST FOR STARCH 
The extract is added with weak 
iodine solution. 
No blue colour is 
formed 
Absence of  
Starch. 
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6.  TEST FOR FERRIC IRON 
The extract is acidified with 
Glacial acetic acid and 
potassium ferro cyanide. 
Blue colour 
develops 
Indicates the 
presence of 
Ferric Iron 
7.  TEST FOR FERROUS IRON 
The extract is treated with 
concentrated Nitric acid and 
ammonium thiocyanate solution. 
Blood red colour 
is formed 
Indicates the 
presence of 
Ferrous Iron. 
8.  TEST FOR PHOSPHATE 
The extract is treated with 
ammonium molybdate and 
concentrated nitric acid. 
No yellow 
precipitate is 
formed 
Absence of 
Phosphate. 
9.  TEST FOR ALBUMIN 
The extract is treated with 
Esbach’s reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
Albumin 
10. TEST FOR TANNIC ACID 
The extract is treated with ferric 
chloride. 
No blue black 
precipitate is 
formed. 
Absence of 
Tannic acid 
11. TEST FOR 
UNSATURATION 
Potassium permanganate 
solution is added to the extract 
It does not get 
decolourised 
Absence of 
Unsaturated 
compound. 
12. TEST FOR THE REDUCING 
SUGAR 
5ml of Benedict’s qualitative 
solution is taken in a test tube 
and allowed to boil for 2 mts 
and added 8-10 drops of the 
No colour change 
occurs. 
Absence of 
Reducing 
Sugar. 
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extract and again boil it for 2 
mts. 
13. TEST FOR AMINO ACID 
One or two drops of the extract 
is placed on a filter paper and 
dried it well.  After drying, 1% 
Ninnydrin is sprayed over the 
same and dried it well. 
No Violet colour 
is formed 
Absence of 
Amino Acid. 
 
14. TEST FOR ZINC: 
The extract is treated with 
potassium ferro cyanide 
No white 
precipitate is 
formed 
Absence of 
Zinc.  
 
Inference: 
 The given sample of “AyaChenduram”  indicates the presence of  
Calcium, Chloride, ferric iron and Ferrous Iron. 
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PHARMACOLOGICAL  ANALYSIS 
Pharmacological Analysis of trial medicine: 
 Study on the haematinic effect of AyaChenduram on Albino rats. 
To prove its haematinic effect of AyaChenduram an attempt was made to 
study its effect using “Albino rats”. For this purpose rats are made anemic 
by the following procedure. 
Artificially induced iron deficiency: 
The albino rats taken for this experiment were kept in aluminum 
cages and provided with drinking water and milk, free from iron. The 
administration of the iron preparation under investigation was started 
when the haemoglobin level fall to 5.28 gms /100ml at the beginning of 
the experiments   Hb mg% were determined. 
Study on rates: 
 The albino rats were first divided into 2 equal groups with five rats 
in each group. The first group received AyaChenduram 20mg/100gm 
body weight with hot water. The second group received normal diet. All 
the procedures were continued for five weeks in once a day the 
haemoglobin levels of rats were measured for I, II, III, IV, V weeks. The 
result is observed are tabulated in the following chart. 
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STUDY OF HAEMATINIC ACTION 
Sl. 
No. 
 
Drugs 
 
Dose 
Before drug 
Administration 
After Drug 
Administrati
on Remarks 
Initial 
Reading 
I 
week 
II 
week 
III 
week 
IV 
week 
V 
week 
 
 
1. 
 
 
Control 
(Water) 
 
 
2ml 
7.0 
6.8 
7.0 
6.7 
6.5 
6.7 
7.0 
6.8 
7.0 
6.7 
6.5 
6.7 
6.8 
6.6 
6.8 
6.5 
6.3 
6.5 
6.5 
6.5 
6.6 
6.4 
6.2 
6.1 
6.0 
5.9 
6.1 
5.8 
5.6 
5.4 
5.8 
5.6 
5.8 
5.4 
5.3 
5.1 
 
 
5.5 
 
 
2. 
 
 
Aya 
Chendura
m 
 
 
100 
mg 
6.5 
6.7 
6.3 
6.4 
6.2 
6.1 
6.6 
6.8 
6.5 
6.7 
6.4 
6.3 
7.0 
7.4 
7.3 
7.5 
7.6 
7.2 
8.4 
8.7 
8.5 
8.8 
8.9 
8.4 
9.6 
9.8 
9.4 
9.5 
9.8 
9.3 
11.4 
11.5 
10.8 
11.7 
11.6 
10.5 
 
 
11.25 
 
Result: 
The trail drug AyaChenduramhas significant Haematinicaction. 
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MICROBIOLOGICAL ANALYSIS 
ANTI – MICROBIAL ACTIVITY 
BY KIRBY BAUER METHOD 
Aim: 
To determine the Antimicrobial activity of “AyaChenduram” 
Components of Muller Hintan Agar Medium: 
Beef Extract   -  300 gms /lit 
Agar    - 17 gms /lit 
Starch   - 1.5 gms / lit 
Casein Hydroxylate -  17.5 gms/lit 
Distilled water  -  1000 ml. 
PH    -  7.6 
Procedure: 
The method of antimicrobial activity study is UPS Diffusion 
Method. 
Antibiotic discs are prepared with known concentration of 
antibiotic  are placed on agar plates that has been inoculated with the 
known pathogenic micro organism. The antibiotic diffuses through the 
agar producing an antibiotic concentration, gradient antimicrobial  
susceptibility is proportional to the diameter of the inhibitory zone around 
the disc. If the micro organism which grows upto the edge of the disc are 
resistant to the antimicrobial agent. 
The recommended medium in this method is Muller Hinton Agar, 
its PH should be between 7.2 – 7.6 and should be poured to uniform 
thickness of 4mm in the petri plate (25ml)  
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Methodology: 
 Muller Hinton Agar plates are prepared and Escherichia coli, Candida 
albicans, Staphylococcus aureus, Streptococcus pneumoniae and 
Pseudomonas aeruginosa are inoculated separately. 
 The prepared discs of AyaChenduram are placed over the incubated 
plate using sterile forceps and incubated for 24 hours at 37 celcius. 
 The plates after 24 hours incubation are observed for the zone of 
inhibition. 
Result:  
S.No. Test Drug Organism (culture) Susceptibility 
1.  
 
AyaChenduram 
Escherichia coli Resistant 
2. Candida albicans Resistant 
3. Staphylococcus aureus Resistant 
4. Streptococcus 
pneumoniae 
Resistant 
5. Pseudomonas 
aeruginosa 
Resistant 
 
Result : 
 The test drug  has no Anti-microbial activity. 
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FOURIER TRANSFORM INFRARED 
SPECTROSCOPY(FTIR) 
Also quantitative estimation is possible in certain cases 
forchemicals, pharmaceuticals, petroleum products, etc. Resins from 
industries, water andrubber samples can 
INSTRUMENT DETAILS: 
Model   :  Spectrum one: FT-IR Spectrometer 
Scan Range  :  MIR 450-4000 cm-1 
Resolution   :  1.0 cm-1 
Sample required  :  50 mg, solid or liquid. 
Fourier Transform Infrared Spectroscopy (FTIR) is an analytical 
technique usedto identify mainly organic materials. Infrared Spectroscopy 
gives information on the vibrational and rotational modes of motion of a 
molecule and hence an important technique for identification 
andcharacterisation of a substance.. The Infrared spectrum of an 
organiccompound provides a unique fingerprint, which is readily 
distinguished from the absorption patterns of all other compounds; only 
optical isomers absorb in exactly the same way. Hence FTIR is an 
important technique for identification and characterization of a 
substanceInfrared spectrum is useful in identifying the functional groups 
like -OH, -CH3,-CH2,-N-H,unsaturated aldehyde etcbe analyzed 
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SP  3601  4000.0  400.0  3.1  100.0  4.0  %T  4  2.0 
PT 
REF 4000 96.6 2000 93.2 600 
3986.3  93.3   3917.8  74.5   3889.8  74.3   3859.3  71.1   3834.2  79.3    
3733.2  25.3   3678.2  63.9   3618.1  17.9   3417.1  3.1    3321.3  5.3     
3195.6  18.5   2987.6  26.9   2604.1  65.3   2350.0  51.5   1634.1  93.4    
1405.9  76.0   1058.6  37.4   628.6   64.7    
END 18 PEAK(S) FOUND 
COMMENT: 
The compound contains water molecule, 2987cm-1 shows the 
presence of CH3 groups, 1634cm-1 shows unsaturated aldehyde in the 
drug it may be due to citrol or citronellal, lower frequencies shows the 
presence alkanes like CH2 , 3417cm-1 due to presence of OH group, 
3195cm-1- is due to presence of chelated or H-bonded OH group, 
3321cm-1- N-H band, above 3700cm-1 is due to water hydroxyl, 3678cm-1 
is due to free hydroxyl group. 
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SEM-Micro graph particle size average range is 50 nm 
SCANNING ELECTRON MICROSCOPE (SEM) 
The Scanning Electron Microscope (SEM) is a microscope that 
was electronsrather than light to form an image. There are many 
advantages to using the SEM insteadof a light microscope. 
Resolution : 
1.2 nm gold particle separation on a carbon substrate 
Magnification : 
From a min of 12 x to greater than 1, 00,000 X 
A scanning electron microscope (SEM) is a type of electron 
microscope that produces images of a sample by scanning it with a 
focused beam of electrons. The electrons interact with electrons in the 
sample, producing various signals that can be detected and that contain 
information about the sample's surface topography and composition. The 
electron beam is generally scanned in a raster scan pattern, and the beam's 
position is combined with the detected signal to produce an image. SEM 
can achieve resolution better than 1 nanometer. Specimens can be 
observed in high vacuum, low vacuum and in environmental SEM 
specimens can be observed in wet condition. 
SEM Picture of Aya Chenduram 
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INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION 
SPECTROMETRY (ICP-OES): 
Inductively coupled plasma atomic emission spectroscopy (ICP-
AES), alsoreferred to as inductively coupled plasma optical emission 
spectrometry (ICP-OES), is ananalytical technique used for the detection 
of trace metals. 
It is a type of emission spectroscopy that uses the inductively 
coupled plasma toproduce excited atoms and ions that emit 
electromagnetic radiation at wavelengthscharacteristic of a particular 
element. The intensity of this emission is indicative of theconcentration 
of the element within the sample. 
Optical emission spectrometry (OES) using arc and spark 
excitation is the preferred method to determine the chemical composition 
of metallic samples. This process is widely used in the metal making 
industries, including primary producers, foundries, die casters and 
manufacturing. Due to its rapid analysis time and inherent accuracy, 
Arc/Spark OES systems are most effective in controlling the processing 
of alloys. 
These spectrometers can be used for many aspects of the 
production cycle including in-coming inspection of materials, metal 
processing, quality control of semi-finished and finished goods and many 
other applications where a chemical composition of the metallic material 
is required 
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Sample ID ELEMENT CONCENTRATION 
Aya Chenduram 
As193.696 BDL 
Bi 306.772 02.141 mg/L 
Cd 226.502 BDL 
Cu 324.754 3.312 mg/L 
Co 228.616 2.148 mg/L 
Fe 238.204 782.141 mg/L 
Hg253.652 BDL 
Ni 58.693 BDL 
Pb 230.204 BDL 
S 181.975 35.421 mg/L 
Sb 206.833 31.314 mg/L 
Zn 213.856 35.164 mg/L  
BDL – Below Detection Limit  
 
Ferrous Iron is  much greater than other amounts. The  presence  of  
ferrous form of Iron  is  necessary  for  the  formation  of  heme  part  of  
thehaemoglobin . The others are sulphur,stannum,zinc,copper,cobalt and 
bismuth, meanwhile, is important for maintainingthe integrity of cell 
membranes and functions as a vital electrolyte. All are essential to 
thestructure and function of the body. 
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TOXICOLOGICALANALYSIS 
ACUTE TOXICITY STUDY 
ANIMAL USED FOR THE STUDY: 
Wister albino rats bred in the animal house attached to the Post 
Graduate Pharmacology Department, Govt. Siddha Medical College, 
Palayamkottai were used. 
Sex: 
 Animals of both sex were used. 
Weight: 
Animals weighing 100-120gms were selected. 
Food and water: 
 The animals were maintained with standard laboratory pellet food 
and water ad-Libitum. 
Preparation of Animals: 
 The animals were randomly selected and were marked with picric 
acid on for and kept in their cages for five days prior to dosing, to allow 
acclimatization to the laboratory conditions. 
Separation of Animals in Groups: 
 10 rats were divided into 5 groups each consisting of 2 rats, one 
group is kept as control group by giving water alone. 
Dose Levels: 
 The following dose levels were arbitrarily fixed by persuming 
range of least toxic to high toxic doses. 
 I Group - 40 mg/kg body weight of animal 
 II Group - 80 mg/kg body weight of animal 
 III Group - 160 mg/kg body weight of animal 
 IV Group - 320 mg/kg body weight of animal 
 V Group - 640 mg/kg body weight of animal 
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Route of Administration: 
 The drug was administered orally. 
Test Dose Preparation: 
 The preparation was done in such a way as 1ml of the suspension 
contained 40mg of test drug and administered as given above in each 
group. The drug was administered once on the day of the experiment and 
there after other 24 hour parameters were used. 
Experimental set up: 
 All the five groups were fasted for over night prior to dosing. 
Following the period of fasting the animals were weighed and test 
substance was administered through “Rat oral intubation tube”. 
After the administration of the test drug, food was withheld for 1 to 
2hrs. 
OBSERVATION: 
 The following parameters were noted. 
Central effects: 
I. Stimulation  
 Hyper activity  
 Piloerection 
 Twitching 
 Rigidity 
 Irritability 
 Jumping 
 Colonic convulsion 
 Tonic convulsion 
II. Depression 
 Ptosis 
 Sedation 
 Sleep 
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 Loss of traction 
 Loss of Pinna reflex 
 Ataxia 
 Catatonia 
 Loss of muscle tone 
 Analgesia 
Autonomic Effect: 
 Straub’s   tail flicking 
 Laboured respiration 
 Cyanosis 
 Blanching 
 Reddening 
 Abnormal secretions 
At the end of 24 hrs, the number of animals dead in each group was 
noted and the approximate LD50 was determined. The animals were 
morphologically examined for any toxic symptoms. 
Result: 
During the acute toxicity study none of the albino rat was found 
dead. During morphological examination of the rats no toxic symptoms 
were found. This proves the safety of the test drug. 
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CLINICAL ASSESSMENT 
 The drug “Ayachenduram” is therapeutic agents specifically 
indicated for paandunoi in Siddha literatures. 
 A clinical trial of Haematinic activity of this drug on Paandunoi 
was carried out in Govt. Siddha Medical College Hospital, Palayamkottai. 
 Patients of both sexes with age ranging from 20-60 years were 
selected in Out patient and In patient ward of Govt. Siddha Medical 
College Hospital. 
 The patients were diagnosed as Paandunoi according to the criteria 
derived by ancient Siddhars.  Now a day the patients are examined 
meticulously by modern investigation such as lab investigation. 
 The patients were selected as Paandunoi in accordance with the 
following including and excluding criteriae. 
DESIGN OF THE STUDY: 
Open clinical trial, phase II B 
Inclusion criteria: 
 Hb – 7 to 10 gms% 
 Pallor of conjunctiva and nail beds.  
 Loss of appetite 
 Ulceration of mouth 
 Lassitude 
 Emaciation 
 Palpitation 
 Dyspnoea on exertion 
 Fatigue 
 Breathlessness 
 Tiredness 
 Age 20 to 60 yrs 
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 Patient willing to attend the op once in 7 days or willing to be 
admitted in the IP for 30 to 45 days. 
Exclusion criteria: 
 Chronic liver failure 
 Chronic renal failure 
 Myxoedema 
 Thalassemia 
 Worm Infestation 
Withdrawal Criteria: 
 Any other acute severe illness 
 Drug intolerance 
Termination Criteria: 
 Voluntary termination 
 Not reporting subsequently. 
Clinical Pathological Examination: 
Blood Test: 
 Total count 
 Differential count  
 Hemoglobin 
 Erythrocyte sedimentation rate  
 Blood sugar 
 Blood urea 
 MCV - Mean Corpuscular Volume 
 PCV - Packed Cell Volume 
URINE EXAMINATION: 
 Albumin  
 Sugar 
 Deposits 
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MOTION EXAMINATION: 
 Ova 
 Cyst 
 Occult blood 
Line of Treatment: 
 The drug Ayachenduram was administered orally in a dose of 
100mg two times a day with butter after meals. 
Diet and Medical Advice: 
 Iron rich diet  
 Green leafy vegetables 
 Fruits  
 Meat 
 Sea foods 
 Nuts  
 Cereals 
 Eggs 
 Citrus fruits, tomatoes helps the body to absorbing iron from food. 
 Increase dietary fibre to prevent constipation. 
 Eat fresh uncooked fruits and vegetables often.  Don’t eat over 
cooked food. It may destroy folic acid. 
Observation: 
 The haematinic action of Ayachenduram was observed on the basis 
of the relief of symptoms and confirmed by routine lab investigations. 
 The clinical improvement was recorded for every seven days.  The 
laboratory investigations were done for the patients before and after 
treatment.  At last the prognosis was noted. 
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Results: 
 Among the 40 patients selected, 29 patients showed good response 
9 patient showed fair response and remaining 2 patients showed poor 
response. 
 
Table Illustrating the sex Distribution 
S. No Sex No. of patients Percentage 
1 Male 11 27.50% 
2 Female 29 72.50% 
 Total 40 100% 
 
 
Table Illustrating the age Distribution 
S.No Age in years No. of patients Percentage 
1 20-40 18 45% 
2 41-60 22 55% 
 Total 40 100% 
 
 
Table Illustrating the Prognosis 
S.No Prognosis No. of patients Percentage 
1 Good 29 72.50% 
2 Fair 9 22.50% 
3 Poor 2 5% 
 Total 40 100% 
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BIO – STATISTICAL ANALYSIS 
 The clinical trials of the drug AyaChenduramare differentiated in 
terms of percentages. The effectiveness of the drug is assessed by Non 
parametric chi-square and Binomial test (Z proportion test) within the 
groups. The responses of the patients to the drug are analyzed in terms of 
proportions. The above statistical procedures are performed by the 
statistical package S.P.S.S (13.0) The P-values is set at 0.05 which is 
considered as statistically significant. 
 Description of the study subjects: 
 The study subjects of AyaChenduramwere described according to 
their sex and age. 
Table 1: Sex wise distribution of clinical trials. 
Age group 
(Years) 
Males Females Total 
n % n % N % 
20-29 1 9.09 4 13.79 5 12.50 
30-30 1 9.09 10 34.48 11 27.5 
40-49 6 54.5 8 27.58 14 35 
50-59 2 18.18 6 20.68 8 20 
60-69 1 9.09 1 3.4 2 5 
Total 11 100 29 100 40 100 
 
 The table -1 above shows that the male participation was 27.5% 
and the female is 72.5% and are normally distributed about the mean age.  
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Table – 2 Comparison of male and female according to their age. 
Sex 
Age (Years) 
‘t’ d.f 
Significance 
P Mean S.D 
Male 46.5 9.07 
0.05 38 P>0.05 
Female 39.5 11.14 
  
The study subjects are compared with reference to their age and 
sex in the above table – 2. The mean ages of male and female were 
46.5±11.14 years respectively. The difference of mean age 7 years 
between the sexes was not statistically significant (P>0.05). The subjects 
selected for the study are same regarding the age. Now it is very clear that 
the age and sex may not a confounding factor for the test drug.  
Effectiveness of AyaChenduram in the control of Paandu: 
The effectiveness of AyaChenduram was studied by comparing the 
haemoglobin level before and after treatment of the patients. Similarly the 
MCV and PCV levels were also compared between the before and after 
treatment. The following table explain the above analysis. 
Table – 3: Effectiveness of AyaChenduram in Controlling the 
Paandu 
Variables No 
Before 
treatment 
After 
treatment 
Increase ‘t’ D.S 
Significa
nce 
Hb 40 9 0.5 10.3 0.5 1.3 0.5 8.4 39 P<0.001 
MCV 20 84.9 4.2 93.7 6.4 8.8 3 7.41 39 P<0.001 
PCV 20 31.3 2.6 39.8 3.0 8.5 2.8 6.41 39 P<0.001 
 
The above table – 3 evaluates the effectiveness of AyaChenduram 
for controlling the Paandu. The mean haemoglobin level before the 
treatment was 9.0 ± 0.5 and the same after the treatment was 10.3 ± 0.5 
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(mg). The mean increase was 1.3 ± 0.5 mg. The mean increase was 
statistically figure ‘t’ early  (t =8.4 d.f = 39 and P<0.001). Similarly the 
MCV and PCV before treatment were 84.9 ±4.2 and 31.34 ± 2.6 
respectively. The same after treatment were 93.7 ±6.4 and 39.8 ± 3.0 
respectively. The mean increase of MCV and PCV were 8.8 ± 3.0 and 8.5 
± 2.8 respectively. The mean increase of MCV was significant (t = 7.41 
d.f =19 and P<0.001). Similarly the mean increase of PCV was also 
significant ( t=6.41 d.f = 19 and P<0.001). 
Prognosis of AyaChenduram: 
 The prognosis of AyaChenduram was diagnosed as Good, Fair and 
Poor based on the improvements of variables haemoglobin, MCV and 
PCV. 
Table -4 Percentage  distribution of the prognosis 
Response 
Subsides 
No % 
Good 29 72.5 
Fair 9 22.5 
Poor 2 5 
Total 40 100.0 
  
The above table -4explains the response of the drug. Among the 40 
patients 29 (72.5%) had shown Good response, 7 (17.5%) had shown Fair 
response  and only 4 (10%) had shown Poor response. 
The above  results clearly shows that the drug AyaChenduram 
improves the haemoglobin level, MCV and PCV level significantly from 
before treatment to after treatment (P<0.001) 
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RESULTS&DISCUSSION 
 The  drug  Aya  chenduram  is  selected  to  study  its therapeutic 
efficacy in the management of  Paandu  noi  as  per  Siddha  literatures. 
The  drug  is prepared  and  given  patients   at  the  dose 100mg  bd  with  
butter   after  meals.The  drug  is  subjected  to the physiochemical, Bio 
chemical  ,SEM,FTIR,ICP-OES ,pharmacological  analysis and clinically. 
 According  to  Siddha  Maruthuvam  among  the  vital  forces, 
Pitham is  mainly  affected  in  Paandu  noi.Following Pitham,Kabam and 
vatham are also dearanged.so the principle aim in the treatment,aspect is 
to made the dearanged vital forces to normal by giving the trial drug 
.Before starting the actual treatment efforts are made to normalise the 
dearanged thathus.This is explained in siddha as follows. 
“tpNurdj;jhy; thje; jhOk; 
rj;jpahy; gpj;je; jhOk; 
mQ;rdj;jhy; fgk; jhOk;” 
         Usually for pitha disease emetics are to be given to normalise the 
dearanged Pitham.But there are some exceptions to this rule .For 
instances in paandu noi.Since the patients is already Weak and drowsy 
the administration of emetic drug is excluded from the line of treatment.  
 37‘gpj;jkjp fhpg;gpd; NgRk; ghpfhuk; 
 Rj;jj; JtNuhL nrhy;ypdpg;Gr; rj;jhFk; 
 ifg;Gr; RitNa fUJtjd; tPW 
 va;g;gilA nkd;Wiuj;jh hpq;F” 
JtHg;G> ,dpg;G> ifg;G ,k;%d;W RitfSk; gpj;j kpFjpiar; 
rkdg;gLj;Jk;. 
JtHg;gpd; nra;if:; ; ;; ; ;; ; ;  
38“FUjp Rj;jp ahf;Fk; 
nfhba gpj;jk; Nghf;Fk; 
nghUJg; Gz;iz ahw;Wk; 
                                                 
37Neha; ehly; Neha; Kjy; ehly; jpul;L> ghfk; - 1> gf;f vz; - 24 
38rpj;j kUj;Jthq;f RUf;fk;> gf;f vz; - 40 
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nghy;yh itak; khw;Wk; 
kUT ke;jk; Njf;Fk; 
tsHf;F khkk; Njf;Fk;  
FUtpd; Fzj;j jhNy  
FspHe;j JtHg;gpd; Ntiy” 
Bio  chemical  analysis  shows  that  Aya  chenduram  contains  
Calcium,   Chloride, Ferric  Iron  and Ferrous Iron 
39The  presence  of  ferrous form of Iron  is  necessary  for  the  
formation  of  heme  part  of  thehemoglobin.Ferrous form of iron is 
easily absorbed than Ferric form. 
Calcium prevents muscle weakness in my trial drug which is one of 
the symptoms of anaemia. 
Chloride regulates the acid base balance of the body. 
Pharmacological  analysis  of  Aya  chenduram  is  done  inthe  
department  of  pharmacology, Govt   siddha  medical  college, 
Palayamkottai.This  results  reveals  that  the  drug  has  got  significant  
action. 
 Toxicity  studies  shows, no  toxin  related  remarkable  
pathological  changes  on  Albino  rats. So  the  drug  reveals  safe  for  
long  term  as  well  as  short  term  therapies 
In chemical and elemental analysis done with sophisticated 
analytical instruments namely ICP-OES, it showed the presence of the 
following elementsnamely Fe,S,Sb,Zn,Cu,Co,Bi, in the descending 
manner in quantitative and qualitative basis. 
Sulphur has got Anti bacterial activity. 
Zinc is also used in Haemoglobin formation and it has Anti oxidant 
property. 
 
                                                 
39
 Essentials of medical physiology by Sembulingum, Page No: 56 
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Copper  is  necessary  for  the  absorption  of  iron  from  the  
gastrointestinal  tract. 
Cobalt are essential for the utilization  of  iron  duringhemoglobin  
formation. 
Physico chemical analysis, The analytical parameters like total Ash 
value, Acidinsoluble ash value, Loss on drying values are helping us to 
interpret the digestion andsolubility capacity of the crude extract. As per 
the result the tested sample contains goodpercentage of solubility as well 
as digestive capacity. 
In FTIR,it showed the functional groups related tounsaturated 
aldehyde,amides,phenols,alcohols,alkanes and carboxyl groups. 
SEM picture shows Nano particle (Micro level) size of thesample 
is 50nm Which is within the normal limit. The extremely small size of 
nanoparticles allows them topenetrate cells and interact with cellular 
molecules. Due to nanoparticle size a low dose of thedrug can cure the 
diseases. 
Microbiological studiesthat the drug has no Anti microbial activity. 
For  the  clinical  study  40  patients  were  selected.Among  this  
29(72.5%) cases  showed  good  response, 9(22.5%) cases  showed  fair  
response  and  2(5%) cases  showed  poor  response. 
Bio  statistical  analysis  also  revealed  that  this  drug  has  got  
significant  effect  in  treating  Paandu  noi. 
The  trial  medicine have  the  properties  of  neutralizing  pitham  
is  compensated  by  astringent, bitter  and  sweet  tastes. 
During  the  course  of  treatment  the  patients  have  no  side  
effects. 
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SUMMARY 
 The  drug  Aya  chenduram  were  selected  for  this  dissertation  
taken  from  the  text  Prana  raksamirtha  sinthu. 
 The   drug  Aya  chenduram  has  been  to  establish  its  efficacy  
in  treating  Paandu  noi. The  dose  of  Aya  chenduram  is  100mg  
twice  daily  with  butter  taken  after  food. 
The  review  of  literature  about  the  drug  and  the  significance  
in  Siddha  medicine  were  done. 
Information  about  the  drug  was  collected  from  various  
sources  like  abstract  from  literatures  and  internet  files. 
Bio  chemical   analysis  of  the  drug  reveals  the  presence  of  
Calcium,  Chloride, Ferric  Iron  and  Ferrous Iron. 
Pharmacological  analysis  shows  that  the  drug  has  got  
significant  action. 
Quantitative  analysis  of  Aya  chenduram  bychemical and 
elemental Analysis done with sophisticated analytical instruments namely 
ICP-OESwas  done  and  their  reports  are  tabulated  and  discussed. 
Toxicity  studies  shows  no  toxins  related  to  pathological  
changes  on  albino  rats. So the  drug  reveals  safe  for  short  term  
therapies. 
In  the  clinical  trials  out  of  the  patients  72.5%  patients  
showed  good  response  22.5%  patients  showed  fair  response  and  5%  
patients  showed  poor  response. 
No  adverse  reaction  were  noted  during  the  treatment. 
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CONCLUSION 
It is concluded that the test drug Aya  chenduram  has  significant  
Haematinic  activity effect and it has no adverse effects. 
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NAME: Murugasvaran AGE: 60 SEX: male O.P.NO: 39021 NO.OF DAYS TREATED:4 FROM:25/05/2012TO:29/05/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Bleeding per 
anum and pain 
,itching,burning 
sensation since 
10 days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
6
th
 day 
No significant 
adverse effects 
TC:   7800Cells/Cumm URINE TC:  7800 Cells/Cumm URINE 
DC:  P 64%   L:38%E:6% Alb:Nil DC: P:  68%  L:40%E: 8% Alb: Nil 
ESR ½hr   8mm  Sug:  Nil ESR ½hr 6mm   Sug: Nil 
 1hr    6mm  Dep:  NAD  1hr  10mm   Dep: NAD 
Hb: 78%    BT:4m    CT: 4m5s Hb:  80%    BT: 2m50s    CT:3m  RESPONSE 
BloodSugar(R):  149 mgs% MOTION BloodSugar(R):140  mgs% MOTION  
 
Good 
Blood Urea:        20mgs% Ova:  Nil Blood Urea: 20mgs% Ova: Nil 
Serum Cholesterol:  220mgs% Cyst:  Nil Serum Cholesterol:230mgs% Cyst: Nil 
B.P.  122/84mmHg Occult Blood: Nil B.P. 120/80mmHg Occult Blood : Nil 
Serum Calcium: 7mg% 
Proctoscopy: 
Serum Calcium:9mg% 
Proctoscopy: 
 
 
 
NAME: Monika AGE: 26 SEX: Female O.P.NO: 39377 NO.OF DAYS TREATED:4FROM:26/05/2012TO:30/05/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Bleeding per 
anum and  pain , 
itching,constipati
on pain ,burning 
sensation since 
10 days 
 
 
. 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC:7200    Cells/Cumm URINE TC:  7200  Cells/Cumm URINE 
DC: P:68%   L: 18%E: 6% Alb: Nil DC:  P:  74%    L: 24%E:8% Alb: Nil 
ESR ½hr   8mm   Sug: Nil ESR ½hr   10mm   Sug: Nil 
 1hr    6mm   Dep:  NAD  1hr  12mm   Dep: NAD 
Hb:  64%   BT:  3m25s    CT:4m20s  Hb:  68%  BT:  2m 20s CT:3m10s  RESPONSE 
BloodSugar(R): 140 mgs% MOTION BloodSugar(R):142  mgs% MOTION  
 
Good 
Blood Urea: 20 mgs% Ova:  Nil Blood Urea: 24  mgs% Ova:  Nil 
Serum Cholesterol: 170mgs% Cyst: Nil Serum Cholesterol: 184mgs% Cyst: Nil 
B.P. 120/80mmHg Occult Blood: Nil B.P. 130/82mmHg Occult Blood : Nil 
Serum Calcium: 8mg% 
Proctoscopy: 
Serum Calcium:10mg% 
Proctoscopy: 
 
 
 
  
OUT- PATIENTS 
NAME: Selvi AGE: 42 SEX: female O.P.NO: 41719 NO.OF DAYS TREATED:4FROM:04/06/2012TO:08/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Bleeding per 
anum and pain, 
itching,burning 
sensation since 7 
days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC:  9600 Cells/Cumm URINE TC: 9600  Cells/Cumm URINE 
DC:  P:58%   L:  34%E:2% Alb: Nil DC: P: 64%   L:38%E:6% Alb: Nil 
ESR ½hr  20mm   Sug: Nil ESR ½hr 28mm   Sug: Nil 
 1hr   10mm Dep:NAD  1hr  18mm   Dep: NAD 
Hb: 62% BT: 3m2s CT:4m 45s  Hb: 72%  BT: 2m40s  CT:3m30s  RESPONSE 
BloodSugar(R):  80 mgs% MOTION  BloodSugar(R): 92   mgs% MOTION  
 
Good 
Blood Urea:        28mgs% Ova: Nil  Blood Urea:      30 mgs% Ova: Nil 
Serum Cholesterol:170 mgs% Cyst: Nil  Serum Cholesterol: 184mgs% Cyst:Nil 
B.P. 120/84mmHg Occult Blood: Nil  B.P, 128/88mmHg Occult Blood : Nil 
Serum Calcium:8mg% 
Proctoscopy: 
Serum Calcium:9mg% 
Proctoscopy: 
  
 
NAME: Esakiyamal AGE: 43 SEX: Female O.P.NO: 42119 NO.OF DAYS TREATED:4FROM:06/06/2012TO:10/06/2012 
DRUG: madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Bleeding per 
anum and pain 
,itching,burning 
sensation since 4 
days 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC:  9400  Cells/Cumm URINE TC: 9400 Cells/Cumm URINE 
DC: P: 58%  L: 44%E: 6% Alb: Nil DC:  P: 64%   L: 48%E:8% Alb: Nil 
ESR ½hr 18mm   Sug: Nil ESR ½hr  28mm   Sug: Nil 
 1hr   12mm  Dep:   NAD  1hr  32mm   Dep: NAD 
Hb:  72%  BT: 3m   CT:4 m20s  Hb:  78%  BT: 2m30s  CT:3m  RESPONSE 
BloodSugar(R):  130 mgs% MOTION BloodSugar(R):118 mgs% MOTION  
 
Good 
Blood Urea:  30 mgs% Ova:Nil Blood Urea: 34  mgs% Ova: Nil 
Serum Cholesterol: 180 mgs% Cyst: Nil Serum Cholesterol: 182mgs% Cyst: Nil 
B.P. 120/90mmHg Occult Blood: Nil B.P. 124/80mmHg Occult Blood: Nil 
Serum Calcium:9mg% 
Proctoscopy: 
Serum Calcium:11mg% 
Proctoscopy: 
 
  
  
  
NAME: Chelathay AGE: 35 SEX: female O.P.NO: 43030 NO.OF DAYS TREATED:  5FROM:09/06/2012TO:14/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus 
,bleeding from 
anus ,burning 
sensation since 6 
days. 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC:8200   Cells/Cumm URINE TC: 8200 Cells/Cumm URINE 
DC: P:52%   L: 44%E:4% Alb: Nil DC: P: 58% L: 46% E: 6% Alb: Nil 
ESR ½hr  15mm   Sug: Nil ESR ½hr 55mm   Sug: Nil 
 1hr20mm  Dep:  NAD  1hr 40mm   Dep: NAD 
Hb: 68%    BT: 3m45s  CT:4 m 10s  Hb: 78% BT: 2m45s CT:3m30s  RESPONSE 
Blood Sugar (R):  92 mgs% MOTION Blood Sugar(R):96    mgs% MOTION  
 
Good 
Blood Urea:  30  mgs% Ova: Nil Blood Urea: 30 mgs% Ova: Nil 
Serum Cholesterol: 165 mgs% Cyst: Nil Serum Cholesterol: 185mgs% Cyst:  Nil 
B.P.  124/90mmHg Occult Blood: Nil B.P. 130/80mmHg Occult Blood : Nil 
serum Calcium: 9mg% 
Proctoscopy: 
 
Serum Calcium:9mg% 
Proctoscopy: 
  
 
NAME: Jothi lakshmi AGE: 27 SEX: female O.P.NO: 47515 NO.OF DAYS TREATED:4FROM:07/06/2012TO:11/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus 
,bleeding from 
anus during 
detecation , 
burning 
sensation in the 
anus since 4 
days. 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
BLOOD BLOOD Bleeding arrested on 
5
th
  day 
No significant 
adverse effects 
TC: 9300 Cells/Cumm URINE TC:  9300 Cells/Cumm URINE 
DC: P: 62%   L: 48%E: 6% Alb: Nil DC: P:  68%   L: 56%E: 8% Alb: Nil 
ESR ½hr  16mm   Sug: Nil ESR ½hr   26mm   Sug: Nil 
 1hr  20mm   Dep:  NAD  1hr   30mm   Dep: NAD 
Hb:  78%    BT:  4m 30s    CT:4 m 20s  Hb: 80%   BT: 3m  CT:3m 50s  RESPONSE 
Blood Sugar (R): 140  mgs% MOTION Blood Sugar (R):148  mgs% MOTION 
Ova:  Nil 
 
 
 
Good 
Blood Urea: 38 mgs% Ova: Nil Blood Urea:   40 mgs% 
Serum Cholesterol: 148 mgs% Cyst: Nil Serum Cholesterol: 150mgs% Cyst: Nil 
B.P. 128/82mmHg Occult Blood: Nil B.P. 120/80mmHg Occult Blood : Nil 
Serum Calcium:8mg% 
Proctoscopy: 
Serum Calcium:10mg% 
Proctoscopy: 
  
  
NAME: Selvaraj AGE: 41 SEX: Male O.P.NO: 43186 NO.OF DAYS TREATED:5FROM:10/06/2012TO:15/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: Driver 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus 
,bleeding from 
anus during 
detecation , 
burning 
sensation since 7 
days. 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
BLOOD BLOOD Bleeding arrested on 
6
th
 day 
No significant 
adverse effects 
TC: 9300  Cells/Cumm URINE TC: 9300  Cells/Cumm URINE 
DC: P: 44%   L:48%E:4% Alb: Nil DC: P:  52%   L:  52%E: 6% Alb: Nil 
ESR ½hr   14mm   Sug: Nil ESR ½hr  24mm   Sug: Nil 
 1hr    20mm  Dep:NAD  1hr  20mm   Dep: NAD 
Hb: 76%   BT: 3m 40s  CT:4 m  Hb: 78%  BT: 3m     CT:3m 40s  RESPONSE 
Blood Sugar (R): 75  mgs% MOTION Blood Sugar (R): 80  mgs% MOTION  
 
Fair 
Blood Urea: 34 mgs% Ova: Nil Blood Urea: 38  mgs% Ova: Nil 
Serum Cholesterol: 130 mgs% Cyst: Nil Serum Cholesterol: 134mgs% Cyst: Nil 
B.P. 132/82mmHg Occult Blood: Nil B.P. 134/84mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
 
serum Calcium:8mg% 
Proctoscopy: 
  
 
NAME: Ramasamy AGE: 60 SEX: Male O.P.NO: 43778 NO.OF DAYS TREATED: 7                            FROM:12/06/2012           TO:19/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
burning 
sensation 
,bleeding from 
anus  since 7 
days. 
 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
 
BLOOD BLOOD Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC: 9200   Cells/Cumm URINE TC: 9200  Cells/Cumm URINE 
DC: P :62%  L:42%E:6% Alb: Nil DC:  P:  64%   L: 48%E: 8% Alb: Nil 
ESR ½hr  44mm   Sug: Nil ESR ½hr  54mm   Sug: Nil 
 1hr16mm  Dep: NAD  1hr  20mm   Dep: NAD 
Hb:  78%  BT:2m 50sCT:3m40s  Hb: 82%   BT: 2m    CT:2m40s  RESPONSE 
Blood Sugar (R): 122 mgs% MOTION Blood Sugar (R):128  mgs% MOTION  
 
 
Good 
Blood Urea:  26  mgs% Ova:  Nil Blood Urea:  28  mgs% Ova: Nil 
Serum Cholesterol: 124 mgs% Cyst: Nil Serum Cholesterol: 132mgs% Cyst: Nil 
B.P. 112/74mmHg Occult Blood: Nil B.P. 120/80mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
  
 
NAME: Aarthy AGE: 31 SEX: female O.P.NO: 44933 NO.OF DAYS: 9 FROM: 16/06/2012 TO: 25/06/2012 
DRUG::madhulai poo chooranam 1gm (bd) DIAGNOSIS: Bleeding piles OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation,bur
ning 
sensation,pain, 
,bleeding from 
anus since 7 
days. 
 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC: 9400  Cells/Cumm URINE TC: 9400  Cells/Cumm URINE 
DC: P: 66%   L: 36%E: 4% Alb: Nil DC: P:  68%     L: 38%E: 6% Alb: Nil 
ESR ½hr  30mm  Sug: Nil ESR ½hr   40mm   Sug: Nil 
 1hr   50mm  Dep: NAD  1hr    56mm   Dep: NAD 
Hb: 78%  BT: 3m50s  CT:5m10s  Hb: 82%   BT: 2m50s   CT:3m30s  RESPONSE 
Blood Sugar (R): 115 mgs% MOTION Blood Sugar (R): 120  mgs% MOTION  
 
Good 
Blood Urea: 24 mgs% Ova:  Nil Blood Urea: 26 mgs% Ova: Nil 
Serum Cholesterol: 168mgs% Cyst:  Nil Serum Cholesterol: 170mgs% Cyst: Nil 
B.P. 110/82mmHg Occult Blood: Nil B.P. 112/84mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME: Murugan AGE: 20 SEX: Male O.P.NO: 45077 NO.OF DAYS: 5 FROM: 16/07/2012 TO: 21/07/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus, 
,bleeding 
sensation,in the 
anus,bleedingfro
m anus since 7 
days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC:  9200   Cells/Cumm URINE TC: 9200 Cells/Cumm URINE 
DC: P:66%   L:38%E:4% Alb: Nil DC: P:  68%   L:42%  E: 6% Alb: Nil 
ESR ½hr  14mm  Sug: Nil ESR ½hr  44mm   Sug: Nil 
 1hr   20mm Dep:  NAD  1hr  28mm   Dep: NAD 
Hb: 76%  BT: 3m20s   CT:4m50s  Hb: 78%   BT: 2m 50s  CT:3m 30s  RESPONSE 
Blood Sugar (R): 144 mgs% MOTION Blood Sugar (R):145 mgs% MOTION  
 
Good 
Blood Urea:  32 mgs% Ova: Nil Blood Urea: 34  mgs% Ova: Nil 
Serum Cholesterol: 212 mgs% Cyst: Nil Serum Cholesterol: 220mgs% Cyst: Nil 
B.P. 120/82mmHg Occult Blood: Nil B.P. 130/82mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
  
 
NAME: Pichumani AGE: 29 SEX: Male O.P.NO: 45662 NO.OF DAYS: 5 FROM: 19/06/2012 TO: 24/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation,pai
n in the 
anus,bleeding 
from 
anus,burning 
sensation 
tiredness since 
10 days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC: 9700  Cells/Cumm URINE TC: 9700 Cells/Cumm URINE 
DC: P :52%   L:46%E:  4% Alb: Nil DC: P:  56%  L: 48%E:6% Alb: Nil 
ESR   ½hr 17mm   Sug: Nil ESR ½hr   37mm   Sug: Nil 
1hr   40mm  Dep : NAD  1hr   50mm   Dep: NAD 
Hb: 78%    BT: 3m50s    CT:4 m  Hb: 82%   BT:3m   CT:3m20s  RESPONSE 
Blood Sugar (R): 82  mgs% MOTION Blood Sugar (R): 86 mgs% MOTION  
 
Good 
Blood Urea: 24  mgs% Ova: Nil Blood Urea:  28  mgs% Ova: Nil 
Serum Cholesterol: 184 mgs% Cyst: Nil Serum Cholesterol: 186 mgs% Cyst: Nil 
B.P.  116/78mmHg Occult Blood: Nil B.P. 120/82mmHg Occult Blood :  Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
NAME: Esakiyamal AGE: 41 SEX: Female O.P.NO: 56433 NO.OF DAYS: 5 FROM: 25/07/2012 TO: 30/07/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation,pai
n in the anus, 
burning 
sensation around 
the anus, 
bleeding from 
anus since 6 days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC: 8600  Cells/Cumm URINE TC: 8600 Cells/Cumm URINE 
DC: P: 55%   L: 42%E: 2% Alb: Nil DC: P: 58%   L:46%E:4% Alb: Nil 
ESR ½hr   33mm   Sug: Nil ESR ½hr  38mm   Sug: Nil 
 1hr18mm  Dep:  NAD  1hr  20mm   Dep: NAD 
Hb: 74%   BT: 4m30s   CT:5 m 30s  Hb:  78%    BT:  3m40s   CT:3m 45s  RESPONSE 
Blood Sugar (R): 94  mgs% MOTION Blood Sugar (R): 96  mgs% MOTION  
 
Good 
Blood Urea:  32 mgs% OVA:  Nil Blood Urea:  34   mgs% OVA: Nil 
Serum Cholesterol: 186mgs% CYST: Nil Serum Cholesterol:188 mgs% CYST: Nil 
B.P. 112/74mmHg Occult Blood: Nil B.P. 116/78mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
NAME: Murugaiya AGE: 44 SEX: Male O.P.NO: 60507 NO.OF DAYS TREATED:5FROM:08/08/2012TO:13/08/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus, 
burning 
sensation in the 
anus, bleeding 
from anus since 
4 days 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
BLOOD BLOOD Bleeding arrested on 
6
th
 day 
No significant 
adverse effects 
TC: 9600  Cells/cumm URINE TC: 9600  Cells/Cumm URINE 
DC: P: 66%  L: 32%E: 8% Alb: Nil DC: P:  68%    L: 36%E:6% Alb: Nil 
ESR ½hr 32mm   Sug: Nil ESR ½hr 42mm   Sug: Nil 
 1hr 18mm  Dep:NAD  1hr 20mm   Dep: NAD 
Hb: 74%  BT: 4m    CT:5 m  Hb: 78%     BT:3m30s   CT:4m 20s  RESPONSE 
Blood Sugar (R): 86  mgs% MOTION Blood Sugar: 88 mgs% MOTION  
 
 
Fair 
Blood Urea: 28 mgs% Ova: Nil Blood Urea: 32  mgs% Ova: Nil 
Serum Cholesterol: 194mgs% Cyst: Nil Serum Cholesterol: 196mgs% Cyst: Nil 
B.P. 118/82mmHg Occult Blood: Nil B.P. 120/86mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
 
 
 
NAME:Muniyamal AGE: 46 SEX: Female O.P.NO: 62098 NO.OF DAYS TREATED:5FROM:13/08/2012TO:18/08/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus, 
bleeding from 
anus during 
detecation, 
burning 
sensation around 
the anus since 5 
days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
7
th
 day 
No significant 
adverse effects 
TC: 9100 Cells/Cumm URINE TC: 9100  Cells/Cumm URINE 
DC: P:  58%   L:32%E: 2% Alb: Nil DC:P:  62%  L:34%E:4% Alb: Nil 
ESR ½hr 16mm   Sug: Nil ESR ½hr 26mm   Sug: Nil 
 1hr 24mm  Dep:NAD  1hr 30mm   Dep: NAD 
Hb:  74%   BT: 4m  CT:3 m 30s  Hb: 78%   BT: 2m 45s  CT:4m  RESPONSE 
Blood Sugar (R):128 mgs% MOTION  BloodSugar(R):132 mgs% MOTION  
 
Fair 
Blood Urea: 28  mgs% Ova: Nil Blood Urea: 32  mgs% Ova: Nil 
Serum Cholesterol:138 mgs% Cyst: Nil Serum Cholesterol: 140mgs% Cyst: Nil 
B.P. 112/82mmHg Occult Blood: Nil B.P. 116/84mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
  
NAME: Vasugi AGE: 19 SEX: Female O.P.NO: 62425 NO.OF DAYS TREATED:5                             FROM:14/08/2012TO:19/08/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus, 
bleeding from 
anus ,burning 
sensation, 
tiredness since 5 
days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
   day 
No significant 
adverse effects 
TC: 9200  Cells/cumm URINE TC:9200 Cells/Cumm URINE 
DC: P: 46%   L:52%E:6% Alb: Nil DC: P:  48%L:56%E: 8% Alb: Nil 
ESR ½hr 33mm   Sug: Nil ESR ½hr 42mm   Sug: Nil 
 1hr 27mm  Dep: NAD  1hr 32mm   Dep: NAD 
Hb: 78%    BT:4m  CT:4 m 20s  Hb: 80%   BT: 2m 40s  CT:2m 50s  RESPONSE 
Blood Sugar(R): 92  mgs% MOTION Blood Sugar(R):96 mgs% MOTION  
 
Good 
Blood Urea: 28 mgs% Ova: Nil Blood Urea: 32 mgs% Ova:  Nil 
Serum Cholesterol: 192 mgs% Cyst: Nil Serum Cholesterol: 196mgs% Cyst: Nil 
B.P. 114/76mmHg Occult Blood: Nil B.P. 118/80mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME: Venkatesh AGE: 22 SEX: Male O.P.NO: 62833 NO.OF DAYS: 7 FROM: 16/08/2012 TO: 23/08/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
burning 
sensation, 
bleeding from 
anus,pain, 
tiredness since 7 
days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
   day 
No significant 
adverse effects 
TC: 9600 Cells/Cumm URINE TC: 9600  Cells/Cumm URINE 
DC: P 54% L: 46% E: 4% Alb: Nil DC: P:  56%  L: 48%E: 6% Alb: Nil 
ESR ½hr 16mm   Sug: Nil ESR ½hr 36mm   Sug: Nil 
 1hr 28mm  Dep:  NAD  1hr 38mm   Dep: NAD 
Hb: 76% BT: 3m50s CT:4m  Hb: 78%  BT: 3m CT:3m  RESPONSE 
Blood Sugar(R): 132 mgs% MOTION  Blood Sugar(R):134 mgs% MOTION  
 
Good 
Blood Urea: 28 mgs% Ova: Nil  Blood Urea:       32   mgs% Ova: Nil 
Serum Cholesterol: 174mgs% Cyst: Nil  Serum Cholesterol: 176mgs% Cyst: Nil 
B.P. 124/84mmHg Occult Blood: Nil  B.P. 126/86mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:10mg% 
Proctoscopy: 
  
 
 
 
NAME: Balamurugan AGE: 50 SEX: Male O.P.NO: 64200 NO.OF DAYS: 5 FROM: 21/08/2012 TO: 26/08/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
bleeding from 
anus, tiredness, 
burning  
sensation after 
detecation since 
7 days 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC:  9100  Cells/Cumm URINE TC: 9100  Cells/Cumm URINE 
DC: P : 68%  L:34%E:4% Alb: Nil DC: P:  70%   L:36%E:6% Alb: Nil 
ESR ½hr 27mm   Sug: Nil ESR ½hr 35mm   Sug: Nil 
 1hr 40mm  Dep:  NAD  1hr 46mm   Dep: NAD 
Hb: 80%  BT: 4m 20s  CT:4 m 10s  Hb: 86%   BT: 3m23s CT:2m 40s  RESPONSE 
Blood Sugar(R): 94  mgs% MOTION Blood Sugar(R):98 mgs% MOTION  
 
Good 
Blood Urea:        36  mgs% Ova: Nil Blood Urea: 38 mgs% Ova: Nil 
Serum Cholesterol:154 mgs% Cyst: Nil Serum Cholesterol:156mgs% Cyst: Nil 
B.P. 124/74mmHg Occult Blood: Nil B.P. 128/82mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME: Vindhya AGE: 27 SEX: Female O.P.NO: 68800 NO.OFDAYS TREATED:9FROM:05/09/2012TO:14/09/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain, burning 
sensation around 
the anus, 
bleeding from 
anus since 5 days 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC: 9700 Cells/Cumm URINE TC: 9700 Cells/Cumm URINE 
DC: P:  66%   L:  32%E: 4% Alb: Nil DC: P: 68% L: 34% E: 6% Alb: Nil 
ESR ½hr 25mm   Sug: Nil ESR ½hr 35mm   Sug: Nil 
 1hr 40mm  Dep: NAD  1hr 29mm   Dep: NAD 
Hb: 74%    BT: 3m30s  CT:5 m  Hb: 78% BT: 2m 40s CT:4m  RESPONSE 
Blood Sugar(R):  124   mgs% MOTION Blood Sugar(R):128 mgs% MOTION  
 
Good 
Blood Urea: 26mgs% Ova: Nil Blood Urea: 28 mgs% Ova:  Nil 
Serum Cholesterol: 136mgs% Cyst: Nil Serum Cholesterol: 134mgs% Cyst: Nil 
B.P. 124/82mmHg Occult Blood: Nil B.P. 126/76mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME: Shabhi AGE: 30 SEX: Female O.P.NO: 69570 NO.OF DAYS TREATED:7FROM:07/09/2012TO:14/09/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain, burning 
sensation, 
bleeding from 
anus since 7 days 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
5
th
  day. 
No significant 
adverse effect 
TC: 9600  Cells/cumm URINE TC: 9600 Cells/Cumm URINE 
DC: P : 72%  L:26%E:8% Alb:Nil DC: P:  74%   L: 28%E:8% Alb: Nil 
ESR ½hr 23mm Sug:  Nil ESR ½hr 35mm   Sug: Nil 
 1hr 34mm Dep:NAD  1hr 48mm   Dep: NAD 
Hb: 72%  BT: 3m30s  CT:4 m20s  Hb: 78%    BT: 2m 30s    CT:3m 40s  RESPONSE 
Blood Sugar(R): 114  mgs% MOTION Blood Sugar(R): 118  mgs% MOTION  
 
Good 
Blood Urea: 18 mgs% Ova: Nil Blood Urea: 20 mgs% Ova: Nil 
Serum Cholesterol: 168 mgs% Cyst:  Nil Serum Cholesterol: 172mgs% Cyst: Nil 
B.P.  114/84mmHg Occult Blood: Nil B.P. 122/78mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
NAME: Sembhukutti AGE: 45 SEX: Male O.P.NO: 69810 NO.OFDAYS TREATED:7FROM:07/09/2012TO:14/09/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: House Wife 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain, burning 
sensation in the 
anus, bleeding 
from anus since 
5 days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on  
5
th
 day 
No significant 
adverse effects 
TC: 9300 Cells/cumm URINE TC: 9300  Cells/Cumm URINE 
DC: P: 56%      L: 44%E: 6% Alb: Nil DC: P:   58%   L: 46%E:8% Alb: Nil 
ESR ½hr 25mm   Sug: Nil ESR ½hr 45mm   Sug: Nil 
 1hr 40mm  Dep: NAD  1hr 50mm   Dep: NAD 
Hb: 68%   BT: 3m 30s   CT:  5m  Hb: 72%  BT: 2m40s  CT: 4m  RESPONSE 
Blood Sugar(R): 116  mgs% MOTION BloodSugar (R):118 mgs% MOTION  
 
 
Good 
Blood Urea: 24 mgs% Ova: Nil Blood Urea: 26  mgs% Ova: Nil 
Serum Cholesterol: 154mgs% Cyst: Nil Serum Cholesterol: 156mgs% Cyst: Nil 
B.P. 110/78mmHg Occult Blood: Nil B.P. 114/74mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
 
 NAME: Ramaiya AGE: 30 SEX: Male O.P.NO: 71211 NO.OFDAYS: 5 FROM: 12/09/2012 TO: 17/09/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
bleeding from 
anus, tiredness 
since 6 days 
 
 
KURUTHI 
MOOLAM 
 
 
 
BLOOD  Bleeding arrested on 
6
th
  day 
No significant 
adverse effects 
TC: 9100 Cells/Cumm URINE TC: 9100 Cells/Cumm URINE 
DC: P: 56%    L: 42%E:4% Alb: Nil DC: P: 58%  L: 46%E:6% Alb: Nil 
ESR ½hr 25mm Sug:     Nil ESR ½hr 35mm   Sug: Nil 
 1hr 40mm Dep:NAD  1hr 50mm   Dep: NAD 
Hb:76%     BT: 4m   CT:4 m  Hb: 78%  BT:4m  CT:3m 40s  RESPONSE 
Blood Sugar(R): 92mgs% MOTION Blood Sugar(R):94 mgs% MOTION  
 
Fair 
Blood Urea: 26mgs% Ova: Nil Blood Urea: 24  mgs% Ova: Nil 
Serum Cholesterol: 196mgs% Cyst: Nil Serum Cholesterol:198 mgs% Cyst: Nil 
B.P. 114/82mmHg Occult Blood: Nil B.P. 116/84mmHg Occult Blood : Nil 
serum Calcium: 9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
NAME: Mariyappan AGE: 40 SEX: Male O.P.NO: 75285 NO.OFDAYS: 7 FROM: 24/09/2012 TO: 01/10/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: House Wife 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain,bleeding 
from anus, since 
4 days 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC: 9200  Cells/Cumm URINE TC:   9200   Cells/Cumm URINE 
DC: P : 68%    L: 32%E: 4% Alb: Nil DC: P: 70%    L: 34%E: 6% Alb: Nil 
ESR ½hr 16mm   Sug: Nil ESR ½hr 26mm   Sug: Nil 
 1hr 18mm  Dep: NAD  1hr 30mm   Dep: NAD 
Hb: 78%  BT: 2m40s  CT:4 m  Hb: 82%   BT: 2m20s  CT:3m 40s  RESPONSE 
Blood Sugar(R):94 mgs% MOTION Blood Sugar(R): 96 mgs% MOTION  
 
 
Fair 
Blood Urea: 36 mgs% Ova: Nil Blood Urea: 36 mgs% Ova:Nil 
Serum Cholesterol: 154mgs% Cyst: Nil Serum Cholesterol: 153mgs% Cyst: Nil 
B.P. 114/72mmHg Occult Blood: Nil B.P. 120/82mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
 NAME: Senthil AGE: 30 SEX: Male O.P.NO: 75286 NO.OF.DAYS TREATED:5FROM:24/09/2012TO:29/09/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain, tiredness, 
burning 
sensation, 
bleeding fron 
anus since 7 days 
 
 
 
KURUTHI 
MOOLAM 
 
 
 
BLOOD BLOOD Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC: 8400 Cells/Cumm URINE TC: 8400 Cells/Cumm URINE 
DC: P: 52%   L: 46%E:4% Alb: Nil DC:   P:  52%    L: 48%E:6% Alb: Nil 
ESR ½hr 23mm Sug: Nil ESR ½hr 23mm   Sug: Nil 
 1hr 18mm Dep: NAD  1hr 18mm   Dep: NAD 
Hb: 72%    BT: 4m30s   CT:4 m 20s  Hb:  72%   BT: 3m   CT:3m10s  RESPONSE 
Blood Sugar(R): 122  mgs% MOTION Blood Sugar(R) : 126  mgs% MOTION  
 
Good 
Blood Urea: 26mgs% Ova: Nil Blood Urea: 24  mgs% Ova: Nil 
Serum Cholesterol: 172 mgs% Cyst: Nil Serum Cholesterol: 172mgs% Cyst: Nil 
B.P. 128/72mmHg Occult Blood: Nil B.P. 130/80mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8gm% 
Proctoscopy: 
  
 
 
NAME:Sankaran AGE: 28 SEX: Male O.P.NO: 76074 NO.OFDAYS TREATED:5                  FROM:26/09/2012TO:01/10/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation, 
pain in the anus,  
burning 
sensation, 
bleeding fron 
anus since 4 days 
 
 
 
 
KURUTHI 
MOOLAM 
 
 
BLOOD BLOOD Bleeding arrested on 
5
th
 day 
No significant 
adverse effects 
TC:9400 Cells/Cumm URINE TC: 9400  Cells/Cumm URINE 
DC: P: 56%    L: 42%E: 2% Alb: Nil DC: P: 58%   L: 38%E: 4% Alb: Nil 
ESR ½hr 14mm   Sug: Nil ESR ½hr 24mm   Sug: Nil 
 1hr 30mm  Dep: NAD  1hr 40mm   Dep: NAD 
Hb: 78%   BT:  4m20s   CT:5 m30s  Hb: 78%   BT: 3m45s    CT:3m 40s  RESPONSE 
Blood Sugar(R): 94 mgs% MOTION Blood Sugar(R): 94 mgs% MOTION  
 
Good 
Blood Urea: 36mgs% Ova: Nil Blood Urea: 36 mgs% Ova: Nil 
Serum Cholesterol: 154mgs% Cyst: Nil Serum Cholesterol: 154mgs% Cyst: Nil 
B.P. 122/62mmHg Occult Blood: Nil B.P. 120/68mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
  
NAME: Sundarajan AGE: 60 SEX: Male O.P.NO: 76075 NO.OFDAYS TREATED:7                            FROM:26/09/2012TO:03/10/2012 
DRUG:madhulai poo chooranam 1gm (bd)   OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
bleeding from 
anus , tiredness 
since 5 days 
 BLOOD BLOOD Bleeding arrested on 
4
th
   day 
No significant 
adverse effects 
TC: 9200  Cells/Cumm URINE TC: 9200  Cells/Cumm URINE 
DC: P :62%    L: 34%E: 6% Alb: Nil DC: P: 62%   L: 38%E: 6% Alb: Nil 
 KURUTHI 
MOOLAM 
 
 
ESR ½hr 15mm Sug:  Nil ESR ½hr 25mm  Sug:    Nil 
 1hr 20mm Dep: NAD  1hr 20mm  Dep: NAD 
Hb: 80%   BT: 4m40s  CT:5 m30s  Hb: 80%    BT: 3m   CT:4m  RESPONSE 
Blood Sugar(R): 112 mgs% MOTION Blood Sugar(R): 112 mgs% MOTION  
 
Good 
Blood Urea: 28mgs% Ova: Nil Blood Urea: 28 mgs% Ova: Nil 
Serum Cholesterol: 124 mgs% Cyst: Nil Serum Cholesterol: 124 mgs% Cyst: Nil 
B.P. 120/80mmHg Occult Blood: Nil B.P. 120/82mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
 
 
NAME: Sivakumar AGE: 45 SEX: Male O.P.NO: 80064 NO.OFDAYS TREATED:5FROM:08/10/2012TO:13/10/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain , burning 
sensation , 
bleeding from 
anus , tiredness 
since 7 days . 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
3
rd
 day 
No significant 
adverse effects 
TC: 9600 Cells/Cumm URINE TC: 9600  Cells/Cumm URINE 
DC: P: 60%   L: 34%E: 4% Alb: Nil DC: P:  58%   L: 38%E:4% Alb: Nil 
ESR ½hr 33mm   Sug: Nil ESR ½hr 23mm   Sug: Nil 
 1hr 40mm Dep:Nil  1hr 40mm   Dep: NAD 
Hb: 72%    BT: 4m30s    CT:4m  Hb: 72%    BT: 3m   CT:3m  RESPONSE 
Blood Sugar(R): 84 mgs% MOTION Blood Sugar(R): 84  mgs% MOTION  
 
 
Good 
Blood Urea:         26mgs% Ova: Nil Blood Urea:    26 mgs% Ova: Nil 
Serum Cholesterol: 154 mgs% Cyst: Nil Serum Cholesterol: 156mgs% Cyst: Nil 
B.P. 112/80mmHg Occult Blood: Nil B.P. 112/78mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
 
  
NAME: Rajarajan AGE: 50 SEX: Male O.P.NO: 80065 NO.OF DAYS TREATED:5FROM:08/10/2012TO:13/10/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain , burning 
sensation , 
bleeding from 
anus since 4 days 
. 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
6
th
 day 
No significant 
adverse effects 
TC: 8400  Cells/Cumm URINE TC: 8400 Cells/Cumm URINE 
DC: P :64%    L: 32%E:4% Alb: Nil DC: P:  64%   L: 34%E: 6% Alb: Nil 
ESR ½hr 25mm Sug:     Nil ESR ½hr 45mm   Sug: Nil 
 1hr 50mm Dep:    NAD  1hr 40mm   Dep: NAD 
Hb: 72%    BT: 3m40s    CT:4m 30s  Hb: 72%    BT:3m   CT:4m  RESPONSE 
Blood Sugar(R): 94 mgs% MOTION Blood Sugar(R):  94  mgs% MOTION  
 
 
Fair 
Blood Urea: 26  mgs% Ova: Nil Blood Urea: 26   mgs% Ova: Nil 
Serum Cholesterol: 164 mgs% Cyst: Nil Serum Cholesterol: 164mgs% Cyst: Nil 
B.P. 132/82mmHg Occult Blood: Nil B.P. 132/82mmHg Occult Blood : Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME : Jaganathan AGE: 45 SEX: Male O.P.NO: 82376 NO.OFDAYS TREATED:5FROM:16/10/2012TO:21/10/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain , bleeding 
from anus , 
tiredness since 7 
days 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
6
th
 day 
No significant 
adverse effects 
TC: 9200  Cells/Cumm URINE TC: 9200 Cells/Cumm URINE 
DC:P: 64%   L:32%E: 4% Alb: Nil DC: P:  64%   L: 32%E: 4% Alb: Nil 
ESR ½hr 24mm Sug: Nil ESR ½hr 34mm   Sug: Nil 
 1hr 30mm Dep: NAD  1hr 50mm   Dep: NAD 
Hb: 74%    BT: 4m20s    CT:5m  Hb: 74%   BT: 3m40s  CT:4m 35s  RESPONSE 
Blood Sugar(R):86mgs% MOTION Blood Sugar(R): 86  mgs% MOTION  
 
 
Fair 
Blood Urea: 26  mgs% OVA: Nil Blood Urea: 26  mgs% Ova: Nil 
Serum Cholesterol: 172mgs% CYST: Nil Serum Cholesterol: 172mgs% Cyst: Nil 
B.P. 110/80mmHg Occult Blood: Nil B.P. 112/84mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
  
NAME: Elango AGE: 55 SEX: Male O.P.NO: 84292 NO.OF DAYS TREATED :     6FROM:22/10/2012TO:28/10/2012 
DRUG: madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain in the anus  
, bleeding from 
anus , tiredness 
since 7 days 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
6
th
 day 
No significant 
adverse effects 
TC: 9800 Cells/Cumm URINE TC: 9800   Cells/Cumm URINE 
DC: P: 64%    L: 32%E: 4% Alb: Nil DC: P: 65%    L: 30%E:5% Alb: Nil 
ESR ½hr 22mm   Sug: Nil ESR ½hr 52mm   Sug: Nil 
 1hr 46mm Dep: NAD  1hr 46mm   Dep: NAD 
Hb: 74%    BT: 3m50s    CT:4 m 50s  Hb: 74%        BT: 3m 10s     CT:4m  RESPONSE 
Blood Sugar(R): 112 mgs% MOTION Blood Sugar(R): 112 mgs% MOTION  
 
 
Fair 
Blood Urea: 26 mgs% Ova: Nil Blood Urea: 26  mgs% Ova: Nil 
Serum Cholesterol: 122 mgs% Cyst: Nil Serum Cholesterol: 122mgs% Cyst: Nil 
B.P. 110/84mmHg Occult Blood:  Nil B.P. 120/82mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
NAME: Chinathai AGE: 50 SEX: Female O.P.NO: 42953 NO.OFDAYS TREATED : 5FROM:02/11/2012TO:06/11/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain ,pain in the 
anus  , bleeding 
from anus since 
7 days 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
3
rd
  day 
No significant 
adverse effects 
TC: 9200 Cells/Cumm URINE TC: 9200  Cells/Cumm URINE 
DC: P : 64%  L: 34%E: 4% Alb: Nil DC: P:  66%    L:34%E:4% Alb: Nil 
ESR ½hr 44mm   Sug: Nil ESR ½hr 34mm   Sug: Nil 
 1hr 28mm Dep: NAD  1hr 58mm   Dep: NAD 
Hb: 76%    BT: 4m20s    CT:5 m  Hb: 76%   BT: 3m 25s   CT:3m20s  RESPONSE 
Blood Sugar(R): 92  mgs% MOTION Blood Sugar(R):  92mgs% MOTION  
 
 
Good 
Blood Urea: 28 mgs% Ova: Nil Blood Urea: 28 mgs% Ova: Nil 
Serum Cholesterol: 152mgs% Cyst: Nil Serum Cholesterol: 152mgs% Cyst: Nil 
B.P. 122/74mmHg Occult Blood: Nil B.P. 122/74mmHg Occult Blood : Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
 
IN- PATIENTS 
 
NAME: Vallithai AGE: 50 SEX: Female I.P.NO: 1853 NO.OF DAYS TREATED: 5             DAO:09/06/2012                      DOD:14/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: House Wife 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain in the anus 
,bleeding from 
anus , during 
detecation , 
burning 
sensation since 3 
weeks . 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
BLOOD BLOOD Bleeding arrested on 
6
th
 day 
No significant 
adverse effects 
TC:8400  Cells/Cumm URINE TC:  8400 Cells/Cumm URINE 
DC:P: 64%   L:32%   E:6% Alb:  Nil DC:P:  66%    L:34%E:8% Alb: Nil 
ESR ½hr 38mm   Sug: Nil ESR ½hr  36mm   Sug: Nil 
 1hr 40mm Dep: NAD  1hr   40mm   Dep: NAD 
Hb:72% BT:4m  CT:3 m 50s  Hb: 72%     BT:3m 40s    CT:3m10s  RESPONSE 
Blood Sugar(R): 84 mgs% MOTION Blood Sugar(R): 84  mgs% MOTION  
 
 
Fair 
Blood Urea:         28 mgs% Ova:  Nil 
Cyst: Nil 
Blood Urea: 26   mgs% Ova:Nil 
Serum Cholesterol: 192 mgs% Serum Cholesterol:196mgs% Cyst: Nil 
B.P. 138/82mmHg Occult Blood: Nil B.P. 138/80mmHg Occult Blood:Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
   
 
 
NAME: Mariyama AGE: 48 SEX: Female I.P.NO: 2017 NO.OF DAYS TREATED:8                        DAO:21/06/2012DOD:29/06/2012 
DRUG:madhulai poo chooranam 1gm (bd) OCCUPATION: House wife 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain in the anus , 
bleeding per the 
anus since  1 
weeks . 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
3
rd
 day 
No significant 
adverse effects 
TC:  8800  Cells/Cumm URINE TC: 8800 Cells/Cumm URINE 
DC:   P: 68%   L:30%E:4% Alb: Nil DC:P:  68%  L:30%E:6% Alb: Nil 
ESR ½hr  34mm   Sug: Nil ESR ½hr   34mm   Sug: Nil 
 1hr20mm Dep: NAD  1hr    40mm   Dep: NAD 
Hb: 76%    BT:4m   CT:5 m  Hb:76%  BT: 2m40s CT:4m  RESPONSE 
Blood Sugar(R):  86  mgs% MOTION Blood Sugar(R): 86  mgs% MOTION  
 
 
Good 
Blood Urea: 26  mgs% Ova: Nil Blood Urea:  26 mgs% Ova: Nil 
Serum Cholesterol: 204mgs% Cyst: Nil Serum Cholesterol:206mgs% Cyst: Nil 
B.P.   120/74mmHg Occult Blood: Nil B.P. 120/74mmHg Occult Blood: Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
  
NAME: Ratha AGE: 50 SEX: Female I.P.NO: 2013 NO.OFDAYS TREATED:6              DAO:21/06/2012                DOD:27/06/2012 
DRUG: madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain, burning 
sensation 
,bleeding from 
anus since 3 
weeks . 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD  Bleeding arrested on 
3
rd
 day 
No significant 
adverse effects 
TC: 9200  Cells/Cumm URINE TC:  9200   Cells/Cumm URINE 
DC: P: 64%   L:32%E:6% Alb: Nil DC:  P:  64%  L:34%E:6% Alb: Nil 
ESR ½hr 25mm   Sug: Nil ESR ½hr  25mm   Sug: Nil 
 1hr  30mm  Dep:NAD  1hr   50mm   Dep: NAD 
Hb: 72%     BT;4m    CT:4m 30s  Hb: 70%    BT:2m30s   CT:3m  RESPONSE 
Blood Sugar(R): 86mgs% MOTION Blood Sugar(R):86  mgs% MOTION  
 
 
Good 
Blood Urea:   28 mgs% Ova: Nil Blood Urea:   28 mgs% Ova: Nil 
Serum Cholesterol: 184 mgs% Cyst: Nil Serum Cholesterol: 184 mgs% Cyst: Nil 
B.P. 112/72mmHg Occult Blood: Nil B.P. 110/40mmHg Occult Blood: Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
NAME: Lakshmi AGE: 45 SEX: Female I.P.NO: 2012 NO.OF DAYS TREATED:7                    DOA:21/06/2012              DOD:28/06/2012 
DRUG: Madhulai poo chooranam 1gm (bd)   OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain in the anus , 
bleeding from 
the anus , 
burning 
sensation since 4 
days . 
 
 
 
 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD  Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC:  8400  Cells/Cumm URINE TC: 8400 Cells/Cumm URINE 
DC: P: 62%    L: 34%E: 4% Alb: Nil DC:  P:  62%    L:36%E: 4% Alb: Nil 
ESR ½hr    24mm   Sug: Nil ESR ½hr  44mm   Sug: Nil 
 1hr    38mm  Dep:  NAD  1hr   48mm   Dep: NAD 
Hb: 72%    BT:4m   CT6m 15s  Hb: 72%   BT: 3m    CT:4m 40s  RESPONSE 
Blood Sugar(R):96mgs% MOTION Blood Sugar(R):96 mgs% MOTION  
 
Good 
Blood Urea:    32 mgs% Ova: Nil Blood Urea: 32 mgs% Ova: Nil 
Serum Cholesterol: 210mgs% Cyst: Nil Serum Cholesterol: 210mgs% Cyst: Nil 
B.P. 110/82mmHg Occult Blood: Nil B.P. 112/82mmHg Blood Occult: Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
  
NAME: Manimaran AGE: 26 SEX: Male I.P.NO: 2208 NO.OFDAYS TREATED:7                       DOA:10/06/2012              DOD:17/06/2012 
DRUG:Madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
burning 
sensation , 
bleeding from 
anus , pain since 
5 days .. 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
3
rd
  day 
No significant 
adverse effects 
TC: 9200  Cells/Cumm URINE TC:  9200   Cells/Cumm URINE 
DC: P: 62%    L: 34%E: 2% Alb: Nil DC: P:  62%  L: 36%E: 4% Alb: Nil 
ESR ½hr  35mm   Sug: Nil ESR ½hr   45mm   Sug: Nil 
 1hr  12mm Dep:NAD  1hr    42mm   Dep: NAD 
Hb:  64%  BT:4mCT:5m  Hb: 66%   BT: 3m12s    CT:4m  RESPONSE 
Blood Sugar(R):144 mgs% MOTION Blood Sugar(R):144  mgs% MOTION  
 
Good 
Blood Urea:  26 mgs% Ova: Nil Blood Urea:  26  mgs% Ova: Nil 
Serum Cholesterol: 216 mgs% Cyst: Nil Serum Cholesterol: 216 mgs% Cyst: Nil 
B.P.  112/74mmHg Occult Blood: Nil B.P. 112/74mmHg Blood Occult: Nil 
serum Calcium:9mg% 
Proctoscopy: 
serum Calcium:9mg% 
Proctoscopy: 
  
 
 
NAME: Vellsamy AGE: 45 SEX: Male I.P.NO: 2488 NO.OFDAYS TREATED:8                   DOA:30/07/2012               DOD:07/08/2012 
DRUG:Madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain ,burning 
sensation , 
bleeding from 
anus , tiredness 
since 4 days . 
 
 
 
 
 
KURUTHI 
MOOLAM 
 
BLOOD BLOOD Bleeding arrested on 
3
rd
  day 
No significant 
adverse effects 
TC: 7600  Cells/Cumm URINE TC:  7600   Cells/Cumm URINE 
DC: P: 60%    L: 36%E: 4% Alb: Nil DC: P:  60%  L: 38%E: 4% Alb: Nil 
ESR ½hr  37mm   Sug: Nil ESR ½hr   46mm   Sug: Nil 
 1hr  40mm Dep:NAD  1hr    30mm   Dep: NAD 
Hb:  68%  BT:4m  CT:6m  Hb: 68%   BT: 2m30s    CT:5m  RESPONSE 
Blood Sugar(R):136 mgs% MOTION Blood Sugar(R):136  mgs% MOTION  
 
Good 
Blood Urea:  28 mgs% Ova: Nil Blood Urea:  28  mgs% Ova: Nil 
Serum Cholesterol: 210 mgs% Cyst: Nil Serum Cholesterol: 210 mgs% Cyst: Nil 
B.P.  112/76mmHg Occult Blood: Nil B.P. 112/76mmHg Blood Occult: Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
NAME: Udhayal AGE: 50 SEX: Female I.P.NO: 2557 NO.OFDAYS TREATED:10                     DOA:22/08/2012                DOD:30/08/2012 
DRUG:Madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain , burning 
sensation around 
the anus , 
bleeding from 
anus since 6 
days. 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC: 8600  Cells/Cumm URINE TC:  8600  Cells/Cumm URINE 
DC: P: 68%    L: 38%E: 4% Alb: Nil DC: P:  68%  L: 38%E: 4% Alb: Nil 
ESR ½hr  45mm   Sug: Nil ESR ½hr   44mm   Sug: Nil 
 1hr  25mm Dep:NAD  1hr    20mm   Dep: NAD 
Hb:  72%  BT:3m 10s CT:6m30s  Hb: 72%   BT: 3m    CT:5m  RESPONSE 
Blood Sugar(R):82 mgs% MOTION Blood Sugar(R):82  mgs% MOTION  
 
Good 
Blood Urea:  24 mgs% Ova: Nil Blood Urea:  24  mgs% Ova: Nil 
Serum Cholesterol: 132 mgs% Cyst: Nil Serum Cholesterol: 132 mgs% Cyst: Nil 
B.P.  112/82mmHg Occult Blood: Nil B.P. 112/82mmHg Blood Occult: Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME: Rajyamal AGE: 50 SEX: Female I.P.NO: 3652 NO.OFDAYS TREATED:7                        DOA:20/10/2012            DOD:27/10/2012 
DRUG:Madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain , burning 
sensation , 
bleeding from 
anus since 5 
days. 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
4
th
 day 
No significant 
adverse effects 
TC: 9400  Cells/Cumm URINE TC:  9400   Cells/Cumm URINE 
DC: P: 56%    L: 44%E:4% Alb: Nil DC: P:  56%  L: 42%E: 4% Alb: Nil 
ESR ½hr 46mm   Sug: Nil ESR ½hr   45mm   Sug: Nil 
 1hr  12mm Dep:NAD  1hr    40mm   Dep: NAD 
Hb:  74%  BT:4m 10s CT:5m50s  Hb: 74%   BT: 3m    CT:4m 20s  RESPONSE 
Blood Sugar(R):94 mgs% MOTION Blood Sugar(R):94 mgs% MOTION  
 
Good 
Blood Urea:  30 mgs% Ova: Nil Blood Urea:  30  mgs% Ova: Nil 
Serum Cholesterol: 174 mgs% Cyst: Nil Serum Cholesterol: 174 mgs% Cyst: Nil 
B.P.  124/72mmHg Occult Blood: Nil B.P. 124/72mmHg Blood Occult: Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME: Sankaramal AGE: 40 SEX: Female I.P.NO: 85524 NO.OFDAYS TREATED:6                 DOA:27/10/2012                 DOD:02/11/2012 
DRUG:Madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Consti pain , 
burning 
sensation around 
the anus , 
bleeding from 
anus , tiredness 
since 7 days . 
 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
9
th
 day 
No significant 
adverse effects 
TC: 9,000  Cells/Cumm URINE TC:  9,000  Cells/Cumm URINE 
DC: P: 66%    L: 36%E: 4% Alb: Nil DC: P:  66%  L: 34%E: 4% Alb: Nil 
ESR ½hr  25mm   Sug: Nil ESR ½hr   35mm   Sug: Nil 
 1hr  30mm Dep:NAD  1hr   10mm   Dep: NAD 
Hb:  72%  BT:3m30s  CT:5m  Hb: 72%   BT: 3m     CT:5m  RESPONSE 
Blood Sugar(R):84 mgs% MOTION Blood Sugar(R):84  mgs% MOTION  
 
Poor 
Blood Urea:  34 mgs% Ova: Nil Blood Urea:  34 mgs% Ova: Nil 
Serum Cholesterol: 210 mgs% Cyst: Nil Serum Cholesterol: 210 mgs% Cyst: Nil 
B.P.  110/82mmHg Occult Blood: Nil B.P. 110/82mmHg Blood Occult: Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
 
 
NAME: Rangamal AGE: 50 SEX: Female I.P.NO: 3818 NO.OFDAYS TREATED:7                 DOA:09/11/2012                   DOD:16/11/2012 
DRUG:Madhulai poo chooranam 1gm (bd) OCCUPATION: Coolie 
COMPLAINTS DIAGNOSIS INVESTIGATION BEFORE TREATMENT INVESTIGATION AFTER TREATMENT OBSERVATION 
Constipation , 
pain around the 
anus , bleeding 
from anus , 
tiredness since 7 
days . 
 
 
 
 
KURUTHI 
MOOLAM 
BLOOD BLOOD Bleeding arrested on 
8
th
 day 
No significant 
adverse effects 
TC: 9500  Cells/Cumm URINE TC:  9500   Cells/Cumm URINE 
DC: P:62%    L: 34%E: 4% Alb: Nil DC: P:  62%  L: 36%E: 6% Alb: Nil 
ESR ½hr 25mm   Sug: Nil ESR ½hr   45mm   Sug: Nil 
 1hr  34mm Dep:NAD  1hr    34mm   Dep: NAD 
Hb:  78%  BT:3m20s  CT:4m10s  Hb: 78%   BT: 3m CT:4m  RESPONSE 
Blood Sugar(R):92 mgs% MOTION Blood Sugar(R):92 mgs% MOTION  
 
Poor 
Blood Urea:  30 mgs% Ova: Nil Blood Urea:  30 mgs% Ova: Nil 
Serum Cholesterol: 184 mgs% Cyst: Nil Serum Cholesterol: 184 mgs% Cyst: Nil 
B.P.  120/82mmHg Occult Blood: Nil B.P. 120/80mmHg Blood Occult: Nil 
serum Calcium:8mg% 
Proctoscopy: 
serum Calcium:8mg% 
Proctoscopy: 
  
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 1 OP.NO: 39187 NAME:Mariammal AGE/SEX: 62/F OCCUPATION: Coolie 
FROM: 25/05/2012 TO: 29/06/2012 NO. OF DAYS TREATED: 36 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 54% (8.2gms%) Ova:        - Nil Hb: 67% (9.7gms%) Ova:        - Nil 
MCV:         -90cumm Cyst:        - Nil MCV:       -98cumm Cyst:        - Nil 
PCV:           -28% Occult Blood: -  Nil PCV:         -48% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 2 OP.NO: 41625 NAME: Ayirathammal AGE/SEX: 26/F OCCUPATION: Coolie 
FROM: 04/06/2012 TO: 09/07/2012 NO. OF DAYS TREATED:  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 2 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:  7600 cells/cumm Albumin: Nil TC: 8400 cells/cumm Albumin: Nil 
DC:  P-63%    L-35%      E-2% Sugar: Nil DC:  P-60%    L-37%   E-3% Sugar: Nil 
ESR:  ½ hr: 8mm Deposits: Occ.epithelial cells ESR:  ½ hr: 5mm Deposits: NAD 
          1 hr: 15mm MOTION           1 hr: 10mm MOTION 
Hb: 59% (8.6gms%) Ova:      - Nil Hb: 61% (9.1gms%) Ova:       - Nil 
MCV: 82cumm Cyst:       - Nil MCV:        - 90cumm Cyst:       - Nil 
PCV: 32% Occult Blood:   - Nil PCV:          - 44% Occult Blood: -Nil 
Sugar(R): 101 mgs%  Sugar(R): 96mgs%  
Urea:      -  Urea: 21mgs%  
Cholesterol:  221mgs%  Cholesterol: 210mgs%  
   Response:                                    Poor 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
OUT  - PATIENTS 
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 3 OP.NO: 41946 NAME:Thirumani AGE/SEX: 
39/F 
OCCUPATION: Coolie 
FROM: 05/06/2012 TO: 10/07/2012 NO. OF DAYS TREATED: 35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Dyspnoea on exertion 
• Tiredness 
• Loss of appetite 
Since 3 weeks 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 9700 cells/cumm Albumin: Nil TC: 10200 cells/cumm Albumin: Nil 
DC: P-57%     L-38%     E-5% Sugar: Nil DC:  P-55%      L-40%      E-5% Sugar: Nil 
ESR:  ½ hr: 2mm Deposits: NAD ESR:  ½ hr: 4mm Deposits: NAD 
          1 hr: 4mm MOTION           1 hr: 8mm MOTION 
Hb: 54% (7.7gms%) Ova:        - Nil Hb: 75% (10.7gms%) Ova:        - Nil 
MCV: 90cumm Cyst:        - Nil MCV:       - 96cumm Cyst:        - Nil 
PCV:  35% Occult Blood: - Nil PCV:         - 42% Occult Blood: -Nil 
Sugar(R): 87mgs%  Sugar(R):  92mgs%  
Urea: 25mgs%  Urea: 24mgs%  
Cholesterol: 165mgs%  Cholesterol: 182mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 4 OP.NO: 42447 NAME: Gandhimathi AGE/SEX: 
44/F 
OCCUPATION: coolie 
FROM: 07/06/2012 TO: 12/07/2012 NO. OF DAYS TREATED: 34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Giddiness 
• Dyspnoea on exertion 
• Tiredness 
Since 2 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:  10500 cells/cumm Albumin: Nil TC: 10200 cells/cumm Albumin: Nil 
DC:  P-57%    L-35%      E-8% Sugar: Nil DC:  P-61%    L-35%   E-4% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: NAD ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 20mm MOTION           1 hr: 16mm MOTION 
Hb: 60% (8.7gms%) Ova:      - Nil Hb: 78% (11.1gms%) Ova:       -Nil 
MCV:         -82cumm Cyst:       - Nil MCV:        -90cumm Cyst:       -Nil 
PCV:           -28% Occult Blood: - Nil PCV:          -40% Occult Blood:- Nil 
Sugar(R): 89mgs%  Sugar(R): 102mgs%  
Urea: 12mgs%  Urea: 24mgs%  
Cholesterol:  163mgs%  Cholesterol: 182mgs%  
   Response:                                    Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 5 OP.NO: 44936 NAME:Rajeswari AGE/SEX: 42/F OCCUPATION: House wife 
FROM: 16/06/2012 TO: 21/07/2012 NO. OF DAYS TREATED:36 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Palpitation 
• Giddiness 
• Tiredness 
Since 1 month 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7000 cells/cumm Albumin: Nil TC: 8900 cells/cumm Albumin: Nil 
DC: P-55%     L-40%     E-5% Sugar: Nil DC:  P-55%      L-42%      E-3% Sugar: Nil 
ESR:  ½ hr: 6mm Deposits: NAD ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 12mm MOTION           1 hr: 4mm MOTION 
Hb: 68% (9.7gms%) Ova:        - Nil Hb: 77% (11gms%) Ova:        - Nil 
MCV:        -82cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:          -30% Occult Blood:   - Nil PCV:         -40% Occult Blood:  Nil- 
Sugar(R): 109mgs%  Sugar(R):  88mgs%  
Urea: 27mgs%  Urea: 20mgs%  
Cholesterol: 198mgs%  Cholesterol: 212mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 6 OP.NO: 45948 NAME: Ruby AGE/SEX: 
58/F 
OCCUPATION: House wife 
FROM: 20/06/2012 TO: 25/07/2012 NO. OF DAYS TREATED: 45 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Dyspnoea on exertion 
• Loss of appetite 
• Tiredness 
Since 20days.  
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:  8900 cells/cumm Albumin: Nil TC: 9300 cells/cumm Albumin: Nil 
DC:  P-56%    L-39%      E-5% Sugar: Nil DC:  P-49%    L-50%   E-1% Sugar: Nil 
ESR:  ½ hr: 5mm Deposits: NAD ESR:  ½ hr: 1mm Deposits: NAD 
          1 hr: 10mm MOTION           1 hr: 2mm MOTION 
Hb: 64% (9.1gms%) Ova:      - Nil Hb: 72% (10.3gms%) Ova:       - Nil 
MCV: 88cumm Cyst:       - Nil MCV:        - 96cumm Cyst:       - Nil 
PCV:  30% Occult Blood: -  Nil PCV:          - 40% Occult Blood: - Nil 
Sugar(R): 82mgs%  Sugar(R): 97mgs%  
Urea: 18mgs%  Urea: 22mgs%  
Cholesterol:  146mgs%  Cholesterol: 186mgs%  
   Response:                                    Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 7 OP.NO: 53082 NAME: Subramanian 
 
AGE/SEX: 52/M OCCUPATION: Coolie 
FROM: 13/07/2012 TO: 17/08/2012 NO. OF DAYS TREATED: 35days 
 
 
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Malaise 
• Dyspnoea on exertion 
• Loss of appetite 
Since 8 months 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 8100 cells/cumm Albumin: Nil TC: 8300 cells/cumm Albumin: Nil 
DC: P-61%     L-36%     E-3% Sugar: Nil DC:  P-64%      L-34%      E-2% Sugar: Nil 
ESR:  ½ hr: 1mm Deposits: NAD ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 3mm MOTION           1 hr: 4mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 70% (10gms%) Ova:        - Nil 
MCV:        -87cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:          -32% Occult Blood: - Nil PCV:         -40% Occult Blood: -Nil 
Sugar(R): 111mgs%  Sugar(R):  110mgs%  
Urea: 14mgs%  Urea: 14mgs%  
Cholesterol: 168mgs%  Cholesterol: 150mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 8 OP.NO: 53623 NAME: Esterammal AGE/SEX: 65/F OCCUPATION: House wife 
FROM: 16/07/2012 TO: 20/08/2012 NO. OF DAYS TREATED: 34days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Palpitation 
• Tiredness 
• Loss of appetite 
Since 10 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC:  9800 cells/cumm Albumin: Nil TC: 9700 cells/cumm Albumin: Nil 
DC:  P-63%    L-34%      E-3% Sugar: Nil DC:  P-60%    L-36%   E-4% Sugar: Nil 
ESR:  ½ hr: 2mm Deposits: NAD ESR:  ½ hr: 2mm Deposits: NAD 
          1 hr: 4mm MOTION           1 hr: 3mm MOTION 
Hb: 66% (9.9gms%) Ova:      - Nil Hb: 77% (11gms) Ova:       - Nil 
MCV: 82cumm Cyst:       - Nil MCV: 90cumm Cyst:       - Nil 
PCV:  32    % Occult Blood: - Nil PCV:   40 % Occult Blood: - Nil 
Sugar(R): 80mgs%  Sugar(R): 85mgs%  
Urea: 20mgs%  Urea: 22mgs%  
Cholesterol:  119mgs%  Cholesterol: 108mgs%  
   Response:                                    Fair 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
DRUG:Ayachenduram100mg bd with honey DIAGONOSIS: PAANDU 
S.NO: 9 OP.NO: 53627 NAME: Mariammal AGE/SEX: 46/F OCCUPATION: Coolie 
FROM: 16/07/2012 TO: 20/08/2012 NO. OF DAYS TREATED: 34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
• Dyspnoea on exertion 
• Palpitation 
• Loss of appetite 
Since 2 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 10,000 cells/cumm Albumin: Nil TC: 10,000 cells/cumm Albumin: Nil 
DC: P-63%     L-32%     E-5% Sugar: Nil DC:  P-65%      L-31%      E-4% Sugar: Nil 
ESR:  ½ hr: 7mm Deposits: NAD ESR:  ½ hr: 5mm Deposits: NAD 
          1 hr: 8mm MOTION           1 hr: 6mm MOTION 
Hb: 63% (9.0gms%) Ova:        - Nil Hb: 69% (9.8gms%) Ova:        - Nil 
MCV:        - 74cumm Cyst:        - Nil MCV:       - 75cumm Cyst:        - Nil 
PCV:          -36.8% Occult Blood:    - Nil PCV:         - 40% Occult Blood: - Nil 
Sugar(R): 126mgs%  Sugar(R):  125mgs%  
Urea: 16mgs%  Urea: 8 mgs%  
Cholesterol: 128mgs%  Cholesterol: 128 mgs%  
   Response:            Fair 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 10 OP.NO:54575 NAME:balya AGE/SEX: 
20/F 
OCCUPATION: Coolie 
FROM: 19/07/2012 TO:20/08/2012 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-64%      L-35%      E-1% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus  
cells/cu.mm 
ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -74cumm Cyst:        - Nil MCV:       -80cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:      Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptom 
 
 DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 11 OP.NO: 54576 NAME:Bhuvana AGE/SEX: 25/F OCCUPATION: Coolie 
FROM: 19/07/2012 TO: 21/08/2012 NO. OF DAYS TREATED: 33 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-62%      L-36%      E-2% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -74cumm Cyst:        - Nil MCV:       -76cumm Cyst:        - Nil 
PCV:           -28% Occult Blood: -  Nil PCV:         -42% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 12 OP.NO: 56456 NAME:Rajeshwari AGE/SEX: 20/F OCCUPATION: Coolie 
FROM: 25/07/2012 TO: 28/08/2012 NO. OF DAYS TREATED: 34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-59%     L-38%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 12mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
1 hr: 20mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.5gms%) Ova:        - Nil Hb: 68% (8.7gms%) Ova:        - Nil 
MCV:         -72cumm Cyst:        - Nil MCV:       -80cumm Cyst:        - Nil 
PCV:           -30% Occult Blood: -  Nil PCV:         -36% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Poor 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 13 OP.NO: 60875 NAME:Amala AGE/SEX: 30/F OCCUPATION: Coolie 
FROM: 09/08/2012 TO: 10/09/2012 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-62%      L-36%      E-2% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 7mm Deposits: NAD 
          1 hr: 23mm MOTION 1 hr: 17mm MOTION 
Hb: 52% (7.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -76cumm Cyst:        - Nil MCV:       -89cumm Cyst:        - Nil 
PCV:           -32% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 14 OP.NO: 60874 NAME:Sowmiya AGE/SEX: 32/F OCCUPATION: Coolie 
FROM: 09/08/2012 TO: 13/09/2012 NO. OF DAYS TREATED: 35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-61%      L-38%      E-1% Sugar: Nil 
ESR:  ½ hr: 11mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
1 hr: 24mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.9gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -78cumm Cyst:        - Nil MCV:       -89cumm Cyst:        - Nil 
PCV:           -38% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:        Fair 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 15 OP.NO: 62716 NAME:Deepa AGE/SEX:28/F OCCUPATION: Coolie 
FROM:15/08/2012 TO: 16/09/2012 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-61%      L-37%      E-2% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.5gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -30% Occult Blood: -  Nil PCV:         -42% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 16 OP.NO: 68069 NAME:Pandian AGE/SEX:32/M OCCUPATION: Coolie 
FROM: 03/09/2012 TO: 07/10/2012 NO. OF DAYS TREATED: 34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-62%      L-37%      E-1% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 54% (6.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -38% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
 DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 17 OP.NO: 68801 NAME:Sugumar AGE/SEX: 37/M OCCUPATION: Coolie 
FROM: 05/09/2012 TO: 07/10/2012 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-39%       E-1% Sugar: Nil DC:  P-62%      L-37%      E-1% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 7mm Deposits: NAD 
          1 hr: 23mm MOTION 1 hr: 14mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -82cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -28% Occult Blood: -  Nil PCV:         -39% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 18 OP.NO: 71218 NAME:Jeeva AGE/SEX: 20/M OCCUPATION: Coolie 
FROM: 12/09/2012 TO: 17/10/2012 NO. OF DAYS TREATED:  35days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 58% (7.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -79cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -32% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 19 OP.NO: 75288 NAME:Sindhya AGE/SEX: 20/F OCCUPATION: Coolie 
FROM: 24/09/2012 TO: 26/10/2012 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-59%     L-38%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 12mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
1 hr: 25mm MOTION           1 hr: 15mm MOTION 
Hb: 60% (8.2gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -86cumm Cyst:        - Nil MCV:       -94cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 20 OP.NO:75284 NAME:Chitra AGE/SEX: 20/F OCCUPATION: Coolie 
FROM: 24/09/2012 TO: 30/10/2012 NO. OF DAYS TREATED:36  days  
COMPLAINTS AND DURATION INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.1gms%) Ova:        - Nil Hb: 68% (8.7gms%) Ova:        - Nil 
MCV:         -79cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -32% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Poor 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 21 OP.NO: 76076 NAME:Bhuvana AGE/SEX: 20/F OCCUPATION: Coolie 
FROM: 26/09/2012 TO: 31/10/2012 NO. OF DAYS TREATED: 35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 13mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
1 hr: 26mm MOTION           1 hr: 15mm MOTION 
Hb: 57% (7.3gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -78cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -34% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 22 OP.NO: 76866 NAME:Parvathi AGE/SEX: 22/F OCCUPATION: Coolie 
FROM: 28/09/2012 TO: 30/10/2012 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-62%      L-37%      E-1% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.5gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -78cumm Cyst:        - Nil MCV:       -92cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 23 OP.NO: 77594 NAME:Keerthana AGE/SEX: 40/F OCCUPATION: Coolie 
FROM:01/10/2012 TO: 05/11/2012 NO. OF DAYS TREATED: 36 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 60% (8.1gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -89cumm Cyst:        - Nil 
PCV:           -38% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 24 OP.NO: 77593 NAME:Monika AGE/SEX: 29/F OCCUPATION: Coolie 
FROM:01/10/2012 TO: 06/11/2012 NO. OF DAYS TREATED: 37 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 59% (8.0gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -76cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -40% Occult Blood: -  Nil PCV:         -46% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 25 OP.NO: 80062 NAME:Malarkodi AGE/SEX: 36/F OCCUPATION: Coolie 
FROM: 08/10/2012 TO: 09/11/2012 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 14mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
1 hr: 28mm MOTION           1 hr: 15mm MOTION 
Hb: 54% (6.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 26 OP.NO: 
82374 
NAME:Chitradevi AGE/SEX:22/F OCCUPATION: Coolie 
FROM:  
16/10/12 
TO: 
20/11/12 
NO. OF DAYS TREATED: 35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 12mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 57% (7.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -86cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 27 OP.NO: 
82375 
NAME:Nishana AGE/SEX:20/F OCCUPATION: Coolie 
FROM:  
16/10/12 
TO:  
25/11/12 
NO. OF DAYS TREATED: 40 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 14mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 22mm MOTION           1 hr: 15mm MOTION 
Hb: 60% (8.4gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -90cumm Cyst:        - Nil MCV:       -96cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 28 OP.NO: 
84290 
NAME:Sandhiya AGE/SEX:25/F OCCUPATION: Coolie 
FROM:  
22/10/12 
TO:  
24/11/12 
NO. OF DAYS TREATED: 33 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 59% (7.3gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -78cumm Cyst:        - Nil MCV:       -80cumm Cyst:        - Nil 
PCV:           -32% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 29 OP.NO:  
86377 
NAME:Lakshmi AGE/SEX:28/F OCCUPATION: Coolie 
FROM: 
30/10/12 
TO:  
9/12/12 
NO. OF DAYS TREATED:  40days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-59%     L-38%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 11mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 24mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -78cumm Cyst:        - Nil MCV:       -80cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 30 OP.NO: 86364 
 
NAME:Thendral AGE/SEX: 22/F OCCUPATION: Coolie 
FROM: 30/10/12 TO:1/12/12 NO. OF DAYS TREATED:32  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 55% (6.5gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -84cumm Cyst:        - Nil MCV:       -94cumm Cyst:        - Nil 
PCV:           -30% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 31 IP.NO: 1811 NAME:Veeralakshmi AGE/SEX: 50/F OCCUPATION: Coolie 
FROM: 06/06/12 TO: 10/07/12 NO. OF DAYS TREATED: 34 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-59%     L-37%       E-4% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 62% (8.5gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -78cumm Cyst:        - Nil MCV:       -86cumm Cyst:        - Nil 
PCV:           -32% Occult Blood: -  Nil PCV:         -42% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO:32 IP.NO: 1808 NAME:Vanniyan AGE/SEX: 60/M OCCUPATION: Coolie 
FROM: 06/06/12 TO: 12/07/12 NO. OF DAYS TREATED:36  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 52% (7.0gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -38% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
IN - PATIENTS 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 33 IP.NO: 1835 NAME:Leela AGE/SEX: 50/F OCCUPATION: Coolie 
FROM: 07/06/12 TO: 17/07/12 NO. OF DAYS TREATED: 40 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 13mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 25mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -82cumm Cyst:        - Nil MCV:       -94cumm Cyst:        - Nil 
PCV:           -32% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 34 IP.NO: 1955 NAME:Ponnu AGE/SEX:60/M OCCUPATION: Coolie 
FROM: 18/06/12 TO:23/07/12 NO. OF DAYS TREATED: 35 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 65% (8.9gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -42% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 35 IP.NO: 1977 NAME:Uchimakali AGE/SEX: 50/F OCCUPATION: Coolie 
FROM: 19/06/12 TO: 21/07/12 NO. OF DAYS TREATED: 32 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-61%     L-37%       E-2% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 62% (8.8gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -82cumm Cyst:        - Nil MCV:       -92cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 36 IP.NO: 47349 NAME:Shanmugathai AGE/SEX: 60/F OCCUPATION: Coolie 
FROM: 25/06/12 TO: 04/08/12 NO. OF DAYS TREATED:  40days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-59%     L-38%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -78cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -38% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 37 IP.NO: 2067 NAME:Vanniyaperumal AGE/SEX: 60/M OCCUPATION: Coolie 
FROM: 27/06/12 TO: 03/08/12 NO. OF DAYS TREATED:37  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -42% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 38 IP.NO: 2019 NAME:Kaliyammal AGE/SEX: 55/F OCCUPATION: Coolie 
FROM: 04/07/12 TO:12/08/12 NO. OF DAYS TREATED: 39 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (7.8gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -84cumm Cyst:        - Nil MCV:       -92cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Good 
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
  
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 39 IP.NO: 81174 NAME:Subammal AGE/SEX: 50/F OCCUPATION: Coolie 
FROM:11/10/12 TO: 19/11/12 NO. OF DAYS TREATED: 39 days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 62% (8.8gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -90cumm Cyst:        - Nil 
PCV:           -36% Occult Blood: -  Nil PCV:         -40% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
Cholesterol: 155mgs%  Cholesterol: 155mgs%  
   Response:                                    Fair 
 
DRUG:Ayachenduram 100mg bd with Honey DIAGONOSIS: PAANDU 
S.NO: 40 IP.NO:76077 NAME:Kaliyamma AGE/SEX:50/F OCCUPATION: Coolie 
FROM: 26/09/12 TO: 29/10/12 NO. OF DAYS TREATED:33  days  
COMPLAINTS AND DURATION                                                                               INVESTIGATION 
 
 
• Loss of appetite 
• Dyspnoea on exertion  
• Palpitation 
Since 6 months. 
BEFORE TREATMENT AFTER TREATMENT 
BLOOD URINE BLOOD URINE 
TC: 7600 cells/cumm Albumin: Nil TC: 9200 cells/cumm Albumin: Nil 
DC: P-60%     L-37%       E-3% Sugar: Nil DC:  P-60%      L-37%      E-3% Sugar: Nil 
ESR:  ½ hr: 10mm Deposits: 2-3 pus cells/cu.mm ESR:  ½ hr: 8mm Deposits: NAD 
          1 hr: 23mm MOTION           1 hr: 15mm MOTION 
Hb: 61% (8.7gms%) Ova:        - Nil Hb: 68% (9.7gms%) Ova:        - Nil 
MCV:         -80cumm Cyst:        - Nil MCV:       -92cumm Cyst:        - Nil 
PCV:           -38% Occult Blood: -  Nil PCV:         -44% Occult Blood: - Nil 
Sugar(R): 120mgs%  Sugar(R):  94mgs%  
Urea: 32mgs%  Urea: 20mgs%  
  Response:Fair  
 
+ Mild                        ++ Moderate                  +++ Severe 
Good Response – Significant relief of symptoms   Fair Response – Partial relief of symptoms   Poor response – Insignificant relief of symptoms 
 


















